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Abstract 
Articular cartilage is a highly organised connective tissue lining the ends of 
bones where it acts to provide load support and a low friction bearing surface for 
locomotion. Due to its limited intrinsic healing capacity, cartilage damage frequently 
results in further tissue deterioration, in turn leading to debilitating pain, disability, 
and the development of degenerative joint conditions. Currently available surgical 
interventions for symptomatic cartilage lesions commonly fail to restore the 
physiological structure and function of the tissue, prompting the development of 
alternative repair strategies. As such, functional tissue engineering aims to create 
new cartilage using a combination of cells, biomaterials, and physiological factors. 
Hydrogel biomaterials and bioreactors are a key part of cartilage research and 
tissue engineering applications. Besides providing structural support, the molecular 
and physical clues encoded within the hydrogel matrix regulate chondrogenic 
differentiation and neo-cartilage formation, and allow the investigation of cellular 
behaviour in a controlled microenvironment. The biosynthetic activity of hydrogel-
encapsulated cells can further be promoted using specialised mechanical stimulation 
bioreactors to accelerate or improve tissue growth and maturation. However, despite 
extensive research efforts, the generation of cartilage tissues with mechanical 
functionality remains challenging. To address these shortcomings, this thesis aims to 
advance current tissue engineering approaches by investigating the effects of the 
composition and properties of photocrosslinkable hydrogels and dynamic mechanical 
stimulation on chondrocyte behaviour and neo-cartilage formation. 
In the first part of this thesis, bilayered hydrogel constructs permitting control 
over surface frictional properties were developed and characterised. When sliding 
shear motion was applied, shear strains in constructs with low surface friction were 
minor, inducing chondrogenesis and accumulation of cartilage-specific extracellular 
matrix molecules. Dynamic loading of high friction constructs, on the other hand, 
resulted in excessive shear strains which inhibited chondrogenesis and promoted the 
expression of proteases involved in the pathology of articular cartilage. These 
findings demonstrate that the frictional properties of tissue-engineered cartilage 
constructs may act as a potent regulator of chondrocyte mechanotransduction and 
neo-tissue formation. 
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The progress in advancing our understanding of cartilage pathology and 
regeneration is hampered by a lack of hydrogels with cell-instructive bioactivity. 
Aiming to overcome these limitations, the second part of this thesis comprises a step-
by-step protocol for the synthesis and application of photocrosslinkable hydrogels 
based on gelatin methacryloyl (GelMA). GelMA hydrogels allow for cell attachment, 
proteolytic degradation, and the control of physicochemical characteristics such as 
stiffness and porosity. Serving as a base material, GelMA can further be 
complemented with other chemically functionalised extracellular matrix components 
such as hyaluronic acid methacrylate (HAMA) to promote chondrogenic 
differentiation and neo-cartilage growth.  
 In the third experimental part, a novel shear and compression bioreactor 
system was designed, manufactured, and validated. Controlled by user-friendly 
software, the system facilitates precise displacement-controlled shear and 
compressive stimulation to tissue-engineered cartilage constructs in an oxygen-
controlled environment. While the device primarily functions as a bioreactor that 
mimics the native biomechanical environment of articular cartilage, it is also fitted 
with a 50 Newton load cell to provide real-time force feedback and mechanical 
testing. In short-term experiments, both uni- and biaxial mechanical stimulation 
promoted cartilage marker gene expression of chondrocytes encapsulated in 
hydrogels composed of GelMA and HAMA. Further confirming the efficacy of the 
system, long-term intermittent biaxial stimulation of tissue-engineered cartilage 
constructs significantly enhanced the accumulation of cartilage-specific extracellular 
matrix molecules.  
  The final experimental part of this thesis focused on the development of 
mechanically tough double-network hydrogels for functional cartilage tissue 
engineering prepared from orthogonally crosslinked GelMA and alginate. 
Overcoming the brittleness of conventional hydrogels, these constructs displayed 
superior mechanical properties, recoverable energy dissipation, shape recovery, and 
withstood large magnitudes of compression without failure. Additionally, double-
network hydrogels promoted chondrogenesis and supported the accumulation of high 
quantities of hyaline cartilage-specific extracellular matrix which was further 
enhanced by intermittent biaxial shear and compressive stimulation.  
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In summary, the findings of this thesis demonstrate that (i) response of cartilage cells 
to physiological loading is highly dependent on the hydrogel properties, (ii) 
hydrogels can be engineered to mimic natural extracellular matrices, (iii) mechanical 
stimulation can be used to improve the outcomes of cartilage tissue engineering, and 
(iv) biomaterial-based hydrogels can be engineered to withstand and recover from 
harsh loading conditions whilst retaining cell-instructive bioactivity and 
cytocompatibility. 
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1.1 INTRODUCTION 
Synovial joints are truly remarkable, providing a nearly frictionless bearing 
surface which can withstand the high forces generated by physical activities 
throughout our life-time. While diarthrodial joints are highly complex and their 
performance relies on the interplay of several tissues and cells, proper function of 
articular cartilage is of utmost importance for pain-free and unimpaired skeletal 
movement. However, cartilage is often damaged, and unlike most other tissues in the 
body, almost entirely lacks the intrinsic capacity to heal itself. Although cartilage 
pathology has posed a significant medical burden for thousands of years, until this 
date, there are no effective clinical solutions that can fully restore the physiological 
function of the tissue. In 1993, Langer and Vacanti brought the concept of tissue 
engineering into the focus of the scientific community [1]. This novel paradigm 
involved an interdisciplinary approach to regenerate native tissue composition and 
function using a combination of scaffolding matrices, cells, and bioactive factors. 
Since then, these concepts have been applied increasingly, not only in the effort to 
regenerate diseased tissues, but also to improve in vitro models of cellular function 
and tissue pathogenesis. However, despite major advances in the field, significant 
challenges impeding the clinical translation of research outcomes still exist.  
 
1.2 ARTICULAR CARTILAGE 
Articular cartilage is a highly organized connective tissue lining the end of long 
bones in diarthrodial mammalian joints. Its primary function is to cushion and 
distribute forces, and to provide a nearly frictionless bearing surface for locomotion 
[2]. Articular cartilage is hyaline in nature and the macromolecular composition and 
structure of the extracellular matrix (ECM) is critical to its function. The main 
component of mature human cartilage is water (60-80 % of wet weight), while the 
solid components predominantly consists of collagens (10-20 % of wet weight), 
proteoglycans (10-15_% of wet weight), and minor quantities of glycoproteins and 
lipids (less than 5 % of wet weight) [2-4]. Chondrocytes, the sole cell type within 
cartilage, only account for less than 5 % of tissue volume, but are essential for the 
synthesis and maintenance of the ECM [5]. Cells and the ECM composition and 
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structure are organized in distinct zones which vary throughout the depth of the 
tissue with gradual transition between adjacent zones. 
 
 Biochemical composition 1.2.1
Water 
Water is the main component of articular cartilage accounting for 60-80 % of 
the wet weight. Approximately 30 % of this fluid content is associated with the 
intrafibrillar space of collagens. The remaining 70 % are contained within the pores 
of the ECM, while only a minor fraction is associated with the chondrocytes [2, 6]. 
The interstitial fluid contains inorganic ions and mainly associates with charged 
proteoglycans to forms a gel-like structure [7, 8] which is embedded within the 
collagenous network of the ECM.  
 
Collagens 
Collagens are extracellular matrix proteins which serve a structural role in 
connective tissues throughout the body and also represent the predominant 
component of the solid cartilage matrix. Three α chains composed of repeating 
peptide triplets of glycine-X-Y (X and Y can be any amino acid but are often L-
proline and L-4-hydroxyproline) assemble to form triple-helical supramolecular 
structures [9] providing cartilage with its unique shear and tensile characteristics [2]. 
The ECM of human hyaline cartilage contains at least 8 types of collagen: type II, 
III, VI, IX, X, XI, XII,  and XIV [10]. Collagen type II comprises more than 50 % 
the dry weight of the tissue [11] and over 90 % of the entire collagen content [12]. 
This type of collagen crosslinks covalently with itself, as well as collagens type IX 
and XI to form the fibrillary network of the cartilage ECM [13]. Although the 
functions of collagen IX and XI in this heteropolymer are not fully understood yet, 
these proteins seem to be of crucial importance for the function of cartilage since 
mutations in the corresponding genes result in chondrodysplasia phenotypes that 
feature osteoarthritis (OA) [10]. Type VI collagen was shown to self-assemble into 
disulfide bond- mediated dimers, tetramers and individual networks, and is 
predominantly localized to the pericellular regions surrounding chondrocytes [14], 
but is also distributed loosely throughout the bulk matrix [10]. Collagen type X is 
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located in the calcified region of articular cartilage, the interface between cartilage 
and subchondral bone, and is involved in the endochondral ossification process by 
regulating matrix mineralization and compartmentalizing matrix components [15].  
 
Proteoglycans  
Proteoglycans are large macromolecules comprised of a protein core and 
attached glycosaminoglycan (GAG) chains. In articular cartilage, they represent the 
second-most abundant group of organic ECM macromeres and account for 10-15 % 
of wet weight [2]. Chondroitin and keratan sulphates are the most prevalent GAGs in 
cartilage (Figure 1.1C). These linear carbohydrate polymers of repeating 
disaccharide units contain an amino sugar with at least one negatively charged 
sulphate or carboxylate group [16]. Due to electrostatic repulsion, proteoglycan-
associated GAGs spread away from the core protein in a brush-like manner [17].  
Characteristic for articular cartilage is its high content of aggrecan (Figure 1.1), 
a large proteoglycan monomer forming aggregates with the un-sulfated GAG 
hyaluronic acid (HA). The central core protein of aggrecan has a mass of 
approximately 230 kDa and contains 3 globular domains (G1-3). Over 100 
chondroitin and keratan sulfate chains may be attached to areas between G2 and G3, 
resulting in a molecular mass of up to 2.2 MDa [8, 18]. Stabilized by a link protein 
[19], up to 100 aggrecan molecules bind non-covalently to HA, resulting in 
supramolecular structures of 50-200 MDa [20-22]. Due to their large size, these 
aggregates are immobilized and retained within the collagen network of the cartilage 
ECM [17]. The agglomeration of many proteoglycans into large, negatively charged 
macromolecules is crucial for the functionality of cartilage tissue. Due to the tissue’s 
overall negative charge facilitated by GAGs (known as “fixed charge density”), the 
ECM imbibes fluid from its surroundings, leading to swelling of the tissue [23]. 
Equilibrium is maintained through the elastic restraint of the collagen network which 
balances the swelling pressure [24]. Since it contributes to the tissue’s ability to resist 
high loads under compression, the functionality of healthy cartilage is strongly 
dependent on fluid pressurization provided through the present osmotic environment 
[25]. Additionally, when the tissue is compressed, the negatively charged GAG 
chains of aggrecan molecules become more concentrated, which in turn increases 
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their mutual electrostatic repulsion and further contributes to the compressive 
resistance of cartilage. 
 
Figure 1.1: Structure and composition of aggrecan. (A) Electron micrograph showing proteoglycan 
aggregates from bovine articular cartilage. The aggregates consist of central hyaluronan filaments and 
multiple attached aggrecan molecules (adapted from [5]). (B) Schematic structure of a proteoglycan 
aggregate in articular cartilage. (C) Chemical structure of the repeating disaccharide units in cartilage-
associated GAGs ((B) and (C) from [26]).  
 
Proteoglycan 4 (PRG4), another important glycosylated protein specific to the 
superficial zone of cartilage (originally termed lubricin or superficial zone protein), 
is a 345 kDa molecule which was shown to facilitate boundary lubrication in 
articulating joints, thus contributing to the low friction properties of the cartilage 
surface [27, 28]. PRG4 is secreted by cells of the superficial zone of articular 
cartilage, as well as in the meniscus, tendon, ligaments, and the synovium [29, 30]. 
Besides somatomedin-B- and hemopexin-like domains at the N- and C-terminus, 
mucin-like repeats with extensive O-linked glycosylation have been identified by 
structural analysis [30, 31]. PRG4 and several other splicing variants such as 
lubricin, megakaryocyte stimulating factor, and superficial zone protein are encoded 
by the gene PRG4 [28]. The over-expression of this gene in cartilage protects against 
the development of degenerative joint conditions, further emphasizing its importance 
for the maintenance of cartilage homeostasis [32].   
 
Non-collagenous proteins and glycoproteins 
In addition to collagens and proteoglycans, articular cartilage also contains a 
number of non-collagenous proteins and glycoproteins. Among others, fibronectin, 
thrombospondin, cartilage oligomeric protein, tenascin, matrix-GLA (glycine-
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leucine-alanine) protein, vitronectin, biglycan and chondroalcin have been identified 
in the tissue [33-35]. Although the functions of these proteins in cartilage are not 
fully understood [2], the presence of several of these molecules in the pericellular 
matrix of chondrocytes suggests roles in cell-matrix interactions and collagen 
fibrillogenesis [5, 36].  
 
 Zonal structure  1.2.2
Cartilage exhibits a zonal organization in respect to depth within the tissue, 
varying from the articulating surface down to the subchondral bone (Figure 1.2). 
Typically, the tissue is divided into four zones (superficial/tangential, 
middle/transitional, deep/radial and calcified zone) which can be identified by their 
unique biochemical composition and structure of the ECM, as well as the 
characteristic arrangement and morphology of the cells within the tissue [37, 38] 
(Figure 1.2). Similarly, due to the avascularity of the tissue, oxygen content 
decreases with increasing distance from the articulating surface. The zonal structure 
also results variations of the mechanical properties throughout the thickness of the 
tissue, which are crucial for the ability of cartilage to resist and recover from 
extensive mechanical loading.  
The surface of articular cartilage is covered by an accellular, non-fibrous layer 
with a thickness from hundreds of nanometers to a few micrometers, termed lamina 
splendens [37, 39]. Although the precise role of the lamina splendens is not known, it 
is hypothesized that this very thin layer provides low friction properties and protects 
the cartilage surface from wear and tear [40]. Other hypotheses suggest the formation 
of the lamina splendens due to advancing accumulation of molecules and proteins 
from the synovial fluid, or that it is simply a visual artefact of cartilage microscopy 
[37]. However, different imaging techniques like confocal microscopy, scanning 
electron microscopy or atomic force microscopy have confirmed the presence of the 
lamina splendens in recent studies [41, 42], suggesting that this may not be the case. 
The superficial zone of articular cartilage (upper 10-20 % of the tissue thickness) is 
characterized by having densely packed collagen fibers with a small diameter, which 
are aligned parallel to the surface and provide tensile strength [38, 43]. The 
superficial zone matrix exhibits relatively low proteoglycan content (around 15 % of 
dry weight) as well as low permeability [44]. Total collagen content in this zone 
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typically varies from 80-90 % of the tissue dry weight [44]. The cells in this layer are 
packed densely along collagen fibers in tangential direction and display a flattened 
and discoidal shape [45, 46]. Furthermore, chondrocytes in this zone secrete PRG4: a 
glycosylated protein facilitating low friction and boundary lubrication [29, 47]. Other 
proteins specifically expressed by cells of this region include clusterin [48], 
developmental endothelial locus-1 [49] (Figure 1.2) and pleiotrophin, an embryonic 
growth and differentiation factor. Re-expression of pleiotrophin in mature cartilage 
may be associated with early onset of OA [50].  
 
 
Figure 1.2: Zonal organization in normal articular cartilage. (A) Three-dimensional histology and 
schematic depicting cell and collagen fibril orientation as well as collagen content as % of dry weight 
in the respective zone. Also shown are changes in levels of oxygen (O2), collagen crosslinks 
(lysylpyridinoline (LP), hydroxylysylpyridinoline (HP)), and compressive modulus (HA0) through 
tissue thickness. (B) EPIC micro-CT map of depth-dependent glycosaminoglycans (GAG) distribution 
of human articular cartilage (GAG content as % of dry weight). (C) PRG4 and (D) developmental 
endothelial locus-1 as markers of the superficial zone.  (E) Cartilage intermediate layer protein is 
specific to interterritorial regions of the middle and deep zone, whereas (F) Jagged 1 is highly 
expressed in cells of the middle and deep zones (taken from [38]). 
 
The middle (transitional) zone of cartilage represents 40-60 % of total tissue 
thickness and contains randomly and arcade-like arranged collagen fibers [51]. The 
proteoglycan content peaks in this region (20-25 % of tissue dry weight), but the cell 
density is much lower and the cells appear more spherical [44, 45]. Collagen 
constitutes 60-70 % of the dry weight of this zone [44]. 
Characteristic to the deep (radial) zone of articular cartilage are large bundle- 
forming collagen fibers that are oriented perpendicular to the articulating surface and 
are often anchored in the subchondral bone [44]. In this region, the cell density is the 
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lowest of the three cartilaginous zones [45], and the slightly elongated cells are 
commonly grouped in a columnar organization parallel to the present collagen fibers 
[46]. Specifically expressed zonal proteins include cartilage intermediate layer 
protein [52] and jagged-1 (a notch receptor ligand) [53]. 
In between the deep and the calcified zone of articular cartilage, a thin line 
termed “tidemark” is present [54]. It marks the beginning of the calcified zone, a 
region that transitions into the subchondral bone and minimizes the gradient of 
rigidity between the stiff bone and more flexible cartilage [55]. Typically, among 
other proteins and macromolecules, collagen X expression is usually confined to 
chondrocytes in this zone. 
 
 Matrix regions around chondrocytes 1.2.3
The structure and composition of the cartilage ECM also varies with increasing 
distance from the chondrocytes, from the pericellular, to the territorial and 
interterritorial matrix [56]. The pericellular matrix (PCM) is a narrow region that 
surrounds chondrocytes, and, with the chondrocyte(s) itself, is referred to as a 
chondron. In this structural unit, several laminin subunits, perlecan, nidogen and 
collagen type IV have been localized [57]. Besides the hypothesis that these proteins 
form a functional basement membrane equivalent maintaining cell phenotype and 
viability [58], it is likely that the PCM acts as a transducer of both biomechanical and 
biochemical signals, and protects the chondrocytes from excessive mechanical stress 
[57, 59, 60]. The territorial matrix is a transitional zone mainly composed of fine 
collagen fibrils, forming a basket-like structure around the cells and protecting cells 
from excessive mechanical stresses similar to the PCM [61, 62]. Given the low 
cellularity of articular cartilage, the interterritorial matrix represents the bulk ECM 
and is the predominant contributor to the tissues’ biomechanical properties [63]. As 
discussed earlier, it is mainly composed of collagen fibrils and proteoglycans which 
are organized in zones varying throughout the depth of cartilage. 
 
 Biomechanical function 1.2.4
Articular cartilage is a thin (~1.65 to 2.65 mm for human femoral condyles 
[64]), avascular, and aneural connective tissue providing a smooth, lubricated 
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bearing surface and facilitating the distribution of mechanical loads to the underlying 
subchondral bone. The unique biomechanical functionality relies heavily on the 
biochemical and structural organization in which water, negatively charged 
proteoglycans and collagens interact to provide the tissue with its characteristic 
compressive, tensile and shear properties [7, 8]. The mechanobiology of cartilage can 
be best interpreted when viewed as a biphasic medium consisting of a fluid and a 
solid phase. Water, as the fluid constituent of the tissue, forms a gel-like structure 
with charged proteoglycan aggregates, while the solid phase is represented by the 
porous and permeable ECM. The swelling facilitated by proteoglycans within the 
restraining collagenous ECM leads to fluid pressurization and, in turn, the high 
compressive strength of the tissue [2]. However, the compressive properties alone are 
not sufficient to facilitate the functionality of the tissue. Another important 
characteristic frequently overlooked in tissue engineering applications is its 
viscoelasticity. Viscoelastic materials display properties of both viscous and elastic 
materials, resulting in time-dependent mechanical properties when a constant load or 
deformation is applied [65]. In cartilage, this behaviour stems from two distinct 
mechanisms which can be characterized as flow-dependent and flow-independent. 
Flow-dependent viscoelasticity results from the frictional drag of the interstitial fluid 
against the solid ECM in response to an applied deformation. In more detail, when 
cartilage is loaded, the gel-like fluid redistributes within, or exudes from the porous 
ECM. As the hydraulic permeability of the tissue is very low [66], this results in high 
frictional forces between the flowing interstitial fluid and the solid collagenous 
matrix, in turn leading to high compressive resistance and the typical biphasic 
viscoelastic behaviour [7]. Since the exudation of fluid from the matrix also results in 
the build-up of a thin fluid film between opposing cartilage surfaces during loading, 
this mechanism also provides the tissue with its self-lubricating ability necessary to 
prevent wear-and-tear [2, 67]. The flow-independent viscoelastic properties of 
cartilage, on the other hand, are associated with the motion and rearrangement of 
proteoglycan and collagen macromolecules during loading [68]. Together, these 
mechanisms results in creep and stress-relaxation responses to loading. In particular, 
the deformation of articular cartilage increases over time when a constant 
compressive stress is applied (this behaviour is known as creep) until it reaches an 
equilibrium [69]. Similarly, when a constant compressive strain is applied, 
mechanical stress within the tissue peaks initially, followed by a gradual decrease 
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over time until an equilibrium value is reached [70]. This behaviour is known as 
stress-relaxation and results from the redistribution of interstitial fluid and 
macromolecular rearrangement. Accordingly, compressive loads are initially 
predominantly borne by the fluid phase of articular cartilage. As the fluid exudes the 
tissue and de-pressurizes, the solid ECM begins to bear the load increasingly.  
The tensile and shear properties of articular cartilage mainly result from 
elasticity and arrangement of collagen fibrils in the superficial and middle-zone [2, 
71]. The sliding of opposing cartilages against each other leads to stretching of the 
elastic collagen fibrils in the superficial zone of the tissue providing the great tensile 
strength. Joint articulation also causes shear strain within the tissue which diminishes 
with depth, partially due to the change from the tangential to a more arcade-like 
arrangement of collagen fibers and the resulting increase in shear-modulus from the 
superficial to middle-zone [72].  
Healthy articular cartilage exhibits remarkable coefficients of friction which 
are lower than those of any known synthetic material (~ 0.005 – 0.025) [5, 73, 74]. 
Several mechanisms were proposed to explain the low friction values between 
cartilage surfaces. These include elasto-hydrodynamic lubrication [75], squeeze film 
lubrication provided by synovial fluid [76], boundary lubrication between thin 
molecular films absorbed to the articulating surfaces [77-80], and fluid pressurization 
[67, 81-83]. The relative contribution of these lubrication mechanisms is influenced 
by the normal and tangential forces, as well as relative velocities of the contacting 
surfaces against each other; however, recent findings suggest that fluid pressurization 
is the most influential mechanism [67]. Nevertheless, under load, cartilage interstitial 
fluid de-pressurizes over time and the compressive and frictional forces are 
increasingly supported by the solid parts of the cartilage matrix (e.g. the collagen 
network), and boundary lubrication becomes the dominant mechanism of lubrication 
[81, 84, 85]. Boundary lubrication is mediated by lubricant molecules including 
PRG4, HA, and surface-active phospholipids [86-88]. The lubrication provided by 
cartilage surface interactions may be intrinsically linked to cartilage function and 
homeostasis. Inadequate lubrication is likely to play a key role in cartilage wear and 
the development of degenerative diseases such as OA [89, 90]. As osteoarthritic 
changes progress, solid-to-solid contact increases and may lead to abnormal shear 
and compressive forces within the tissue. However, surprisingly few studies have 
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investigated the consequences of changes in friction on the metabolic phenotype of 
chondrocytes and its role in tissue engineering and cartilage pathology [89-91], 
potentially due to the lack of suitable model systems.  
 
 Articular chondrocytes 1.2.5
In comparison to other tissues, articular cartilage is only populated sparsely by 
cells. Chondrocytes account for only 1-10 % of cartilage tissue volume [5, 92] and 3-
5 % of the wet weight [93]. These highly specialized cells differentiate from 
mesenchymal progenitors [94] and share mutual gene and protein expression 
profiles, surface markers, and cell metabolism. Nevertheless, differences exist in 
genetic, synthetic, and mechanical traits with respect to the zone of cell origin 
(Figure 1.1) [95-98]. Occurring isolated or in small groups, chondrocytes are 
responsible for the restricted matrix remodelling within the tissue. However, recent 
studies suggest that the collagen network of the ECM represents a permanent 
structure after skeletal maturation without significant remodelling in both healthy 
and diseased cartilage, which may be related to the poor intrinsic repair capacity of 
the tissue [99]. Other components such as aggrecan were shown to be remodelled 
with a half-life of approximately 3.4 years in humans, and 8-300 days in rabbits [100, 
101]. As cartilage is avascular, chondrocytes are strongly dependent on obtaining 
nutrients by diffusion from the synovial fluid, which may also be related to their 
limited matrix remodelling capacity [102].  
Chondrocytes are a significant challenge as a cell source for tissue engineering 
applications. Due to the low cell density in articular cartilage, it is frequently 
necessary to increase the number of cells in vitro to obtain sufficient cells for tissue 
culture approaches. However, chondrocytes lose their phenotype during expansion in 
monolayer culture, a process termed de-differentiation [103, 104]. De-differentiation 
is typically accompanied by a change from a spherical to a fibroblast-like cell 
morphology following integrin-mediated adhesion on tissue culture-treated plastic, 
leading to increased expression of the mechanically inferior collagen I [105]. 
Additionally, chondrocytes in expansion culture increasingly lose their ability to 
express phenotypic markers such as collagen type II and aggrecan [106]. 
Nevertheless, this process can be reversed by cultivation in a 3D environment with 
cell-instructive bioactivity [107], growth factor supplementation (e.g. transforming 
 Chapter 1: Introduction and literature review 32 
growth factor beta 3, or TGF-ß3), and application of other physiological stimuli such 
as mechanical loading.  
 
 Mechanical stimulation 1.2.6
Articular cartilage is a mechanosensitive tissue that can respond either 
favourably or unfavourably to biomechanical stimuli. The application of mechanical 
stimuli such as stress, strain, and pressurization can affect phenotypic expressions of 
chondrocytes through a phenomenon termed mechanotransduction, a process by 
which cells convert physical forces into chemical signals. As the chondrocytes are 
isolated individually, interactions with the environment are limited to extracellular 
matrix/cell interactions. Therefore, mechanical stimulation facilitated by joint 
movement represents an important signalling factor in cartilage development [108], 
chondrocyte homeostasis [109], matrix-protein biosynthesis and deposition [110], 
maintenance of cartilage volume [111], and matrix-metalloproteinase (MMP)-
induced matrix degradation [112]. On the other hand, altered load distribution is 
believed to be a crucial risk factor for the development of OA [113]. Changes in 
biomechanics following joint injury not only lead to possible cartilage lesions [114, 
115], but also to excessive compressive loads or loading rates transmitted to 
chondrocytes which may cause a shift towards increased catabolism [116, 117], 
secretion of pro-inflammatory factors, and even chondrocyte death [118-120].  
 
 Cartilage defects and osteoarthritis 1.2.7
Cartilage lesions 
Cartilage lesions are typically classified as micro-fissures, chondral or 
osteochondral cartilage defects. Micro-fissures usually do not immediately cause 
visible changes to the tissue matrix [37]. Nevertheless, the damage to the collagen 
network frequently initiates loss of GAGs and PRG4 [121, 122], thus leading to 
changes in the biomechanical properties of the cartilage ECM and increased surface 
friction [31]. Since the tissue is aneural, even repeated loading of microfractured 
cartilage can continue without pain, frequently leading to further degeneration [123].  
Chondral defects do not extend to the subchondral bone. Often, this type of 
defect arises from prior cartilage micro-fissures, or proceeds from trauma and 
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excessive impact loading [37]. Moreover, as intrinsic repair mechanisms are 
insufficient to restore adequate structure and function of articular cartilage, these 
partial-thickness fissures eventually lead to the development of osteochondral defects 
[123]. 
Osteochondral defects are lesions that traverse cartilage, the tidemark and 
penetrate the subchondral bone [124]. Although progenitor cells and growth factors 
can enter from the vasculature of the underlying bone, the resulting repair tissue, a 
mixture of fibro- and articular cartilage, exhibits inferior functionality [125], thereby 
leading to progressive degeneration into OA.   
 
Osteoarthritis 
Worldwide, OA poses a significant medical burden with heavy impacts on the 
patient’s quality of life. OA impairs mobility, causes severe pain and high levels of 
psychological distress. In Australia alone, approximately 8 % of the total population 
(1.8 million), and nearly 40 % of females and 18 % of males over the age of 65 
suffer from OA, leading to costs of $1.6 billion (AUD) in 2008-09 [126]. Although 
some biological agents may delay the advancement of OA, there is currently no 
treatment that can fully restore the affected tissues, frequently rendering joint 
replacements unavoidable [127]. In Australia, 40,255 knee replacement and 25,169 
hip replacement surgeries were performed between 2013 and 2014, and the rate of 
joint replacements per capita increased by 54 % for knees and 20 % in hips compared 
to the years 2002 and 2003 [126]. 
Clinically, OA is divided into two subtypes: primary (no known causes) and 
secondary OA (identifiable causes) [37]. The bulk of secondary OA is ascribed to 
traumatic joint injury, which may have occurred years before the actual onset or 
diagnosis [128, 129]. Anterior cruciate ligament injury, for example, causes 
immediate changes in biomechanics [130, 131], which may lead to a breakdown of 
the cartilage lubrication system provided by PRG4, surface fibrillation, and changes 
to the bulk matrix [122, 132, 133]. This is accompanied with increasing friction and 
excessive compressive and shear forces transmitted to chondrocytes, ultimately 
eventuating in OA when left untreated [134]. These findings clearly suggest a 
correlation between a change of biomechanical properties following injury and the 
development of OA; however, the exact mechanisms are yet to be elucidated.  
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OA is a chronic disease that leads to slow degradation of articular cartilage and 
pathological changes to the synovium as well as other connective tissues in the joint 
[135]. Symptoms attributed to OA involve debilitating pain in affected joints and 
impaired mobility [136]. Commonly, OA results from a shift of the metabolic 
homeostasis within the tissue to increased activity of proteases (e.g. MMP-2, -3, -9, -
13) opposed to anabolic activity (e.g., collagen type II, aggrecan, PRG4) of 
chondrocytes or other cell types such as synovial cells [137]. Additionally, 
chondrocytes near the eroding region of OA cartilage were shown to have an 
increased cell apoptosis rate, further limiting the repair capacity of the diseased tissue 
[138].  
 
 
Figure 1.3: Progression of OA and total knee replacement. (A) Healthy articular cartilage is white 
and glossy. However, due to traumatic injury or aging, cartilage may degrade and develop OA. [139]  
(B) Advanced OA with severely degraded cartilage (dotted ellipse showing the predominantly 
affected region of knee) (C) Osteoarthritic joints are frequently replaced with a prosthesis to restore 
function and reduce pain (shown here: total knee replacement) ((B) and (C) are taken from [140]).  
  
With the advancement of OA, pro-inflammatory cytokines including 
interleukin-1 and -6 (IL-1, IL-6), as well as tumour necrosis factor- α (TNF-α) cause 
an up-regulation of catabolic pathways in chondrocytes [135]. These cytokines play a 
key role in OA through activation of matrix-degrading aggrecanases (“A Disintegrin 
and Metalloproteinase with Thrombospondin motifs”, or ADAMTS) and MMPs, as 
well as nitric oxide signalling pathways [141]. The counter-activity of TIMPs (tissue 
inhibitors of metalloproteinases) fails to increase to the same extent, resulting in a net 
increase in catabolic activity in the diseased tissue [142]. Additionally, these 
cytokines impair tissue repair mechanisms through inhibition of proteoglycan 
synthesis and inducing chondrocyte apoptosis [143]. Expression of proteins 
including collagen type I and X was observed in the early development of OA. The 
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secretion of these proteins indicates de-differentiation and hypertrophy of OA-
chondrocytes [144, 145].  
While the progression of OA has been long-recognised to be due largely to the 
limited intrinsic repair capacity of articular cartilage, it remains unclear what initiates 
OA. Mechanical stress is believed to be one of the main risk factors and driving 
pathogenic forces for OA and has been identified as a significant inducer of catabolic 
and inflammatory events in articular cartilage [146, 147]. To help in understanding 
the mechanisms of early OA, versatile models are needed that integrate mechanical 
and biological features of articular cartilage. While animal models have been 
extensively utilised for OA related investigations, this is both financially and 
ethically challenging. Alternatively, hydrogel systems have been widely used as 
ECM models for in vitro chondrocyte culture and offer the ability to independently 
tailor the mechanical and biological properties of the matrix. Therefore, hydrogels 
have the potential to improve our understanding of chondrocyte biology and cartilage 
pathology. 
 
1.3 CLINICAL CARTILAGE REPAIR TECHNIQUES 
Chondral and osteochondral lesion commonly lead to the development of OA. 
Due to the limited intrinsic repair capacity, affected joints frequently need to be 
replaced by prosthesis in order to restore function and reduce pain. However, early 
intervention using surgical and tissue engineering approaches is suggested to 
minimize or delay joint degeneration following traumatic cartilage injury. In this 
section, the most commonly administered cartilage repair techniques (Figure 1.4) are 
reviewed with a particular emphasis on short- and long-term clinical outcomes. 
 
 Microfracture surgery 1.3.1
Microfracture surgery is a common bone marrow stimulation technique which 
is currently regarded as the gold-standard of cartilage lesion repair. The technique 
involves creation of 3–4 mm deep channels that penetrate the subchondral bone at a 
cartilage defect site (Figure 1.4C), allowing mesenchymal stem cell migration from 
the bone marrow in to the lesion [127]. However, microfracture surgery frequently 
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results in the deposition of mechanically inferior repair tissue rich in collagen I 
(fibrocartilage) [148] which typically deteriorates within 18-24 months after surgery 
[149]. The penetration of the subchondral bone also leads to the development of 
intralesional osteophytes in 20-50 % of cases [149]. Although microfracture surgery 
may provide short-term relief and delay the advancement of joint deterioration, in 
most cases, failure of the repair tissue can be expected after more than 5 years past 
surgery, regardless of the initial defect size [150, 151]. 
 
Figure 1.4: Cartilage regeneration techniques. (A) A full-thickness focal chondral lesion. (B) The 
lesion is debrided to ensure healthy, stable margins for integration of the host tissue with the 
neotissue. (C)  Microfracture: Channels are created using a 45° awl, spaced 3–4 mm apart, and 3–
4_mm deep to penetrate the subchondral bone, allowing MSCs to migrate from the marrow to the 
cartilage defect. (D) ACI. The debrided lesion is filled with 12–48 million autologous chondrocytes 
and covered with a periosteal flap or mixed collagen type I and type III membrane. (E) MACI. The 
autologous chondrocyte population is expanded in vitro and then seeded for 3 days onto an absorbable 
3D (collagen types I and III or hyaluronic acid) matrix prior to implantation. The cell-seeded scaffold 
is then secured into the lesion with fibrin glue. Abbreviations: ACI, autologous chondrocyte 
implantation; MACI, matrix-assisted autologous chondrocyte implantation; MSC, mesenchymal stem 
cell (figure taken from [127]). 
 
 Autologous chondrocyte implantation (ACI) 1.3.2
In contrast to microfracture, this scaffold-free tissue-engineering technique 
requires two individual operations; one to retrieve a full-thickness cartilage biopsy 
from an unloaded region of the joint, and a second to re-implant expanded 
chondrocytes into the defect site. After the first, arthroscopic operation, autologous 
chondrocytes are isolated from the tissue biopsy using cell-preserving enzymatic 
degradation techniques, and expanded in vitro until sufficient cell numbers are 
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obtained (typically 12-48 million cells). During the second surgery, expanded cells 
are implanted into the defect site, and covered by a membrane to ensure their 
retention. Clinical trials indicate mostly positive, but variable functional outcomes 
for ACI procedures [152], in some cases even 10 years after surgical intervention 
[153]. However, it remains controversial whether outcomes of ACI are superior to 
other surgical treatments and additional long-term trials on a larger scale are 
necessary to make this point conclusive [127]. Benefits of this technique lie in the 
use of autologous cells and the associated reduced risk of an immunogenic response, 
as well as the only minor donor-site morbidity observed due to the small size of 
required biopsies [154, 155]. However, the need for two operations, lengthy and 
expensive in vitro cell expansion under Good Manufacturing Practice (GMP) 
conditions, long recovery times of 6-12 months post-surgery, as well as the 
variability of functional and clinical outcomes represent major drawbacks of this 
technique, rendering microfracture surgery far more common than ACI procedures 
[127].    
 
 Matrix-assisted autologous chondrocyte implantation (MACI) 1.3.3
ACI is a scaffold-free tissue engineering technique involving tissue culture-
expanded chondrocytes. Since these cells de-differentiate under such culture 
conditions (see 1.2.5), the biochemical composition of the resulting repair tissue 
varies from native hyaline cartilage and may partially account for the large 
variability of patient outcomes [127]. Hence, the second generation of ACI has 
focused on the use of 3D scaffolds aiming to improve the chondrogenic re-
differentiation of expanded cells to result in engineered tissues with more hyaline-
like ECM. Most commonly used matrices are derived from porcine collagen 
(predominantly type I or III) or are based on HA. The use of matrices in ACI is 
commonly referred to as matrix-induced ACI, or short, MACI. Similar to the 
traditional ACI, these scaffold-based approaches require a tissue biopsy and in vitro 
cell expansion, but differ in the way the cells are implanted into the defect site. In 
MACI and HA-based procedures, expanded chondrocytes are seeded onto the freeze-
dried matrices, typically three days prior to implantation [127]. Although some trials 
suggested good clinical and histological outcomes indicating a more hyaline-like 
tissue composition when freeze-dried collagen matrices were used [156, 157], the 
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functional outcomes are similar or only slightly better to those of traditional ACI and 
microfracture [158]. For HA-based approaches, more hyaline-like cartilage 
production, as well as improved function and patient quality of life was reported 3 
years after implantation [159], leading to better clinical outcomes compared to 
microfracture [127].  
 
1.4 CHONDROCYTE CULTURE AND FUNCTIONAL CARTILAGE TISSUE 
ENGINEERING 
Clinical studies suggest that the functional outcomes of MACI procedures are 
similar to those of ACI [127, 158, 160]. This may be related to the short pre-culture 
period of only a few days before implantation and, thus, the immaturity and 
vulnerability of MACI neotissues [127]. Additionally, the long recovery times after 
MACI procedures not only cause discomfort and inconvenience to patients, but also 
lead to high medical costs. Thus, the development of novel strategies involving 
extended in vitro pre-culture periods with the application of physiological stimuli 
may improve clinical outcomes in future. In such approaches, isolated autologous 
cells produce ECM in vitro, leading to biological implants with superior biochemical 
composition and mechanical functionality [161-163]. Additionally, these ex vivo 
tissue constructs can also be utilised to study chondrocyte biology as they mimic the 
native tissue environment superior to traditional cell culture approaches [164].  
 
 Hydrogels for chondrocyte culture 1.4.1
Hydrogels are highly hydrated, crosslinked polymer networks which, in many 
ways, are very similar to native tissues. A wide variety of synthetic and natural 
hydrogels are utilised for the in vitro cultivation of chondrocytes [165-168]. 
Advantages of these culture systems include the highly controllable 3D environment 
with tuneable material properties such as stiffness, friction and cell-matrix 
interactions [107]. Therefore, individual characteristics can be modified to model the 
native cartilage environment in healthy and pathological conditions. Contrary to 
investigations in animal models or cartilage explants, these materials represent a 
highly reproducible and cost-effective method to study chondrocyte metabolism and 
pathology in vitro. 
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During monolayer-expansion, chondrocyte de-differentiate is evidenced by the 
loss of their chondrogenic properties. The re-differentiation requires culture of 
expanded cells in 3D matrices such as hydrogels. Hydrogel materials include a wide 
variety of natural and synthetic polymers and allow the incorporation of bioactive 
molecules such as collagen [169] or HA [170] in order to stimulate chondrogenic re-
differentiation [171]. Besides synthetic polymers such as poly (ethylene) glycol 
diacrylate (PEG) or poly(lactide-co-glycolide), natural hydrogels like agarose, 
alginate, or gelatin constitute a well-established material platform for cartilage 
models or tissue engineering purposes [135, 172-174]. Similar to the native cartilage 
ECM, the interconnected network of these hydrogels attracts and retains water, 
allowing nutrients and waste-products to diffuse through the constructs. Since they 
form a continuous matrix similar to the ECM of cartilage, mechanical forces applied 
by specialized bioreactors are transmitted to embedded chondrocytes, allowing for 
investigation related to mechanotransduction.  
Stable hydrogels can be fabricated by various forms of polymer crosslinking. 
Traditionally, physically crosslinked hydrogels such as alginate and agarose were 
applied for chondrocyte culture [165, 175]. In the year 2000, Elisseeff et al. 
introduced photocrosslinkable hydrogels as culture systems for chondrocytes [176], 
which, since then, have gained increasing attention in cell culture and tissue 
engineering applications. Such systems rely on the photo-initiated radical 
polymerization of unsaturated vinyl groups to form continuous hydrogel matrices 
under gentle, cell-compatible conditions, and allow for superior control over 
hydrogel physicochemical properties compared to traditional approaches [177].  
 
 Functional tissue engineering 1.4.2
Tissue engineering aims to repair or regenerate tissues and organs by 
combining cells, scaffolds, biological factors and environmental stimuli. Although 
major advances in the past decade led to the clinical translation of several tissue-
engineered or cell-based products [127, 178], the regeneration of tissues which 
predominantly serve a biomechanical function remains a major clinical challenge. 
Seeking to improve these outcomes, Butler et al. introduced the principles of 
‘functional tissue engineering’ in 2000 which aim to guide research efforts towards 
the development of neotissue constructs with improved biomechanical functionality 
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[179]. These guidelines outlined the importance of (i) understanding the native 
tissues’ physiological biomechanical environment to (ii) establish mechanical sub-
failure and failure criteria, (iii) the selection and prioritization of a subset of these 
criteria crucial for the tissue’s functionality, and (iv) the establishment of quantitative 
standards to better assess tissue engineering outcomes based on these criteria [179]. 
Furthermore, the authors emphasized that (v) engineering cell-ECM interactions to 
guide cellular mechanotransduction, and (vi) the preconditioning of tissue-
engineered constructs by application of physiological mechanical stimuli prior to 
implantation may enhance the mechanical functionality of the neotissue, in turn 
leading to better long-term outcomes [179]. In this endeavour, many strategies have 
been trialled to generate cartilage tissue constructs with improved biomechanical 
functionality.  
Generally, these can be differentiated between scaffold-free [180, 181] and 
scaffold-based approaches [182]. Scaffold-free cartilage tissue engineering 
frequently aims to generate tissues by mimicking developmental processes and 
include techniques such as cell-aggregation (pellet cultures) and self-assembly 
processes [183]. While these techniques can succeed in inducing a chondrogenic 
phenotype of expanded cells and result in the production of microtissues with 
hyaline-like biochemical composition [184], major drawbacks are the requirement of 
high cell numbers, limited constructs sizes due to poor diffusion properties, as well 
as the lack of control over construct shapes and, in particular, inadequate mechanical 
properties of generated neotissues [183]. In contrast, scaffold-based approaches 
commonly utilise thermoplastic polymers such as poly(ε-caprolactone) (PCL) [185], 
L-polylactic acid (PLA), poly(D, L-lactic-co-glycolic acid) (PLGA), or their co-
polymers [186], which can be 3D-printed with precise control over architecture and 
porosity [187-189]. Such materials are biodegradable and possess high mechanical 
strength, but they frequently lead to inflammatory degradation products in vivo [189], 
lack cell-instructive biological activity [189], are not viscoelastic, and often allow 
attachment and spreading of cells similar to tissue culture plastics, hence leading to 
de-differentiation the production of fibrocartilage.  
Hydrogels, on the other hand, allow encapsulation of cells under gentle 
conditions, possess tuneable mechanical properties, are biocompatible, and allow for 
high water contents similar to native tissues. They can also be 3D-printed into 
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complex shapes, have viscoelastic properties, possess cell-instructive bioactivity to 
guide chondrogenic differentiation, and allow for accumulation of relevant amounts 
of newly formed ECM with hyaline-like composition. However, a major drawback of 
hydrogels is their high brittleness and inadequate toughness, severely limiting their 
mechanical functionality in cartilage tissue engineering applications. Nevertheless, 
these limitations are currently being addressed as evidenced by the recent 
development of tough hydrogel-based constructs. These strategies include simply 
increasing polymer concentrations and crosslinking densities [190], reinforcement 
with 3D-printed microfibres [163], or the development of sliding-ring hydrogels 
[191], nanocomposite hydrogels [192], and double-network hydrogels [193]. For 
example, reinforcement of gelatin methacryloyl (GelMA)-based hydrogels greatly 
enhances their stiffness and viscoelastic properties under low compressive strains 
whilst retaining bioactivity, as well as cyto- and biocompatibility; however, these 
constructs remain brittle and cannot sustain high compressive strains without failure 
[163]. Synthetic double-network hydrogels, on the other hand, exhibit high 
mechanical strength and capability to resist and recover from large deformations and 
stresses, suggesting their usefulness as scaffolds for tissue engineering of 
mechanically functional cartilage. Yet, they often involve toxic chemicals and 
lengthy fabrication processes which severely limits their cytocompatibility. 
Accordingly, their suitability for cell encapsulation, direction of tissue-specific cell 
differentiation, ECM accumulation, as well as enzymatic degradation remains largely 
unexplored [194]. Only a few instances of cell-laden double-network gels have been 
reported [195-198]; however, most of these studies only demonstrated short-term 
cytocompatibility, while a functional assessment of neotissue formation and 
mechanical properties has rarely been performed.  
 
 Mechanical stimulation bioreactors 1.4.3
The mechanical environment is of crucial importance for cartilage homeostasis 
in vivo. Moderate loading is suggested to induce ECM production and turnover [110, 
112], while excessive mechanical stresses may cause a shift of chondrocyte 
homeostasis towards increased catabolism and lead to the development of OA [113]. 
Since one of the challenges in cartilage tissue engineering is the generation of 
mechanically functional constructs, in vitro mechanical pre-conditioning using 
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specialised bioreactors has been suggested to increase the biosynthetic activity of 
chondrogenic cells and improve or accelerate construct maturation [59].  
Bioreactors are defined as devices in which biological or biochemical 
processes are carried out under monitored and controlled environmental conditions 
such as pH, oxygen tension, temperature, nutrient supply, waste removal, or 
mechanical stimuli [199]. Systems commonly used for studies on chondrocyte 
biology and cartilage tissue engineering include devices facilitating compressive 
loading [38, 200], hydrostatic pressure [201], shear loading [202], and hybrid 
bioreactors incorporating multiple loading regimes [203-207]. Earlier studies 
demonstrated that moderate mechanical stimulation can improve the biosynthesis of 
hydrogel-encapsulated chondrocytes, forming tissues with enhanced mechanical and 
biomechanical properties [110, 205, 207-211]. However, due to the different 
properties of scaffolds or hydrogels and cell sources, loading regimes need to be 
optimised to identify suitable culture conditions for each individual system. It is 
generally accepted that static compression inhibits matrix synthesis, while 
intermittently applied dynamic loading conditions favour chondrocyte biosynthesis 
[212]. Chondrocytes also react sensitively to the loading frequency [213], magnitude 
of force or strain applied [213], as well as static pre-culture and loading durations 
[60]. In addition, tissue-engineered constructs at different stages of development may 
benefit from different mechanical loading regimes. Apart from applications in tissue 
engineering, bioreactors can also serve as valuable in vitro models to study the 
pathophysiological effects of mechanical forces on cells and developing tissues, or to 
predict the cellular behaviour in tissue-engineered constructs following surgical 
implantation.  
 
1.5 KNOWLEDGE GAPS AND HYPOTHESES  
For functional cartilage tissue engineering applications, cell-laden hydrogel 
scaffolds must be able to withstand the harsh loading conditions of synovial joints 
whilst maintaining chondrogenic bioactivity and supporting the accumulation of a 
hyaline-like ECM. While recent advancements led to the development of tough 
hydrogels and hydrogel-composites, a functional assessment of neotissue formation, 
mechanical properties, and the factors influencing chondrocyte response to loading in 
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such systems are yet to be elucidated. In particular, the role of the hydrogel frictional 
properties on chondrocyte response to loading remains unclear, although evidence 
suggests that a change of surface friction may be involved in the pathogenesis of 
articular cartilage in vivo. Accordingly, achieving low frictional properties of tissue-
engineered constructs may be similarly important in order to avoid implant failure 
and progression of joint degeneration. To study such factors in vitro, bioreactors 
capable of replicating the biomechanical environment of articular cartilage are 
necessary. Yet, only very few instances of such devices were reported in the 
literature, and there are currently no commercial bioreactors available which can 
replicate the shear and compressive stimulation cartilage experiences during normal 
joint loading.  
The central hypothesis of this thesis was that hydrogels and bioreactors can be 
engineered to allow the investigation of physicochemical and biological factors 
influencing cellular response to loading, with the ultimate aim of improving the 
functionality of tissue-engineered cartilage constructs. In particular, we hypothesized 
that hydrogel surface friction is a crucial factor governing chondrocyte response to 
loading, and that hydrogels with low surface friction similar to healthy cartilage may 
improve neotissue formation under such conditions. We further hypothesized that 
biaxial mechanical stimulation can be utilised to study chondrocyte 
mechanotransduction and improve the biochemical properties of tissue-engineered 
constructs. Lastly, we hypothesized that hydrogels can be engineered to withstand 
harsh loading conditions while facilitating chondrogenesis and ECM accumulation, 
and that biaxial loading may further improve the biological and mechanical 
functionality of such constructs.  
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1.6 AIMS 
To address these hypotheses, the aims of this thesis were: 
(i) The development and application of a hydrogel-based model to 
investigate the effects of variations in surface friction on the 
biological behaviour of human chondrocytes in response to shear 
loading  
(ii) The development of novel cell culture platforms based on hydrogel 
biomaterials with inherent cell-instructive bioactivity 
(iii) The development and validation of a novel shear and compression 
bioreactor system for cartilage research and tissue engineering 
applications 
(iv) The development and in vitro evaluation of tough double-network 
hydrogels for functional cartilage tissue engineering using 
biomimetic mechanical stimulation techniques 
 
1.7 THESIS OVERVIEW 
Chapters 2 to 5 contain the experimental contributions addressing the 
hypotheses and aims. In Chapter 2, a novel hydrogel model which allows control of 
surface friction without influencing the microenvironment of encapsulated cells was 
developed. The model was applied to study the biological response of chondrocytes 
to shear loading following changes to surface friction. The results of this study 
highlight the importance of low frictional properties of tissue-engineered and native 
cartilage on chondrocyte behaviour. Chapter 3 comprises a protocol for the 
synthesis and application of hydrogels based on GelMA as versatile 3D cell culture 
platforms. Since GelMA is derived from native ECMs, these highly adaptable 
hydrogels can be used to study cellular physiology in a more relevant manner than 
traditional monolayer cultures. To improve our capabilities of replicating the 
biomechanical environment of synovial joints in vitro, a new shear and compression 
bioreactor was developed in Chapter 4. The efficacy of the device was investigated 
in a validation study which demonstrated significant improvements in the maturation 
of tissue-engineered cartilage constructs when intermittent biaxial stimulation was 
 Chapter 1: Introduction and literature review 45 
applied. In Chapter 5, a double-network hydrogel system was developed and applied 
as a scaffold for tissue engineering. Mechanical analysis of the system indicated 
improved toughness and recoverable energy dissipation, while a biochemical 
assessment outlined chondrogenesis of encapsulated cells and hyaline-like ECM 
accumulation, which could further be improved by intermittent biaxial stimulation. 
Finally, the findings and significance of this thesis are discussed in Chapter 6. 
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2.1 INTRODUCTION 
Hydrogels are highly-hydrated three-dimensional (3D) matrices formed of 
crosslinked polymeric networks which show promise in a variety of biomedical 
applications including medical devices, drug delivery, and as scaffolds for tissue 
engineering and regenerative medicine [214]. Hydrogels allow for cell encapsulation 
with high viability [215], can be readily tuned to mimic key features of the native 
extracellular matrix (ECM) [140, 164], permit control of mechanical and 
physicochemical properties [216], and facilitate physiological cell differentiation and 
function [161]. Additionally, their surface friction can be tailored by manipulating 
the gel’s chemical structure, hydrophilicity, crosslinking density, water content, 
elasticity, or charge density [217]. As such, they offer key advantages over 
traditional, two-dimensional cell culture methods which frequently fail to adequately 
mimic the extracellular microenvironment associated with physiological tissue and 
disease-associated processes [218]. As a result, the use of hydrogels as engineered 
microenvironments to study cellular behaviour in a more physiologically relevant 
manner has been increasing steadily [219]. Previous studies using hydrogels as ECM 
mimics emphasized the role of the structural and mechanical properties of the 
cellular microenvironment, in particular ECM stiffness, which has been shown to 
affect cell motility [220], stem cell differentiation [221-223], tumour progression 
[224], cellular reprogramming [225], and other biological phenomena. However, it 
remains largely unclear how these and other physicochemical ECM properties 
impact cellular behaviour when the tissue is loaded mechanically. 
Most mammalian cell types including chondrocytes, the cells within cartilage, 
respond to mechanical stimuli through mechanotransduction - a process by which 
cells convert physical forces to biochemical signals [226]. While mechanical stress 
within a certain, physiological range induces anabolic processes and thus contributes 
to cartilage ECM maintenance and remodelling [110, 112], excessive stress is 
considered to be a main driving factor for catabolic processes initiating joint 
pathology and degeneration in diseases such as osteoarthritis (OA) [227, 228]. To 
prevent excessive tissue strains during joint ambulation, healthy synovial joints 
exhibit remarkably effective lubrication [67, 75, 76, 229, 230] leading to a 
coefficient of friction (COF) as low as 0.001 – 0.025 for cartilage-on-cartilage – a 
value lower than any other known bearing [231-234]. Given these extremely low 
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COFs, shear strains resulting from normal joint articulation are minor and may have 
a rather protective function on cartilage homeostasis, inducing extracellular matrix 
production and turnover [202, 209]. Acute injury, changes in biomechanics, or 
inflammatory events, however, result in a reduced lubricating function and increased 
frictional forces between articulating surfaces [89, 90, 235, 236]. This may in turn be 
involved in the initiation of posttraumatic cartilage degeneration by increasing the 
magnitude of loading-induced tissue strain beyond a physiological level. 
Nevertheless, although earlier studies suggested an increase in shear strain following 
superficial cartilage damage and depleted lubrication [72, 237, 238], surprisingly 
little is known about the functional relationship between the frictional properties of 
native or tissue-engineered cartilage and chondrocyte behaviour upon mechanical 
stimulation.  
In this work, we aimed to harness the adaptability of hydrogel materials to 
investigate the role of variations in surface friction on the biological response of 
articular chondrocytes to physiologically relevant mechanical stimulation. We, 
therefore, established and characterized a poly(ethylene glycol) diacrylate (PEG)-
based hydrogel system that allows for tailoring of the COF to model the frictional 
properties of healthy, damaged, and osteoarthritic cartilage, as well as altered 
lubrication states. Thin sheets of these hydrogels were then co-polymerized with 
chondrocyte-laden, photocrosslinkable alginate methacrylate (ALMA), which 
supports a chondrogenic cell phenotype [239], to form bilayered hydrogel constructs 
with tuneable surface friction. Constructs containing human articular chondrocytes 
were finally subjected to dynamic shear loading in a customized mechanical 
stimulation bioreactor to investigate the effects of variations in surface friction on the 
phenotypic expressions of encapsulated chondrocytes.  
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2.2 MATERIALS AND METHODS 
 Synthesis of alginate methacrylate (ALMA) 2.2.1
Medium viscosity alginate (MW ~ 260 kDa) was modified to include 
photocrosslinkable groups by reaction with methacrylic anhydride (MAAh) (both 
Sigma-Aldrich, St Louis, MO, USA). Alginate was dissolved in distilled water at 2 
% and reacted with a 10-fold molar excess of MAAh over total alginate hydroxyl 
groups for 24 h on ice and under constant stirring [240]. The pH was regularly 
adjusted to 8 using 5 M NaOH. After the reaction period, insoluble MAAh was 
removed by centrifugation, followed by dialysis against deionized water using a 12 
kDa MWCO cellulose dialysis membrane (Sigma-Aldrich) for 5-7 days. The pH of 
the dialyzed polymer solutions was adjusted to 7.4, after which they were lyophilised 
and stored at −20 °C protected from light and moisture. 
 
 Chondrocyte isolation and expansion culture 2.2.2
Articular cartilage was obtained with institutional ethics approval from 
consenting patients undergoing total knee replacement surgeries for osteoarthritis 
(donors: two female + one male, age 62 - 80 years). Chondrocytes were isolated from 
areas of macroscopically normal full-thickness cartilage, as described elsewhere 
[241]. Cells were propagated on tissue culture plastic (3000 cells/cm2) in low-D-
glucose chondrocyte basal medium (Dulbecco’s modified Eagle’s medium (DMEM) 
with 2 mM GlutaMAX™, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES), 0.1 mM nonessential amino acids, 50 U/mL penicillin, 50 µg/mL 
streptomycin, 0.5 µg/mL amphotericin B (Fungizone®) (all Invitrogen, CA, USA), 
0.4 mM L-proline and 0.1 mM L-ascorbic acid (both Sigma-Aldrich)) supplemented 
with 10 % foetal bovine serum (FBS) (Hyclone, Logan, UT, USA).  
Unless stated otherwise, all cells and cell/hydrogel constructs were maintained 
at 37 °C in a humidified 5 % CO2/95 % air CO2 incubator with the medium refreshed 
every 3-4 days. 
 
 Preparation of thin hydrogel sheets with controlled surface friction 2.2.3
To tailor the frictional properties of poly(ethylene glycol) diacrylate-based 
hydrogels (PEG, average Mn = 700 g/mol), various concentrations of negatively 
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charged 4-styrene sulfonic acid (SSA) (both Sigma-Aldrich) were added to the PEG 
precursor solution and covalently incorporated into the PEG network during 
photopolymerization. In order to retain alike total molarities and comparable polymer 
network densities in all PEG-based hydrogels, the uncharged compound methyl 
methacrylate (MMA) was added to hydrogels with a lower SSA content (PEG-40S) 
(Table 2-1). Just like SSA, MMA allows photocrosslinking via its vinyl group, 
resulting in comparable crosslinking densities. Briefly, 2 % w/v ALMA or PEG/SSA 
with or without MMA were dissolved in phosphate-buffered saline (PBS) containing 
0.2 % w/v Irgacure 2959 (1-(4-(2-hydroxyethoxy)-phenyl)-2-hydroxy-2-methyl-1-
propane-1-one, BASF, Ludwigshafen, Germany) and sterile filtered using a 0.2 μm 
syringe filter. Hydrogels were photocrosslinked between two parallel glass slides 
separated with a 300 μm spacer by exposure to 365 nm light at an intensity of ~ 
2.5 mW/cm2 in a CL-1000 crosslinker (UVP, Upland, CA, USA) for 30 minutes. The 
glass slides were separated after solidification, leaving a thin hydrogel layer behind 
on one of the slides. Hydrogels were washed briefly in sterile PBS to remove 
unreacted compounds. 
 
    Table 2.1: Composition of bilayered hydrogels with controlled surface friction 
 
Cell-free surface layer 
  PEG  SSA  MMA  ALMA 
Notation % mol%  % mol%  % mol%  %  Cell-laden layer 
ALMA 0 0  0 0  0 0  2  2 % ALMA 
PEG-40S* 11.3 20  6.7 40  3.2 40  0  2 % ALMA 
PEG-80S* 11.3 20  13.3 80  0 0  0  2 % ALMA 
   * Notations 40S and 80S refer to the percentage of SSA molecules to total hydrogel molarity (mol%)   
 Cell encapsulation and culture  2.2.4
Passage 2 chondrocytes were suspended in 2 % w/v ALMA in PBS containing 
0.05 % w/v Irgacure 2959 at a density of 10 million cells/mL. The cell/polymer 
suspension was then transferred to a custom Teflon casting mold, covered by a glass 
slide, and initially photocrosslinked for 3 minutes until just solidified. To form 
bilayered hydrogels with controlled surface friction, the glass slide was removed 
from the casting mold and replaced by another slide carrying the previously 
crosslinked PEG-SSA or ALMA hydrogel sheets. The constructs were further 
polymerized for 9 minutes to ensure proper bonding of the hydrogel layers. Bilayered 
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hydrogel constructs were removed from the casting mold, rinsed with PBS, and cut 
into constructs with the dimensions of 4 mm x 4 mm x 2 mm using custom cutting 
guides. 
Cell/hydrogel constructs were cultured in serum-free high-D-glucose basal 
chondrocyte medium (see above for composition) with ITS-G (100 × dilution), 
1.25 mg/mL bovine serum albumin (BSA), 0.1 μM dexamethasone (all Sigma-
Aldrich) and 10 ng/mL transforming growth factor beta 3 (TGF-β3) (GroPep, 
Adelaide, SA, Australia), and this media was also used as a lubricant in mechanical 
stimulation experiments.  
 
 Mechanical stimulation 2.2.5
Dynamic shear stimulation was carried out in a custom bioreactor chamber 
(Figure 2.1D) mounted to a commercially available displacement-controlled 
mechanical loading bioreactor (Cartigen C10-12c, Tissue Growth Technologies, 
Minnetonka, MN, USA). The chamber translates the vertical movement of the 
bioreactor actuator to horizontal movement of two loading platens manufactured 
from non-porous stainless steel, each platen stimulating up to 8 cell/hydrogel 
constructs simultaneously without physical contact between the samples. The 
displacement of the platens is not affected by the surface properties of the hydrogel 
constructs, but the dynamic shear strain within the hydrogel depends on the hydrogel 
frictional properties (Figure 2F, G). The chamber was designed to apply an offset 
compression of ~ 15 % of the construct height to all dynamically stimulated 
constructs and static controls. The bioreactor was placed in a humidified 5 % 
CO2/95_ % air CO2 incubator. Sterile gas exchange was assured through a syringe 
filter unit with 0.2 μm pore size mounted onto the bioreactor chamber. 
Gene expression analysis following short-term mechanical stimulation was 
performed to determine a suitable shear loading amplitude for long-term loading 
experiments. Cell/hydrogel constructs were precultured for 7 days under free-
swelling conditions to allow for chondrocyte redifferentiation and formation of a 
protective pericellular matrix [60] prior to mechanical stimulation. Constructs were 
then dynamically stimulated for 1 h at 1 Hz and either 0 mm (static control), 0.15 
mm, 0.315 mm, or 1 mm shear loading amplitude (Figure 2.1E). Long-term 
 Chapter 2: Tailoring hydrogel surface properties to modulate cellular response to shear loading 53 
experiments were performed to determine the effects of variations in surface friction 
on construct biomechanical properties, ECM accumulation, and chondrocyte gene 
expression in response to intermittent shear loading. Constructs were precultured 
under free-swelling conditions for 21 days, followed by intermittent shear 
stimulation for the next 11 days at 1 mm displacement amplitude and a frequency of 
1 Hz for 1 h daily (Figure 2.1F). Since our previous experiments suggested that 
mRNA levels peak at 2 hours post-completion of mechanical loading [60], constructs 
were terminated for qRT-PCR 2 hours after the final shear stimulation cycle had 
ceased.  
 
 Hydrogel frictional properties 2.2.6
Measurement of hydrogel surface friction was performed using a custom 
reciprocating tribometer that enables control of normal force (FN) and lubricant 
temperature. The tribometer was attached to an Instron 5848 microtester configured 
horizontally with a 5 N load cell (Instron, Melbourne, VIC, Australia). Hydrogels 
were fixed to the apparatus with epoxy adhesive (Loctite, Henkel, Düsseldorf, 
Germany) without compromising the gel surface. Defined normal forces of 88 mN, 
176 mN, and 352 mN were applied onto the hydrogel constructs resulting in contact 
pressures of 5.5 kPa, 11 kPa, and 22 kPa, respectively. Frictional forces against the 
loading platen of the shear loading bioreactor (stainless steel) were assessed over a 
sliding distance of 10 mm for 5 reciprocating cycles at a constant sliding velocity of 
1 mm/s in high-D-glucose basal chondrocyte medium with ITS-G (100 × dilution) 
and 1.25 mg/mL BSA. The dynamic coefficient of friction (COF) was calculated for 
each sample based on the average measured frictional forces (Ff) and the applied FN 
using the equation COF = Ff / FN. 
 
 Hydrogel physical properties 2.2.7
The compressive moduli of bilayered hydrogel constructs were measured in an 
unconfined arrangement using an Instron 5848 microtester with a 5 N load cell 
(Instron). During testing constructs were submerged in PBS at 37 °C. A displacement 
rate of 0.01 mm/s was applied using a non-porous indenter, and the modulus was 
taken from the linear region of the stress–strain curve from 10 % to 15 % strain 
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[216]. The mass swelling ratio was determined by the ratio of equilibrium wet weight 
of swollen gels to dry weight of lyophilised gels.  
 
 EPIC-μCT 2.2.8
The distribution of fixed negative charges in bilayered hydrogel constructs was 
visualized using equilibrium partitioning of an ionic contrast agent microcomputed 
tomography (EPIC-μCT) [242]. Constructs were incubated overnight in a mixture of 
40 % ioxaglate (Hexabrix; Aspen, St Leonards, NSW, Australia) in PBS at room 
temperature on a shaker plate. Constructs were then imaged in a μCT 40 scanner 
(Scanco Medical, Brüttisellen, Switzerland) at 45 kV and 177 μA with a 12 μm 
isotropic voxel size. Images were analysed using Scanco μCT software and ImageJ 
(National Institutes of Health, USA). 
 
 Micro-scale shear testing and digital image correlation 2.2.9
Bilayered ALMA, PEG-40S, and PEG-80S hydrogels containing Fluoresbrite® 
fluorescent microspheres (Polysciences, Taipei, Taiwan; 10 million microspheres/mL 
in 2 % (w/v) ALMA layer, 20 million microspheres/mL in variable friction surface 
layer) were prepared as above (cell-free) and incubated in PBS overnight. A custom 
microscope-mounted mechanical loading system capable of applying precise 
compressive and shear stimulation facilitated by a stainless steel loading platen was 
employed to apply sliding shear motion to hydrogel constructs. Testing was 
performed submerged in PBS at a sliding velocity of 0.1 mm/s (~ 15 % offset 
compressive strain). Hydrogel shear strains in the variable friction and ALMA layer, 
respectively, were determined using Vic-2D digital image correlation software 
(Correlated Solutions, Columbia, SC, USA; Step size: 20, subset size: 81). 
 
 Viability assay 2.2.10
Live and dead cells were visualized with fluorescein diacetate (FDA) and 
propidium iodide (PI) (both Sigma-Aldrich), respectively. Hydrogel constructs were 
washed in PBS, incubated in a solution of 10 μg/mL FDA and 5 μg/mL PI in PBS for 
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5 min at 37 °C, and then washed twice in PBS. Images were captured using a Nikon 
Eclipse fluorescence microscope. 
 
 Gene expression analysis 2.2.11
Hydrogel constructs were homogenized in 1 mL of TRIzol reagent 
(Invitrogen), and total RNA was isolated according to the manufacturer’s 
instructions. SuperScript™ III First Strand Synthesis System (Invitrogen) was used 
to synthesize complementary DNA (cDNA). DNase and RNase digestions were 
performed before and after cDNA synthesis, respectively. Quantitative real-time 
polymerase chain reaction (qRT-PCR) was carried out using SybrGreen® Mastermix 
(Invitrogen) and a 7900HT fast real-time PCR system (Applied Biosystems). The 
cycle threshold (Ct) value of each gene was normalized to the geometric mean of the 
housekeeping genes RPL13A and B2M using the comparative Ct method (2-ΔCt). 
Primer sequences were used as published previously (COL1A1 [243], COL2A1 
[243], ACAN [243], PRG4 [243], RPL13A [244] and B2M [244]). Primers for MMP3 
were purchased from Qiagen (Venlo, Netherlands). 
 
 Immunofluorescence analysis 2.2.12
Constructs were frozen in Optimal Cutting Temperature compound (OCT) 
(Sakura, Finetek, Tokyo, Japan) and sectioned at a thickness of 10 μm. Sections were 
fixed with ice-cold acetone, air-dried, and rehydrated in 50 mM BaCl2/100 mM Tris 
HCL buffer (pH 7.3) for 1 h, followed by incubation with 100 mM Tris HCL buffer 
(pH 7.3) for 5 min. Antigen retrieval with 0.1 % hyaluronidase (Sigma-Aldrich) at 37 
°C for 30 minutes was performed on sections to be stained for collagen type I and 
collagen type II. Primary antibodies for aggrecan (969D4D11, Invitrogen; 1:400 
dilution in PBS with 2 % donkey serum), collagen type I (I-8H5, MP Biomed, Solon, 
OH, USA; 1:300 dilution in PBS with 2 % goat serum), and collagen type II (II-
II6B3, Developmental Studies Hybridoma Bank (DSHB), Iowa City, IA, USA; 1:100 
dilution in PBS with 2 % goat serum) were applied in a humidified chamber at 4 °C 
overnight. Secondary antibodies were diluted 1:150 in PBS with 2 % goat/donkey 
serum and 5 μg/mL 4′,6-diamidino-2-phenylindole (DAPI) (Invitrogen) and applied 
for 1 h in the dark (AlexaFluor® 488-labelled donkey anti-mouse, AlexaFluor® 488-
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labelled goat anti-mouse, AlexaFluor® 594-labelled goat anti-mouse; all Jackson 
ImmunoResearch, West Grove, PA, USA). A mouse IgG isotype control antibody 
(Jackson ImmunoResearch; 1:1000 dilution) and secondary antibody only were used 
as negative controls. After two washing steps in PBS and drying, sections were 
mounted with ProLong Gold (Invitrogen) and imaged using a Zeiss Axio 
microscope. 
Integrated fluorescence intensities of histological sections were calculated 
using ImageJ software (National Institutes of Health, USA) and normalized to the 
integrated fluorescence intensity of DAPI stainings in order to correct the obtained 
values for differences in cell numbers between microscopic images. 
 
 Biochemical analysis 2.2.13
To quantify retained glycosaminoglycans (GAG) and DNA, cultured constructs 
were frozen and lyophilised. After careful removal of the cell-free surface hydrogel 
layer, the cell-laden proportions of the constructs were digested overnight in 0.5 
mg/mL proteinase K (Invitrogen) at 56 °C on an Eppendorf® Thermomixer® 
(Eppendorf, Hamburg, Germany). GAG concentration in the digest was measured 
using the dimethyl-methylene blue (DMMB) assay (pH 1.5). Absorbances at 525 and 
595 nm were measured, and concentrations calculated using the ratio of absorbances, 
compared to a quadratic standard curve prepared from chondroitin sulfate C (Sigma-
Aldrich). DNA concentrations in the digests were measured using the Quant-iT™ 
PicoGreen® dsDNA quantification assay (Invitrogen). 
 
 Statistical analysis 2.2.14
Statistical analyses were performed using SPSS software (version 20, IBM 
Corporation, USA). Differences between groups were determined using analysis of 
variance (ANOVA) and Tukey’s or Dunnet’s T3 post-hoc tests as appropriate, with a 
significance level of 0.05. Statistically significant differences are indicated in figures 
using symbols. 
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2.3 RESULTS  
 Tailoring hydrogel friction 2.3.1
We established a PEG-based hydrogel system which allows for control of its 
frictional properties by varying the density of fixed negative charge facilitated by 4-
styrene-sulfonic acid (SSA) (Figure 2.1B, C) to mimic the increase in articular 
cartilage surface friction following damage and degeneration [245]. To accomplish 
this, three separate compositions were prepared to yield thin hydrogel sheets 
containing no SSA (alginate methacrylate, or ALMA; Figure 2.1A), 40 mol % SSA 
(PEG-40S), or 80 mol % SSA (PEG-80S), respectively. The obtained hydrogels 
sheets were then combined with a layer of ALMA containing human articular 
chondrocytes to form bilayered hydrogel constructs by photopolymerization. ALMA, 
which was synthesized by reaction of alginate with methacrylic anhydride, allows for 
polymerization in the presence of a photoinitiator and light under physiological 
conditions, allowing in situ crosslinking and cell encapsulation with high cell 
viabilities (Figure 2.1A) [239].  
The frictional properties of hydrogel constructs were assessed against the 
stainless steel loading platen of the shear bioreactor used in the following 
experiments using cell culture media as lubricant. For PEG-80S constructs, we 
observed kinetic COFs of ~ 0.045 for all investigated normal pressures (Figure 
2.2A), values that approximate to previously reported COFs of healthy cartilage-on-
cartilage (0.001 – 0.025) [231-234]. PEG-40S and ALMA hydrogels exhibited 
significantly higher COFs ranging from ~ 0.085 to ~ 0.092, and ~ 0.155 to ~ 0.170, 
respectively. The latter values correspond to COFs previously reported for cartilage 
affected by moderate to severe OA (stage 3-4; Figure 2.2A) [122, 232, 245]. EPIC-
μCT scans were performed to confirm that the variations in construct surface friction 
were indeed associated with differences in the distribution and concentration of fixed 
negative charges. Due to the repulsion of the anionic contrast agent ioxaglate, μCT 
attenuation levels in the variable friction layer were reduced with increasing 
concentration of negatively charged SSA (Figure 2.2D, E) which resulted in a 
significant change of construct surface friction (Figure 2.2A, p < 0.001).  
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Figure 2.1: Composition of bilayered hydrogel constructs with tailorable surface friction, 
schematic of the shear loading bioreactor and experimental overview. (A) Methacrylation of 
alginate, a natural hydrogel-forming polysaccharide commonly used for chondrocyte culture, enables 
cell-encapsulation by photopolymerization and improved control over construct mechanical 
properties. (B) To tailor frictional properties, synthetic hydrogels based on poly(ethylene glycol) 
diacrylate (PEG) were synthesized with varying concentrations of 4-styrene-sulfonic acid (SSA) and 
methyl methacrylate (MMA) and combined with cell-laden alginate methacrylate (ALMA) hydrogels 
to form bilayered constructs. (C) Schematic depicting shear deformation of low friction constructs 
containing high concentrations of negative charge facilitated by SSA and high friction constructs 
consisting of a cell-containing and a cell-free alginate methacrylate (ALMA) surface layer. (D) 
Rendered partial cross-section of the custom shear loading bioreactor chamber exerting sliding shear 
motion to hydrogel constructs. (E) A short-term experiment for the optimisation of the shear loading 
amplitude was performed at 1 Hz for 1 h with either 0 mm, 0.15 mm, 0.315 mm, or 1 mm shear 
amplitude following 7 days of free-swelling preculture. (F) For long-term experiments, cell-hydrogel 
constructs were precultured for 21 days and subsequently shear loaded for 1 h daily over 11 days at 1 
mm amplitude and a frequency of 1 Hz. 
 
We then proceeded to investigate the deformation of these constructs in 
response to sliding shear motion replicating the mechanical environment of articular 
cartilage using a custom microscope-mounted loading device and digital image 
correlation. Similar to native articular cartilage [72, 238], deformation of the 
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hydrogel constructs was highly dependent on their surface friction (Figure 2.2F, G). 
When applying shear stimulation, initially the construct surfaces adhered to the 
loading platen and began to displace laterally, causing depth-diminishing shear 
deformation of the cell-laden hydrogels which peaked just below the surface 
hydrogel layer. With further displacement, the construct surfaces detached and slid 
relative to the loading platen with a steady-state peak strain. The magnitude of this 
strain was dependent on the surface friction of the constructs with strain magnitudes 
increasing with higher construct COFs (Figure 2.2F, G). Changes in the composition 
of the surface hydrogel layer had no measurable effect on the bulk compressive 
moduli (Figure 2.2B), the mass swelling ratio, or the water content (Figure 2.2C) of 
bilayered constructs which remained statistically similar between construct types.  
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Figure 2.2: Tribological and physicochemical properties of bilayered hydrogel constructs and 
their effect on hydrogel shear deformation. Bilayered ALMA, PEG-40S, and PEG-80S hydrogel 
constructs were analysed to determine their (A) dynamic coefficients of friction (mean ± SD, n = 5, 
*** = p ˂ 0.001), (B) compressive moduli at day 1 (mean + SD, n = 3) and (C) mass swelling ratios 
(bars) as well as water contents (dots) of bilayered constructs (mean ± SD, n = 3). (D) Cross-sections 
and (E) quantified attenuation values from EPIC-μCT scans illustrating differences in surface 
hydrogel negative charge densities in bilayered constructs (attenuation scales range from -5,000 
(black) to 20,000 (white)). (F) Microscopic images of the peak shear strain in ALMA, PEG-40S, and 
PEG-80S hydrogel constructs in response to sliding shear motion and (G) depth-dependent changes in 
shear strains in the variable friction PEG gel and ALMA quantified using digital image correlation 
(mean ± SD, n = 2). 
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 Effects of short-term mechanical stimulation on chondrocyte viability and 2.3.2
gene expression 
Short- and long-term dynamic shear stimulation (Figure 2.1E, F) was carried 
out in a custom bioreactor chamber (Figure 2.1D and Supplementary Video V1) to 
assess the effects of differences in construct surface friction on the biological 
response of encapsulated chondrocytes. In order to investigate whether cell viability 
was affected by dynamic loading, we performed fluorescein diacetate/propidium 
iodide stainings 24 hours after mechanical loading had ceased to allow cells to 
undergo necrotic or programmed cell death. Hydrogel-encapsulated human articular 
chondrocytes exhibited round cell morphologies indicative of a chondrogenic 
phenotype [165] and high cell viabilities (> 90 %) were observed in all construct 
types in both shear-stimulated and static controls, suggesting that neither the 
hydrogel composition nor mechanical loading had cytotoxic effects (Figure 2.3). To 
determine the optimal shear loading amplitude for chondrocyte culture, constructs 
were dynamically stimulated at various shear amplitudes (0.15 mm, 0.315 mm, 1 
mm) in a short-term experiment and changes in gene expression levels were assessed 
using qRT-PCR (Figure 2.4). Among the investigated amplitudes, dynamic 
stimulation at 1 mm loading plate extension led to differential regulation of the 
investigated genes (Supplementary Fig. S2.1), and this amplitude was chosen for the 
following long-term experiments.  
 
Figure 2.3: Cell viability following short-term shear-stimulation of hydrogel constructs with 
variable surface friction. Viability of human articular chondrocytes in bilayered (A, D) ALMA, (B, 
E) PEG-40s, and (C, F) PEG-80S constructs (A-C) after dynamic shear stimulation and (D-F) in 
unstimulated controls. Living cells appear green and dead cells appear red. Scale bar: 500 μm. 
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 Effects of surface friction on chondrocyte gene expression and construct 2.3.3
properties in long-term shear-stimulated hydrogel constructs 
Key biochemical features of articular cartilage include the abundant presence 
of collagen type II and proteoglycans which interact with a fluid environment to 
provide the tissue with its unique biomechanical properties [21]. The expression of 
genes including COL2A1 encoding the alpha chain of collagen type II, ACAN 
encoding the proteoglycan aggrecan, and PRG4 encoding the superficial zone-
specific boundary lubricant proteoglycan 4 (PRG4) are thus commonly used as 
markers of the chondrogenic phenotype. When the expression of these genes was 
investigated after long-term intermittent shear stimulation, we found a distinctive 
transcriptional response of chondrocytes to mechanical stimuli which was highly 
dependent on construct surface friction. While aggrecan transcript levels were 
comparable between all groups (Figure 2.4A), we found ~ 15.8-fold higher 
expression of the chondrogenic marker COL2A1 (Figure 2.4B) and ~ 1.8-fold higher 
expression of PRG4 (Figure 2.4C) in shear-stimulated PEG-80S low friction 
constructs compared to static controls (p = 0.005 for COL2A1; p = 0.041 for PRG4) 
and ALMA high friction constructs (p = 0.006 for COL2A1; p = 0.018 for PRG4). In 
contrast, expression of chondrogenic marker genes in shear-stimulated ALMA 
constructs remained at control levels, while expression of the gene encoding matrix 
metalloproteinase 3 (MMP3), was significantly elevated over static controls (p = 
0.032; Figure 2.4E).  
Articular cartilage has a high content of glycosaminoglycans (GAGs) which 
significantly contribute to the compressive stiffness of the tissue and is used as a 
marker for chondrogenesis [21]. We found that shear stimulation did not affect the 
GAG/DNA content of ALMA and PEG-40S constructs when compared to statically 
cultured controls (Figure 2.4G). However, mechanically loaded PEG-80S constructs 
had significantly elevated GAG/DNA levels than their static controls (p = 0.009), 
PEG-40S (p = 0.001) and ALMA (p = 0.012). Additionally, intermittent application 
of dynamic shear also led to increased stiffness of ALMA (p = 0.036) and PEG-80S 
(p = 0.029) constructs when compared to unstimulated controls (Figure 2.4H). The 
DNA content after a total of 32 days of culture was similar between all construct 
types, with or without application of intermittent shear (Figure 2.4F), suggesting that 
mechanical loading did not cause cell death or influence cell proliferation. 
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Figure 2.4: Relative gene expression levels, biochemical and mechanical properties of hydrogel 
constructs with variable surface friction after long-term intermittent shear stimulation. Relative 
mRNA expression levels of (A) aggrecan, (B) collagen type II, (C) proteoglycan 4, (D) collagen type 
I, and (E) matrix metalloproteinase 3 of human articular chondrocytes embedded and shear-stimulated 
in ALMA, PEG-40S, and PEG-80S constructs. Gene expression of shear-stimulated constructs (shear) 
was normalized to static controls (static; mean relative expression indicated by broken line). (F) DNA 
content, (G) GAG retained in constructs normalized to DNA content, and (H) compressive moduli of 
shear-stimulated and statically cultured ALMA, PEG-40S, and PEG-80S constructs. Significant 
differences between shear-stimulated constructs and static controls are indicated by # (p < 0.05) or ## 
(p < 0.01). Significant differences between constructs types are indicated by * (p < 0.05) or ** (p < 
0.01) (n = 3). 
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To confirm the gene expression data, immunofluorescence analysis was 
performed to assess the accumulation of cartilaginous matrix proteins and the 
chondrocyte de-differentiation marker collagen type I in shear-stimulated and 
statically cultured constructs. While articular cartilage is primarily composed of 
water, the solid fraction predominantly consists of collagen II and aggrecan. Our 
results show that aggrecan, collagen type II, and collagen type I immunoreactivity 
largely confirmed the results observed on mRNA level (Figure 2.5). Aggrecan 
immunostaining was mainly limited to intracellular and pericellular regions and no 
differences were observed between construct types and shear-stimulated or static 
control samples (Figure 2.5A-F, and S). However, the staining intensity for collagen 
type II in dynamically stimulated constructs increased markedly with decreasing 
surface friction and the highest intensities were observed for PEG-80S constructs 
when compared to PEG-40S (p ˂ 0.001) and ALMA (p ˂ 0.001; Figure 2.5G-L, and 
T). When compared to static controls, the average fluorescence intensities were 
higher in PEG-80S (p ˂ 0.001), while loaded ALMA constructs exhibited lower 
intensities than their unstimulated controls (p = 0.009) and PEG-40S (p = 0.011). No 
statistically significant differences were observed for the intensity of collagen type I 
staining, although inter-territorial reactivity appeared stronger in shear-stimulated 
constructs (Figure 2.5M-R, and U).  
 
 
 
 Chapter 2: Tailoring hydrogel surface properties to modulate cellular response to shear loading 65 
 
Figure 2.5: Effect of long-term intermittent shear stimulation on extracellular matrix 
production in bilayered hydrogel constructs with varying frictional surface properties. 
Following a static preculture period of 21 days, ALMA, PEG-40S and PEG-80S hydrogels were (A-C, 
G-I, M-O) intermittently shear-stimulated or (D-F, J-L, P-R) statically cultured for another 11 days. 
Immunoreactive regions for aggrecan (A-F) and collagen type II (G-L) appear green, while 
immunoreactive regions for collagen type I (M-R) appear red. Nuclei were counterstained with DAPI 
(blue). Scale bars: 50 μm. Integrated fluorescence densities for (S) aggrecan, (T) collagen type II, and 
(U) collagen type I stainings were normalized to DAPI intensities and expressed as the ratio of shear-
stimulated to static control constructs. Significant differences in integrated staining intensities between 
shear-stimulated constructs and static controls are indicated by ## (p < 0.01) or ### (p < 0.001). 
Significant differences between construct types are indicated by * (p < 0.05), ** (p < 0.01) or *** (p < 
0.001) (n = 6 images from 2 replicate samples).   
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2.4 DISCUSSION 
Articular cartilage is a mechanically-sensitive tissue that can respond 
favourably or unfavourably to biomechanical stimuli. In healthy diarthrodial joints, 
nearly friction-less articulation is facilitated by lubricant molecules at the cartilage 
surface and in synovial fluid including proteoglycan 4 [29], surface active-
phospholipids [246], and hyaluronic acid [230], as well as other synergistically 
interacting lubrication mechanism such as hydrodynamic lubrication and interstitial 
fluid pressurization [247]. While various pathogenic mechanisms can lead to 
cartilage deterioration and not necessarily involve elevated surface friction [248], 
compelling evidence suggests that a loss of the lubricating properties of synovial 
fluid, often associated with decreased concentrations of proteoglycan 4, results in 
increased articular surface friction following acute joint injury [89, 90, 122, 132, 133, 
235, 249, 250]. The increase in friction also correlates with the severity of 
degeneration and osteoarthritis in affected joints [251, 252], suggesting a potential 
involvement in the pathogenesis of articular cartilage. Interestingly, shear 
deformation of articular cartilage under mechanical loading is significantly greater 
with deficient lubrication and pathological changes to the surface topography such as 
fibrillation of the articular surface [72]. It therefore seems likely that an increase in 
cartilage friction following injury may cause excessive tissue shear deformation 
during joint movement and thus promote catabolic pathways in chondrocytes, 
ultimately leading to the development of degenerative conditions such as OA. To 
address this hypothesis, we developed a cytocompatible hydrogel system which 
allows for targeted changes to its surface friction without affecting other bulk 
physicochemical characteristics. We further employed this system to study the 
biological response of hydrogel-encapsulated articular chondrocytes to shear loading 
to establish, for the first time, a functional relationship between surface friction and 
cellular homeostasis in mechanically loaded tissues. 
In order to approach the low friction values characteristic for healthy articular 
cartilage, we incorporated SSA, a photocrosslinkable derivative of sulfonic acid 
which is anionic at physiological pH, into PEG-based hydrogels and co-polymerized 
these with cell-laden ALMA to form bilayered constructs. The presence of fixed 
negative charges in the surface layer was confirmed using EPIC-μCT (Figure 2.2D) 
which indicated increasing charge densities from bilayered ALMA (high friction gels 
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without SSA) to PEG-40S (moderate friction with 40 mol % SSA) and PEG-80S 
(low friction with 80 mol % SSA) hydrogel constructs. The negative charge densities 
of the surface hydrogel layer inversely correlated with the construct COFs (Figure 
2.2A), suggesting that covalent SSA incorporation reduced the surface friction of 
bilayered hydrogels. While the exact lubrication mechanisms were not investigated it 
this study, it is likely that incorporation of negative charge facilitated by SSA 
increased the electrostatic repulsion between the polyanionic gel and the stainless 
steel bioreactor loading platen, in turn resulting in reduced COFs [217]. Using this 
approach, we were able to tailor construct COFs without significantly affecting the 
bulk compressive moduli (Figure 2.2B), mass swelling ratio, or water content (Figure 
2.2C) of bilayered constructs. We observed COFs of ~ 0.045 for PEG-80S constructs 
which approximate to COFs of healthy cartilage-on-cartilage (0.001 – 0.025) [231-
234], while PEG-40S and ALMA constructs exhibited significantly higher COFs 
ranging from ~ 0.085 to ~ 0.092, and ~ 0.155 to ~ 0.170, respectively (Figure 2.2A). 
These values correspond to kinetic COFs of articular cartilage affected by moderate 
to severe OA (stage 3-4) [122, 232, 245]. However, it has to be considered that the 
COF values of hydrogels and cartilage specimens depend on a variety of parameters 
including the sample geometry, applied normal force, sliding velocity, lubricant 
used, and the properties of the opposing surface. It is hence likely that reported COFs 
of healthy and diseased cartilage may vary from the COFs in vivo. Similarly, 
variations in the COFs determined in friction tests and the bioreactor used in this 
study may exist. In order to minimize these discrepancies, the tribometer was 
designed to permit measurement of hydrogel COFs against the loading platen used in 
the bioreactor with cell culture media as lubricant, hence replicating the loading and 
lubricant conditions employed in short- and long-term mechanical stimulation 
experiments. In diarthrodial joints, lubrication is provided by synovial fluid [91]. 
Since the experiments in this study involved the culture of hydrogel-encapsulated 
chondrocytes [253], the choice of lubricant was limited to a suitable cell culture 
media. Although differences in the lubrication efficacy of media and synovial fluid 
are expected, it was previously shown that testing using various lubricants yields 
fundamentally the same relationships between samples of varying surface properties 
[84], while the absolute COF values may differ between lubricant systems [248]. 
Accordingly, it is expected that the differences in frictional properties between 
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ALMA, PEG-40S, and PEG-80S constructs are preserved when tested using other 
lubricants than culture media.  
Limiting SSA incorporation to a thin surface layer allowed us to control 
hydrogel surface properties without influencing the microenvironment of cells 
encapsulated in ALMA, hence enabling the attribution of cell responses to 
mechanical loading to the frictional properties of the construct rather than differences 
in cell-matrix interactions. Employing a hydrogel-based method also had significant 
advantages over alternative 3D models, such as cartilage explant cultures, which do 
not allow for precise tailoring of the COF or other physicochemical properties. In 
addition, if variations in explant surface friction occur, these are typically linked to 
differences in ECM structure and composition [90] which were shown to affect the 
chondrocyte phenotype through signalling mediated by cell-ECM interactions [254], 
making it challenging to isolate the effects of the explant’s frictional properties on 
the observed cell behaviour following mechanical loading. 
We hypothesized that articular cartilage surface friction and mechanical 
properties are intrinsically linked to chondrocyte homeostasis by governing the 
magnitude of tissue shear during normal joint ambulation. After establishing a means 
to control the frictional properties of hydrogels to mimic healthy, damaged, and 
osteoarthritic cartilage, we thus investigated the deformation of these constructs in 
response to mechanical loading replicating the sliding shear motion of articulating 
joints. As expected, we found that shear strain throughout the cell-containing 
hydrogel layer increased substantially with construct COFs, effectively mimicking 
the changes in cartilage biomechanics after injury and in the early stages of OA [72, 
237]. Similar to the native tissue [72, 237], strain levels peaked in the superficial 
areas just below the variable friction hydrogel layer and diminished with depth 
(Figure 2.2F, G). The magnitude of shear strain in low friction PEG-80S constructs 
(~2 – 4 %) was consistent with previously reported strain levels for healthy cartilage-
on-cartilage lubricated with synovial fluid, while strains in PEG-40S and ALMA 
were substantially higher as in fibrillated and osteoarthritic cartilage, ranging from 
~6 – 13 % and ~8 – 17 %, respectively [72, 237]. However, given the complexity of 
biomechanical stimuli arising from a normal joint usage, shear strains in vivo may 
vary from these values which were obtained in uniaxial shear tests under static 
compression [72, 237], similar to the loading regimes applied in the present study. 
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While this is a simplification of physiological loading conditions [255], previous 
studies indicated that the frictional properties of articular cartilage remain similar 
irrespective of whether compression is applied dynamically or statically [256], 
suggesting that the influence of cyclic compression on the magnitude of 
tissue/hydrogel shear strains may also be minor.   
It was previously reported that excessive mechanical strains in articular 
cartilage can result in cell death [257] and ECM damage [258], in turn further 
reducing the intrinsic capacity for tissue maintenance and repair. The results of our 
short-term study indicated that, in this model, mechanical loading did not impact cell 
viability (Figure 2.3), although shear strains in dynamically stimulated PEG-40S and 
ALMA constructs substantially exceeded physiological levels (Figure 2.2F, G) [72, 
237]. This may be explained by the differences in ECM mechanical properties and 
thus the magnitude of strain-induced mechanical stresses between native human 
tissue (aggregate modulus of ~ 0.5 – 0.9 MPa [259], Young’s modulus of ~ 1.5 - 3 
MPa, unpublished data) and hydrogel constructs (Figure 2.2B). Contrary to our 
hypothesis, construct frictional properties had no significant effect on gene 
expression patterns after one hour of mechanical stimulation in this short-term study 
(Supplementary Fig. S2.1). This lack of discernible differences in cell response may 
be related to insufficient statistical power or the short duration of static pre-culture 
before mechanical stimulation (7 days) which may not allow for sufficient formation 
of a functional pericellular matrix, one of the key transducer of chondrocyte 
mechanotransduction, causing chondrocytes to respond poorly or detrimentally to 
mechanical stimuli [60]. Further reinforcing this hypothesis, the results from our 
long-term gene expression study indicated a much more distinct transcriptional 
response of chondrocytes to dynamic shear following 21 days of preculture which 
was additionally highly dependent on construct surface friction. We found that 
expression of chondrogenic marker genes COL2A1 (Figure 2.5B) and PRG4 (Figure 
2.5C) was significantly up-regulated in dynamically stimulated PEG-80S low friction 
constructs when compared to static controls, as well as high (ALMA) and moderate 
friction (PEG-40S) constructs. On the other hand, expression of chondrogenic 
marker genes remained at control level in shear-stimulated ALMA constructs, while 
MMP3 expression was significantly increased (Figure 2.5E). The protease MMP3 is 
a key mediator of cartilage degradation and has been found to be highly expressed in 
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OA with protein levels correlating to OA severity [260]. These results hence indicate 
that the low level shear strains in PEG-80S induced transcription of chondrogenic 
genes, while constructs with higher COFs (Figure 2.2A) and thus shear strains 
(Figure 2.2F, G) amplified catabolic pathways in chondrocytes. Gene expression data 
were further confirmed on protein level using immunofluorescence staining 
techniques which revealed that the synthesis and accumulation of collagen type II 
was strongly dependent on the surface friction of mechanically stimulated constructs. 
Visual and statistical analysis revealed significantly higher amounts of accumulated 
collagen II in shear-stimulated PEG-80S when compared to static controls and other 
construct types (Figure 2.5G-L, T), while accumulation in loaded ALMA constructs 
was decreased compared to unstimulated controls. These findings are in line with 
previous studies, which indicated that minor dynamic shear strains, as they are occur 
in PEG-80S constructs, produced constructs with 40 % more collagen, 25 % more 
proteoglycan, and 6-fold higher equilibrium modulus [202]. High shear strains, as in 
mechanically stimulated ALMA constructs, however, inhibited macromolecule 
synthesis [202].  
In this study, chondrocytes were isolated from regions of macroscopically 
normal cartilage which was obtained from donors undergoing total knee 
arthroplasties for OA. While we cannot rule out that the phenotype of these cells 
differs from healthy chondrocytes of younger individuals, we have no reason to 
believe that chondrocytes from non-OA sources would show different responses to 
the loading conditions used in our study. During OA as well as propagation on tissue 
culture plastics, chondrocytes undergo dedifferentiation; a process characterized by 
an increase in the expression of collagen I and MMPs, and reduced expression of 
cartilage-specific markers such as collagen II and aggrecan [103, 261, 262]. Yet, the 
low cellularity of cartilage frequently renders monolayer expansion unavoidable in 
order to obtain sufficient cell numbers for clinical applications such as autologous 
chondrocyte implantation [127], as well as investigations in vitro. However, 
chondrocyte dedifferentiation can be reversed by cultivation in suitable 3D matrices 
under chondrogenic conditions [263]. Accordingly, isolated chondrocytes were 
expanded to passage 2 in order to obtain sufficient cell numbers for the bioreactor 
experiments and encapsulated in ALMA hydrogels [239]. Under such conditions, 
osteoarthritic and monolayer-expanded chondrocytes regain their ability to express 
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cartilage-specific markers [239, 263, 264] and react to mechanical stimuli similar to 
cells from normal human [60] or animal cartilage [265]. Moreover, the use of 
chondrocytes derived from elderly human donors with OA in cartilage research is 
appropriate and important as this population is most likely to benefit from any 
improvement in our understanding of chondrocyte behaviour. 
Previous studies suggested that intermittent compressive stimulation of tissue-
engineered cartilage at low and moderate strain levels increased ECM molecule 
synthesis and resulted in higher mechanical properties [265, 266]. Similar to our 
earlier work utilizing ALMA as redifferentiation platform for chondrocytes [239], all 
construct types, independent of the composition of the surface hydrogel layer, were 
softer on day 32 compared to day 1 of culture (compare Figure 2.2B and Figure 
2.4H). This is likely to be attributed to the hydrolytic [267] or non-specific enzymatic 
degradation [268] of ester bonds formed by the methacrylation of alginate hydroxyl 
groups [240]. However, dynamic shear loading partially reversed the decrease in 
construct stiffness, resulting in higher compressive moduli of shear stimulated 
ALMA and PEG-80S constructs when compared to static controls cultured for the 
same period of time (Figure 2.4H). The increase in stiffness was the greatest for 
PEG-80S constructs (~ 2.5-fold increase over SC for PEG-80S; p = 0.029, versus ~ 
1.9-fold increase for ALMA; p = 0.036) (Fig. 2-4H) which may be partially 
explained by the significantly higher accumulation of GAGs (Figure 2.4G) and ECM 
molecules (Figure 2.5) in these constructs following mechanical stimulation. In line 
with the gene expression and immunofluorescence analysis, GAG/DNA levels in 
shear-stimulated ALMA and PEG-40S constructs were similar to static control 
levels, indicating that the high magnitude shear strain impaired the chondrogenic 
capacity of encapsulated chondrocytes when compared to constructs with lower 
COFs. 
 
2.5 CONCLUSION 
In this study, we developed a cytocompatible hydrogel system which allows for 
targeted changes to its frictional properties without affecting other bulk 
physicochemical characteristics. The system is versatile and can be readily adapted 
to accommodate a variety of cell types, as well as hydrogel and scaffold materials, 
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and can be employed to study the effects of variations in surface friction on cellular 
behaviour in response to physiologically relevant mechanical loading. We tested the 
applicability of the model in studying the response of human articular chondrocytes 
to shear loading and demonstrate that cartilage lubrication and surface friction may 
regulate chondrocyte homeostasis by governing the magnitude of tissue shear 
deformation during joint articulation. Our results indicate that dynamic shear 
stimulation of constructs with low surface friction causes low magnitude shear 
strains which significantly promote chondrogenesis and extracellular matrix 
synthesis as assessed by gene expression, immunofluorescence, and biochemical 
analysis. In contrast, shear stimulation of constructs with high surface friction can 
lead to excessive strains which impair chondrogenesis, but induce transcription of 
matrix metalloproteinases involved in the degradation of cartilage extracellular 
matrix in osteoarthritis. Based on these findings, we propose that changes in cartilage 
lubrication and tribology as they occur after traumatic joint injury [89, 90, 235, 236] 
may be involved in the initiation of posttraumatic cartilage degeneration by 
increasing mechanical strains within the tissue beyond a physiological level, causing 
inhibition of cartilaginous matrix synthesis and activation of catabolic pathways.  
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3.1 INTRODUCTION 
 In multicellular organisms, cells are embedded in a pericellular and/or an 
extracellular matrix (ECM). Structurally, the ECM of native tissues is subdivided 
into two general types: filamentous protein networks, as found in connective tissues 
[269], and thin layers with sheet-like organization, which are found in basement 
membranes [270]. It is now thought that the ECM represents more than just a 
structural architecture that provides adhesion sites for cell surface receptors [271]. 
ECM homeostasis is a critical factor in preserving normal tissue function and tissue-
specific mechanical and biochemical properties [272]. The interaction between cells 
and the surrounding ECM regulates a variety of physiological cellular processes, 
including motility, migration, invasion and proliferation [273, 274]. In contrast, the 
cross talk of cells with the local microenvironment promotes the development and 
progression of various diseases, including cancer [275-277]. 
The physicochemical properties of the cellular microenvironment directly 
influence the state of differentiation of various cell types. For example, with regard 
to chondrocytes, the properties of the native or tissue-engineered ECM have a key 
role in the successful development of a functional cartilage matrix [221, 278, 279]. 
These effects of the extracellular microenvironment on cellular behaviour are well 
known; thus, experimental organ-specific model systems need to mimic 
physiological conditions in humans, and their development has, therefore become a 
major focus of biomedical research [280-282]. 
2D cell culture systems, which are based on cells propagated as monolayers 
and are routinely used in research, differ greatly from the native microenvironment, 
and they often fail to adequately model normal tissue and disease processes [218]. To 
address this fundamental drawback of 2D cell culture systems, tissue-engineered in 
vitro platforms have become the preferred model systems for experimental organ-
specific studies [283]. These platforms can rely on different technologies, and thus 
they consist of a 3D modular culture system rather than a stand-alone model. These 
modular systems can therefore enable researchers to adequately engineer complex 
tissue-specific niches. Several 3D culture approaches based on natural, synthetic and 
semisynthetic biomaterials are available to serve as physiologically relevant mimics 
of the ECM for cell biology, tissue engineering and regenerative medicine 
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applications [284]. Most of these 3D cell culture systems consist of hydrogels, which 
are highly hydrated matrices of crosslinked polymer chains that mimic the 3D 
networks observed in native connective tissues [285, 286]. 
 
 
Figure 3.1: Overview of the GelMA-based hydrogel preparation protocol. GelMA is dissolved in 
PBS at 37 °C and mixed with the photoinitiator to obtain the precursor solution. Cells, and optionally 
hyaluronic acid methacrylate (HAMA; indicated by a dashed line), are added to the precursor solution 
before casting it into a custom-made Teflon mold. The casting mold is then covered with glass slides 
and transferred into a UV crosslinker to enable the formation of the hydrogel by photopolymerization. 
By using a custom-made cutting guide, the hydrogel stripes thus obtained are cut into constructs of 
equal size (4 mm × 4 mm × 2 mm), and can be used for biological assays and as a cell delivery vehicle 
for animal studies. 
 
 
Current 3D cell culture systems 
A wide variety of natural, synthetic and semisynthetic hydrogels have been 
successfully used as 3D cell culture systems that mimic the extracellular 
microenvironment during disease development and progression [287, 288], or that 
provide a cell delivery vehicle for animal experiments [289]. Biomaterials used for 
these purposes include natural hydrogel-forming proteins, such as collagen type I 
[290], and more complex mixtures based on reconstructed basement membrane 
proteins, such as Matrigel [291], as well as synthetic polymers, such as PEG [280, 
289]. Although collagen type I gels effectively recapitulate the properties of 
connective tissues and Matrigel enables researchers to conduct cell growth and dif-
ferentiation studies [283], hydrogels derived from natural proteins often lack 
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consistent properties and contain impurities, resulting in high batch-to-batch 
variation [218]. Hence, researchers in the field of materials science have developed 
an array of synthetic hydrogels that are widely explored as 3D ECM mimics [292]. 
Although these synthetic polymers have the advantage of reproducible, well-defined 
and tuneable physicochemical properties, they lack the cell-binding and protease-
cleavage motifs that are naturally found in ECM. This limitation can be overcome by 
adding cell-responsive sites, such as integrin cell-binding motifs, to synthetic 
polymers, thus engineering biomimetic materials [293]. 
 
 
Figure 3.2: GelMA-based hydrogel preparation and 3D cell culture. The custom-made and 
sterilized Teflon mold is filled with cell-laden precursor solution under sterile conditions and covered 
with glass slides. After UV-initiated crosslinking, a custom-made cutting guide is required to cut the 
hydrogel strip into equal squares (4 mm × 4 mm × 2 mm), which are then transferred into culture 
medium to enable cell growth and spheroid formation. Bright-field microscopy indicates the 
appearance of spheroids after 14 d of 3D culture of ovarian cancer OV-MZ-6 cells, which can be 
visualized by confocal microscopy and maximal projections depicting cell nuclei (DAPI, blue) and F-
actin (rhodamine 415–conjugated phalloidin, red). 
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Interestingly, other 3D cell culture approaches use scaffolds instead of 
hydrogels. For example, the work by the Cukierman group [294] introduced cell-
derived matrices as a 3D culture and assay system with the characteristics of 
basement membrane–like substrates in order to analyse cell morphology and 
behaviour. To create a specific type of basement membrane, the Lengyel team [295] 
developed an in vivo–like tumour microenvironment by layering mesothelial cells 
onto an omental basement membrane. This omental basement membrane is generated 
by mixing ECM proteins, including collagen type I, with primary fibroblasts in order 
to study ovarian cancer cell functions during metastasis [296]. Such a 3D culture 
approach for ovarian cancer represents an organotypic model that can be further 
expanded with other tissue-specific cell types that are present in the tumour 
microenvironment, and it enables the high-throughput screening of novel 
therapeutics [297]. Other approaches include the combined silk-collagen scaffolds 
developed by the Kaplan group [298] to build a brain-like tissue, in which the 
biphasic architecture enables the spatially controlled growth of a neuronal network, 
thus mimicking the 3D morphology of the brain cortex. Other scaffold technology 
platforms enable researchers to monitor oxygen levels and determine hypoxia in a 
3D cell culture setup [299], as well as to investigate mechanisms that are altered 
during bone metastasis in patients with prostate cancer [300]. 
 
Development of the protocol 
GelMA is prepared from gelatin, a soluble polypeptide mixture of denatured 
and partially hydrolised collagens derived from animal tissues, such as skin, tendons 
and bones [301]. The main component of gelatin is collagen type I [301]. Depending 
on the hydrolysis processing conditions and tissue sources, a variety of gelatin 
products exist, which have slightly different compositions. According to our 
unpublished (performed by C.M. and T.J.K.) qualitative proteomic analysis, gelatin 
and GelMA mainly contain collagen types I and III, but they also contain traces of 
other collagen types. Although this approach is not covered in this protocol, collagen 
type IV (and its methacryloyl-substituted derivative) can be added to GelMA-based 
hydrogels with control over its concentration, enabling researchers to implement a 
variety of cell-specific applications.  
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Figure 3.3: Application of GelMA-based hydrogels as cell delivery vehicles for an 
intraperitoneal animal model. (A) Ovarian cancer OV-MZ-6 cells were transfected with a luciferase 
vector [289] and encapsulated within GelMA-based hydrogels (5 % (wt/vol) polymer concentration). 
After 2 weeks of 3D cell culture, bioluminescence signals (3.15 × 105 ± 9.32 × 104 
photons/s/cm2/steradian; n = 12) of cell-laden GelMA-based hydrogels were confirmed before 
intraperitoneal implantation into NOD-SCID mice. (B) Bioluminescence imaging confirmed tumour 
growth 8 weeks after implantation (1.80 × 106 ± 1.70 × 106 photons/s/cm2/steradian; n = 6), and ex 
vivo bioluminescence imaging of the peritoneal organs indicated tumour spread. Human-derived 
tumour load was immunohistochemically detected by positive nuclear mitotic apparatus protein 1 
(NuMA; Epitomics, cat. no. s2825, 1:100 dilution) staining, as shown by representative images from 
two different mice per group. (C) Four weeks after implantation, mice were treated with 
intraperitoneal paclitaxel injections (10 mg/kg, twice per week) over 4 weeks, leading to a decreased 
tumour load, as detected by bioluminescence imaging (6.59 × 105 ± 1.01 × 106 
photons/s/cm2/steradian; n = 6). The effect of paclitaxel was also confirmed via ex vivo 
bioluminescent imaging, with only minor tumour spread within the peritoneum. Smaller tumours were 
formed upon paclitaxel treatment, as indicated by NuMA staining. The average radiance indicated a 
paclitaxel response of 63 % (n = 6). All animal experiments conformed to Queensland University of 
Technology animal ethics approval. 
 
 Pure gelatin is water soluble, and it forms thermo-reversible transparent 
hydrogels via physical interactions between collagen molecules [302]. However, this 
type of physical hydrogel is not stable at body temperature, and it does not allow 
researchers to control and fine-tune its properties. To obviate these drawbacks, 
gelatin has been chemically functionalized with unsaturated methacryloyl groups to 
result in GelMA, which forms covalently crosslinked hydrogels by photo-initiated 
polymerization under mild conditions [302, 303] and enables cell encapsulation with 
high viability [278, 304]. Recent data from our research groups suggest that GelMA 
prepared according to the protocol described herein contains a mixture of 
methacrylamide and methacrylate groups, although the methacrylamide groups are 
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the majority (>90 % of all the methacryloyl groups present in the hydrogel) [305]. As 
a result, terms that were widely used to describe this material in the literature, such as 
gelatin methacrylamide, gelatin methacrylate or methacrylated gelatin, are not 
chemically accurate. Instead, we suggest using the term ‘gelatin methacryloyl’ to 
reflect the coexistence of both methacrylamide and methacrylate groups in GelMA 
[305].  
 The mechanical properties of GelMA-based hydrogels are readily tuneable by 
varying the degree of methacryloyl substitution, polymer and photoinitiator 
concentrations, and photocrosslinking time [177, 302]. Specific physical or otherwise 
hydrogel characteristics are discussed in the Experimental design section below. The 
quantitative links between these factors and the predictable mechanical 
characteristics of the resulting hydrogels [278, 304] are taken into consideration in 
our detailed relevant validation procedure. This protocol demonstrates a user-friendly 
and highly reproducible procedure to prepare GelMA-based hydrogels using a 
custom-made Teflon casting mold, which enables matrices with reproducible 
biochemical compositions, sizes and mechanical properties to be obtained. The 
resulting hydrogels are suitable for different biological assays and as cell delivery 
vehicles (Figure 3.1). In addition, we describe how the covalent incorporation of 
methacryloyl-functionalized ECM components, such as hyaluronic acid methacrylate 
(HAMA), yields complex ECM-mimicking matrices that can be adapted to act as 
tissue-specific model systems. 
 
Applications 
Our groups’ modular tissue culture platform is of prime interest, not only to 
biomedical engineers and biomaterial scientists but also to cell and molecular 
biologists working on applying novel biomaterial-based technology platforms to 
cancer research, and more generally to in vitro disease models, tissue engineering 
and regenerative medicine. We have demonstrated that GelMA-based hydrogels 
prepared according to our protocol (Figure 3.2) can serve as 3D model systems for 
studies on ovarian (Figure 3.3), breast (Figure 3.4) and prostate cancers [300], as well 
as for cartilage tissue engineering applications [278]. In expanding the applicability 
of the GelMA toolbox, we developed different hydrogel formulations to generate 
hybrid hydrogels with varying chemical, biological and mechanical properties, which 
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enable the differentiation of stem cells to desired cell types as well as the formation 
of vascular networks (Figure 3.5) [306]. Integration of microchannels into these 
hydrogels can further stimulate vascular network formation [307]. Moreover, 
GelMA-based hydrogels have been used as an injectable gene delivery system to 
stimulate vasculogenesis for myocardial therapy [308]. 
In the context of cancer research, cell-ECM interactions mediate critical steps 
in cancer progression and drug responses [284]. GelMA-based hydrogels were 
successfully used to develop a 3D cell culture model that allows the formation of 
multicellular spheroids from single ovarian cancer cells, which is the initiating 
process during peritoneal metastasis [304]. Variation of hydrogel stiffness resulted in 
changes of the cell morphology, metabolic activity and proliferation rate [304]. In 
addition, this spheroid-based approach was applied to an ovarian cancer animal 
model (Figure 3.3). Cell-laden hydrogels were implanted intraperitoneally into non-
obese diabetic–severe combined immunodeficiency (NOD-SCID) mice. Tumour 
formation occurred 4 weeks after implantation, which enabled the administration and 
screening of a clinically used chemotherapeutic, paclitaxel, over 4 weeks. A 
paclitaxel response of 63 % was detected (Figure 3.3); this value is comparable to 
that determined in our previously published study using GelMA-based hydrogels 
[304] as cell delivery vehicle for ovarian cancer cells in vivo. Similarly, metastatic 
breast cancer cells have been embedded within GelMA-based hydrogels, and they 
showed high cell viability over the duration of 3D cell culture (Figure 3.4). These 
cell-laden hydrogels were then implanted in close proximity to a humanized tissue-
engineered bone construct to mimic invasion of the humanized bone by the breast 
cancer cells (Figure 3.4). Hence, this method provides an approach to study breast 
cancer bone colonization in vivo [309].  
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Figure 3.4: Application of GelMA-based hydrogels in a breast cancer bone colonization animal 
model. (A) Metastatic breast cancer MDA-MB-231BO (MDA-BO) and MDA-MB-231 (MDA) cells 
and non-tumourigenic epithelial MCF10A cells were encapsulated within GelMA-based hydrogels (5 
% (wt/vol) polymer concentration). After 1 week of 3D cell culture, cell viability was assessed by 
confocal microscopy by live/dead staining (FDA, green; PI, red). After 2 weeks of 3D cell culture, cell 
proliferation was measured with an AlamarBlue assay (mean ± s.e.m.; n = 5). (B) Melt-electrospun 
scaffolds seeded with primary human osteoblastic cells were cultured over 8 weeks in vitro before 
subcutaneous implantation together with recombinant human bone morphogenetic protein 7 into 
NOD-SCID mice. After 8 weeks of ectopic bone formation in the humanized tissue-engineered bone, 
cell-laden hydrogels were implanted in close proximity to mimic invasion of the humanized bone by 
human breast cancer cells. Development of breast tumours in contact with the engineered bone was 
observed macroscopically (explant images) and microscopically (H&E staining) for both metastatic 
groups, but not for the control group. Human tumour and bone cells were detected 
immunohistochemically by positive NuMA (Epitomics, cat. no. s2825, 1:100 dilution) staining, as 
shown by representative images from each group. All animal experiments conformed to Queensland 
University of Technology animal ethics approval. AT, adipose tissue; BM, bone marrow; BV, blood 
vessel; CT, connective tissue; hTEBC, humanized tissue–engineered bone construct; NB, new bone; 
T, tumour. 
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In the context of tissue engineering and regenerative medicine, coculture of 
human blood–derived endothelial colony-forming cells (ECFCs) and human bone 
marrow–derived mesenchymal stem cells (MSCs) encapsulated in GelMA-based 
hydrogels supported extensive formation of a 3D capillary-like vascular network in 
vitro (Figure 3.5). The coculture of ECFCs and MSCs can be further expanded by 
coculturing endothelial cells with pericytes or smooth muscle cells. Importantly, 
functional anastomoses between the newly formed vascular network in vitro and the 
native vasculature upon implantation into male athymic nude (nu/nu) mice were 
observed, indicating potential regenerative applications [306]. By combining 
microfluidic systems with GelMA-based hydrogels, GelMA pre-polymers can be 
readily used to coat these microchannels. After photocrosslinking, the hydrogel 
coating layer stimulates functions such as cell adhesion and alignment within the 
microchannels, suggesting that these hydrogels are uniquely qualified for organ-on-
a-chip applications, such as used for cardiomyocyte cultures (Figure 3.6). 
Cardiomyocytes are elongated along the flow direction growing with cardiac fibers 
aligned inside the microchannels (Figure 3.6). This cardiomyocyte microchannel 
approach represents an in vitro model for diagnosis and drug-screening applications, 
owing to the widely known advantages of organ-on-a-chip models, including feasible 
control of the cellular microenvironment, delivery of nutrients and chemical cues to 
the cells through continuous medium perfusion, and reduction of the amount of 
reagents and cells during experiments [310]. 
Many studies described in the literature are stand-alone demonstrations of a 
specific biomaterial or a combination of different methods into a 3D model for a 
single application, but a modular tissue culture platform is still lacking [218]. Our 
protocol covers the complete manufacturing process, including polymer 
functionalisation, standardized preparation of 3D cell cultures, and the application 
and characterization of cell-laden hydrogels, for use in cancer research, stem cell 
research and tissue engineering. This broad spectrum of biomedicine-based research 
provides the much-needed continuity that will enable researchers to cross-validate 
different applications, a feature that is desperately needed in the area of 3D ECM 
mimics [292]. 
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Limitations 
 GelMA-based hydrogels can cover a wide spectrum of physicochemical 
properties by varying key parameters and factors in the hydrogel formulation, 
photocrosslinking conditions and incorporation of additional ECM components to 
generate a library of hydrogels. The protocol described herein thus serves as a basis 
for further optimization, depending on the encapsulated cell type and targeted culture 
model. 
 The surface properties of a wide variety of hydrogels that are commonly used 
for 3D cell culture applications, including GelMA, are highly dependent on the 
properties of the substrate on which it is crosslinked. Even for the same chemical 
structure, a hydrogel prepared on a hydrophobic substrate, such as Teflon, exhibits a 
lower crosslinking density at its surface than a hydrogel prepared on a hydrophilic 
substrate [311]. This effect has been largely neglected in the literature, yet it can be 
observed in a wide variety of hydrogels, including those that are commonly used for 
3D cell culture applications, such as PEG, and, to a far lesser extent, GelMA. 
Although the effects of the crosslinking substrate on the bulk hydrogel 
physicochemical properties are negligible for thick constructs (e.g., 2 mm), thin 
GelMA-based hydrogels (e.g., 1 mm) prepared on Teflon show increased swelling 
and lower compressive moduli compared with thick constructs (Figure 3.7). As this 
substrate effect only occurs at the immediate surface of the hydrogel, the bulk 
mechanical and swelling properties of thick hydrogel constructs remain unaffected 
by the properties of the substrate. Therefore, it is recommended to consistently use a 
standardized protocol and identical experimental conditions to ensure reproducibility. 
 Another limitation is the necessity to optimize the hydrogel composition to 
encapsulate more biologically sensitive cells, such as endothelial cells, with high 
viability. As described herein, these cell types require a low degree of GelMA 
functionalisation and a low crosslinking density of the GelMA-based hydrogel to 
achieve physiological cell behaviour. 
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Figure 3.5: Formation of a humanized vascular network in GelMA-based hydrogels. (A) Human 
ECFCs and MSCs were cocultured within GelMA-based hydrogels (5 % (wt/vol) polymer 
concentration; DoF: 50 %) at a 1:1 ratio, as indicated by confocal microscopy images of DsRed-
ECFCs (left) and CMFDA-MSCs (right) after 6 d of coculture. (B) DsRed-ECFCs were imaged in the 
complete hydrogel construct by confocal microscopy, and a 2D projection (x-y plane) was collected 
along the z axis (left). A 3D reconstruction with a cross-section covering a thickness of 400 μm in the 
direction of the white arrowhead was acquired (right). (C) MSCs differentiated into perivascular cells 
surrounding the ECFC capillaries (left). A confocal microscopy image shows the spatial distribution 
of the DsRed-ECFC-lined capillaries surrounded by alpha smooth muscle actin–expressing (αSMA; 
Abcam, cat. no. ab9465, clone EA-53,1:200 dilution; anti-mouse Alexa Fluor 488, Life Technologies, 
cat. no. A-11001, 1:1,000 dilution) MSCs (right, top). The zoom-in view depicts details of a capillary 
and a cross-section image taken in the direction of the yellow arrowhead (right, bottom). (D) Confocal 
microscopy image showing that lumens were lined exclusively by DsRed-ECFC and surrounded by 
αSMA-expressing MSCs (yellow arrowhead); adapted and used with permission from Chen et al. 
[306]. Functional human vascular network generated in photocrosslinkable gelatin methacrylate 
hydrogels, Adv. Funct. Mat. 22, 2027–2039 (2012), copyright Wiley-VCH Verlag GmbH & Co. 
KGaA. 
 
Experimental design 
A GelMA-based hydrogel experiment can be designed by combining some of, 
but not necessarily all, the procedures described below. GelMA functionalisation, 
dialysis and lyophilisation will need to be included in any experimental study (Steps 
1–11), as well as preparation of GelMA precursor solution and hydrogel construct 
(with or without encapsulated cells, Steps 14–26). It is highly recommended that 
characterization of GelMA functionalisation be performed on every newly 
synthesized and purified batch, to ensure that the intended degree of methacryloyl 
substitution has been obtained (Steps 12 and 13). Mechanical testing is highly 
recommended as a functional quality control test to ensure agreement between 
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batches and experiments (Steps 27–36). In addition, mechanical testing can be an 
assessment of degradation or tissue formation studies. Microscopy imaging will be 
part of most 3D cell cultures (Step 37), as will the assessment of cell viability and 
proliferation (Steps 38 and 39). Total RNA extraction from GelMA-based hydrogels 
can be performed when interested in the gene expression of encapsulated cells grown 
in 3D (Steps 40 and 41). 
 
 
Figure 3.6: Microfluidic channels coated with GelMA-based hydrogels for use in a 
cardiomyocyte culture model. (A) Representation of the coating procedure, with cross-sections of a 
single microfluidic channel perpendicular to the direction of the flow (top) and channel cross-sections 
along the direction of the flow (bottom). GelMA pre-polymer (5 % (wt/vol) polymer concentration; 
DoF: ~80 %) is perfused through the microfluidic channel and exposed to UV-initiated crosslinking. 
Non-crosslinked pre-polymer is then washed away with PBS. The channel can be subsequently seeded 
with cells and perfused with culture medium. PDMS, polydimethylsiloxane. (B) Confocal microscopy 
images of cardiomyocytes stained for F-actin (rhodamine 415–conjugated phalloidin, red) and cell 
nuclei (DAPI, blue) show an elongated morphology and alignment with the GelMA-coated 
microchannel on day 6 after seeding. (C) Confocal microscopy images show immunostaining of 
cardiomyocyte markers: troponin I (red, top; Abcam, cat. no. ab10231, clone 4C2, 1:200 dilution; 
anti-mouse Alexa Fluor 594, Life Technologies, cat. no. A-11005, 1:1,000 dilution), α-SMA (green; 
Abcam, cat. no. ab9465, clone EA-53, 1:200 dilution; anti-mouse Alexa Fluor 488, Life Technologies, 
cat. no. A-11001, 1:1,000 dilution) and connexin-43 (red, bottom; Abcam, cat. no. ab11370, 1:200 
dilution; anti-rabbit Alexa Fluor 594, Life Technologies, cat. no. A-11012, 1:1,000 dilution) inside the 
GelMA-coated microchannel, with cell nuclei counterstaining (DAPI, blue); adapted with permission 
from Annabi et al. [312]. Scale bars, 50 μm. 
 
Hydrogel casting mold. Photo-polymerization of the GelMA precursor solution is 
performed in a casting mold made of Teflon (polytetrafluoroethylene, PTFE). In our 
laboratory, we use a mold to produce hydrogel strips with the dimensions of 50 mm 
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× 4 mm × 2 mm (length × width × height), which are cut into smaller units of 4 mm 
× 4 mm × 2 mm (length × width × height) using custom acrylic cutting guides and a 
scalpel after photopolymerization (Figs. 1 and 2). Before commencing with the 
procedure outlined in this protocol, it is recommended to manufacture Teflon molds 
and laser-cut the cutting guides needed for the preparation of GelMA-based 
hydrogels as per technical drawings provided in the Supplementary Figures 3.1 and 
3.2. Note that the design of both the mold and cutting guides may be customized to 
produce hydrogels of different shapes and sizes, depending on your experimental 
needs. 
 
 
Figure 3.7: Effect of Teflon casting mold depth on mechanical and swelling properties of 
GelMA-based hydrogels. GelMA was dissolved to a final concentration of 10 % (wt/vol) in PBS and 
photocrosslinked in the presence of 0.05 % (wt/vol) Irgacure 2959 by 15 min exposure to 365 nm light 
at an intensity of 2.6 mW/cm2 in a CL-1000 crosslinker (UVP). (A) Compressive moduli of cell-free 
GelMA-based hydrogels prepared in Teflon molds with either 1 or 2 mm depth were determined after 
incubation in PBS at 37 °C overnight (mean ± s.e.m.; n = 6), and they differ significantly (P < 0.001). 
(B) Effective hydrogel swelling was determined by weighing GelMA-based hydrogels immediately 
after crosslinking and again after swelling in PBS at 37 °C overnight and changes significantly (P < 
0.001) with the casting mold depth. The difference in wet weights, before and after swelling, was 
expressed as a percentage (mean ± s.e.m.; n = 6). 
 
Tailoring mechanical properties of GelMA-based hydrogels. As indicated earlier, 
the mechanical properties of GelMA-based hydrogels can be tailored by variation of 
one or more of the following factors: the degree of functionalisation (DoF), the 
polymer and photoinitiator concentrations, as well as photocrosslinking time. For 
example, the DoF directly influences the highest achievable crosslinking density of 
the hydrogel matrix, and ultimately the hydrogel porosity and mechanical properties. 
When other factors remain unchanged, increasing the DoF leads to stiffer hydrogels 
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with a higher crosslinking density and improved shape fidelity [177], whereas the 
pore size decreases [313]. Increasing the polymer concentration or photocrosslinking 
time generally yields stiffer hydrogels [177]. These factors can be varied within a 
large range without affecting handling or compromising cell viability and function, 
but it should be optimized for each cell type. Changes to the photoinitiator 
concentration will affect the crosslinking kinetics, and a shorter photocrosslinking 
time may be required to yield hydrogels with comparable mechanical properties 
when the initiator concentration is increased. Increasing the photocrosslinking time 
leads to a higher crosslinking density and stiffness, both of which plateau when the 
hydrogel is fully crosslinked. For a detailed description of how the above-mentioned 
factors influence hydrogel properties, refer to our previously published work [177]. It 
is recommended that the parameters summarized in Table 3.1 be used as a basis for 
further optimization. 
 
Table 3.1: Recommended parameters for 3D cell cultures in high-DoF GelMA 
 
*For enhanced chondrogenic differentiation, 9.5 % (wt/vol) GelMA and 0.5 % (wt/vol) HAMA can be used 
instead of 10 % (w/v) GelMA [161].  
 
Avoiding oxygen inhibition of photo-initiated polymerization. Oxygen is known 
to affect the photo-initiated polymerization of acrylate and acrylamide-based 
chemistries [314]. Thus, the degree of photocrosslinking and mechanical properties 
of the hydrogels can be compromised by the influx of oxygen during hydrogel 
photopolymerization. It is therefore necessary to remove existing air bubbles and to 
cover the hydrogel precursor solution with a glass slide during photopolymerization, 
as outlined in the following protocol, as well as depicted in Figures 1 and 2. 
Degassing of the hydrogel precursor solution is not necessary. 
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Photopolymerization of GelMA-based hydrogels. UV-initiated crosslinking of 
cell-laden hydrogels is a commonly applied method, and, to our knowledge, no major 
adverse effects on cell viability and function have been reported, despite its extensive 
use with diverse cell types, including primary cells. The damage that UV light may 
cause is highly dependent on its wavelength and the nature of the radicals it creates. 
As DNA has an absorption maximum of 260 nm, it is recommended that a 
wavelength of 365 nm be used to minimize the risk of direct DNA damage. Our most 
recent results suggest that radicals generated by UV exposure preferentially react 
with the unsaturated methacryloyl groups of GelMA, which therefore have a cell-
protective effect [315]. As a result, cell viability and function are not compromised 
by UV-initiated crosslinking [315]. 
 
Co-polymerization of methacryloyl-substituted ECM components for tissue-
specific 3D models. To yield tissue-specific 3D models, methacryloyl-substituted 
ECM components may be co-polymerized with GelMA. For example, for human 
articular chondrocyte cultures, hyaluronic acid can be functionalized with 
methacrylate groups by reaction with methacrylic anhydride to yield HAMA, which 
enables the covalent and stable incorporation of hyaluronic acid into the hydrogel 
matrix and was shown to enhance chondrogenic cell differentiation, accumulation of 
cartilaginous ECM and mechanical properties in articular cartilage tissue engineering 
applications when compared with GelMA alone [162]. The GelMA concentrations 
recommended for in vitro chondrogenesis are within the physiological range of the 
collagen content of human articular cartilage. The mean (range) content of collagen 
type II in normal human articular cartilage is 14 % (9.2–20.8 %; weight per wet 
weight) [316], which is very similar to the 10 % typically used in our experiments 
[162]. Although it is not specifically outlined in the following protocol, this principle 
can also be applied to other relevant ECM components to study their effects on 
cellular behaviour. 
 
Mechanical testing of GelMA-based hydrogels. To perform unconfined 
compression tests (Figure 3.7), in our laboratory, we are using a custom-
manufactured immersion bath comprising an aluminium block with a rectangular 
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recess, which is capable of holding up to 25 mL of buffer for the mechanical testing 
of hydrogels. Beneath this recess, the aluminium block features a longitudinal feed-
through with tubing attachments on either side, which allows perfusion with 
temperature-controlled water using an aquarium water pump, tubing and a 
conventional laboratory water bath. 
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3.2 MATERIALS 
 Reagents 3.2.1
! CAUTION When handling the chemicals used in this protocol, always wear 
suitable personal protective equipment, including a lab coat, nitrile gloves, safety 
goggles and, where indicated, a face shield and respirator. For any chemical listed in 
this protocol, appropriate institutional and governmental safety guidelines must be 
followed. Please refer to the appropriate materials safety data sheets. 
 
GelMA functionalisation, dialysis and lyophilisation 
• Gelatin from porcine skin, type A, gel strength 300 bloom (Sigma-Aldrich, 
cat. no. G2500; store it at room temperature (RT) at 23–25 °C)                   
CRITICAL Other types of gelatin can also be used to prepare GelMA 
by following the same protocol, if necessary. However, this may affect the 
properties of the materials and resulting hydrogels. 
• Methacrylic anhydride (Sigma-Aldrich, cat. no. 276685; store it at RT)      
! CAUTION Methacrylic anhydride is a volatile and toxic organic 
compound, which may cause skin irritation, serious eye damage and 
respiratory irritation if inhaled. Always wear a face shield and respirator. 
Avoid any direct contact. 
• PBS, pH 7.4 (Life Technologies, cat. no. 100100; store it at RT) 
• NaHCO3 (Sigma-Aldrich, cat. no. S6014; store it at RT) 
• Irgacure 2959 (IC2959; BASF, cat. no. 029891301PS04; store it at RT) 
• Hyaluronic acid (Hyasis; Novozymes, molecular weight 0.86 MDa, CAS 
no. 9067-32-7; store it air-tight in a dry place at 4 °C) CRITICAL If 
necessary, hyaluronic acid from other manufacturers can also be used. 
However, the source and molecular weight may influence cell behaviour. 
• Liquid nitrogen ! CAUTION Contact of liquid nitrogen with the skin or 
eyes may cause serious frostbite injury. When handling liquid nitrogen, 
always wear appropriate personal protective equipment, including a long-
sleeve lab coat, thermo-insulated gloves, safety goggles and a full face 
shield. 
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Characterization of GelMA functionalisation 
• Ninhydrin (Sigma-Aldrich, cat. no. 151173; store it at RT)  
• Sodium citrate monobasic (Sigma-Aldrich, cat. no. 71498; store it at RT) 
• HCl (Sigma-Aldrich, cat. no. 84435; store it at RT) 
• Glycerol (Sigma-Aldrich, cat. no. G5516; store it at RT) 
• UltraPure DNase- and RNase-free distilled water (Life Technologies, cat. 
no. 10977-015; store it at RT) 
• Fluoraldehyde o-phthaldialdehyde reagent solution (Life Technologies, 
cat. no. 26025; store it at 4 °C) 
 
Human ovarian cancer cell culture 
• OV-MZ-6 cells [280] or any other cell line of interest and the appropriate 
medium in which to culture these cells ! CAUTION The cell lines used in 
your research should be regularly checked to ensure that they are authentic 
and that they are not infected with mycoplasma. 
• DMEM, high glucose, no sodium pyruvate (Life Technologies, cat. no. 
10566-016; store it at 4 °C) 
• HEPES (Life Technologies, cat. no. 15630-080; store it at 4 °C) 
• Penicillin-streptomycin, 10,000 U/mL (Life Technologies, cat. no. 15140-
122, store it at −20 °C) 
• Gentamycin (Life Technologies, cat. no. 15710-064; store it at 4 °C) 
• FBS (Lonza, cat. no. 14-501F; store it at −20 °C) CRITICAL Always 
use the same batch of FBS for replicate experiments. 
• l-Arginine (Sigma-Aldrich, cat. no. A-5131; store it at RT) 
• l-Asparagine (Sigma-Aldrich, cat. no. A-4159; store it at RT) 
• Versene (Life Technologies, cat. no. 15040-066; store it at 4 °C) 
 
Human chondrocyte culture 
• Human articular chondrocytes (see Reagent Setup) ! CAUTION Informed 
consent must be obtained for experiments involving human tissues and 
cells. Experiments must conform to all relevant institutional and 
governmental regulations. 
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• DMEM, high glucose, sodium pyruvate, no glutamine (Life Technologies, 
cat. no. 10313-021; store it at 4 °C) 
• HEPES (see above) 
• Penicillin-streptomycin (see above) 
• MEM non-essential amino acid solution, 100× (Life Technologies, cat. no. 
11140-050; store it at 4 °C) 
• GlutaMAX supplement (Life Technologies, cat. no. 35050-061; store it at 
4 °C) 
• l-Proline (Sigma-Aldrich, cat. no. P5607; store the powder at RT, and store 
the solution at −20 °C) 
• l-Ascorbic acid (Sigma-Aldrich, cat. no. A92902; store the powder at RT, 
and store solution at −20 °C) 
• Insulin-transferrin-selenium (ITS-G), 100× (Life Technologies, cat. no. 
41400-045; store it at 4 °C) 
• BSA (Sigma-Aldrich, cat. no. A9418; store it at 4 °C) 
• Human recombinant transforming growth factor beta 3 (TGF-β3; GroPep, 
cat. no. BJU100; store it at 4 °C) 
• Dexamethasone (Sigma-Aldrich, cat. no. D4902; store the powder at 4 °C, 
and store the solution at −80 °C) 
• Trypsin (Life Technologies, cat. no. 15090-046; store it at 4 °C) 
 
Coculture of human ECFCs and MSCs for vascular network formation 
• Human ECFCs (see Reagent Setup) ! CAUTION Informed consent must 
be obtained for experiments involving human tissues and cells. 
Experiments must conform to all relevant institutional and governmental 
regulations. 
• Human MSCs (see Reagent Setup) !_CAUTION Informed consent must 
be obtained for experiments involving human tissues and cells. 
Experiments must conform to all relevant institutional and governmental 
regulations. 
• Endothelial basal medium (EBM-2; Lonza, cat. no. CC-3156; store it at 
4_°C) 
• SingleQuots (Lonza, cat. no. CC-4176; store it at 4 °C) 
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• MSC growth medium (MSCGM; Lonza, cat. no. PT-3238; store it at 4 °C) 
• HEPES (see above) 
• Penicillin-streptomycin (see above) 
• GlutaMAX supplement (see above) 
• FBS (see above) 
• Basic fibroblast growth factor (bFGF; R&D System, cat. no. 4826/10; 
store it at 4 °C) 
 
Confocal laser-scanning microscopy (CLSM) 
• Fluorescein diacetate (FDA; Life Technologies, cat. no. F1303; store the 
powder at 4 °C, and store the solution at −20 °C) 
• Propidium iodide (PI; Life Technologies, cat. no. P3566; store it at 4 °C) 
• Triton X-100 (Sigma-Aldrich, cat. no. X100; store it at RT) 
• Glycine (Sigma-Aldrich, cat. no. G8898; store the powder at RT, and store 
the solution at 4 °C) 
• Paraformaldehyde (PFA; Sigma-Aldrich, cat. no. 158127; store the powder 
at 4 °C, and store the solution at −20 °C) !_CAUTION PFA is a potent 
fixative and it is hazardous. Avoid any direct contact and wear appropriate 
personal protective equipment. 
• Rhodamine 415–conjugated phalloidin (Life Technologies, cat. no. R415; 
store it at −20 °C) !_CAUTION Rhodamine 415–conjugated phalloidin is 
toxic and harmful. Avoid any direct contact and wear appropriate personal 
protective equipment. 
• DAPI (Life Technologies, cat. no. D1306; store the powder at RT, and 
store the solution at −20 °C) 
• Cell viability and proliferation assays 
• AlamarBlue cell viability reagent (Life Technologies, cat. no. DAL1025; 
store it at 4 °C) 
• CyQUANT cell proliferation assay kit (Life Technologies, cat. no. C7026; 
store it at −20 °C) 
• Proteinase K (Life Technologies, cat. no. 25530-015; store it at 4 °C) 
• Na2HPO4 (Merck Chemicals, cat. no. 106586; store it at RT) 
• NaH2PO4 × H2O (Merck Chemicals, cat. no. 106342; store it at RT) 
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• Na2EDTA (Ajax Finechem, cat. no. 180-500G; store it at RT) 
• NaCl (Merck Chemicals, cat. no. 106406; store it at RT) 
• EDTA (Merck Chemicals, cat. no. 108418; store it at RT) 
• RNase A (Life Technologies, cat. no. 12091-021; store it at RT) 
• UltraPure DNase- and RNase-free distilled water (see above) 
• Total RNA extraction from GelMA-based hydrogels 
• TRIzol reagent (Life Technologies, cat. no. 15596-026; store it at 4 °C) 
!_CAUTION TRIzol reagent contains phenol (toxic and corrosive) and 
guanidine isothiocyanate (an irritant), and it may be hazardous if not 
handled properly. Follow the manufacturer’s instructions and always work 
in a chemical safety fume hood and wear appropriate personal protective 
equipment. 
• RNaseZap RNase decontamination solution (Life Technologies, cat. no. 
AM9780; store it at RT) 
• Chloroform (Sigma-Aldrich, cat. no. C2432; store it at RT) 
• 2-Propanol (Sigma-Aldrich, cat. no. I9516; store it at RT) 
• Ethanol, 200 proof (Sigma-Aldrich, cat. no. E7023; store it at RT) 
• UltraPure DNase- and RNase-free distilled water (see above) 
• RNeasy Micro kit, including RLT buffer (Qiagen, cat. no. 74004; store it 
at RT and at 4 °C) 
• Borosilicate beads, 3-mm diameter (Sigma-Aldrich, cat. no. Z143928, 
store it at RT), or stainless steel beads, 5 mm diameter (Qiagen, cat. no. 
69989, store it at RT) 
• β-Mercaptoethanol (Sigma-Aldrich, cat. no. M3148; store it at RT) 
!_CAUTION β-Mercaptoethanol is hazardous and toxic. Follow the 
manufacturer’s instructions, work in a chemical safety fume hood and 
wear appropriate personal protective equipment. 
• Agarose, low electroendosmosis (Sigma-Aldrich, cat. no. 11685678001; 
store it at RT) 
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 Equipment 3.2.2
GelMA functionalisation, dialysis and lyophilisation 
• Round-bottom flask with a magnetic stir bar CRITICAL Use a stir bar 
of sufficient size with a powerful stirrer to ensure good dispersion of 
methacrylic anhydride. Alternatively, an overhead stirrer with propeller 
agitator can be used instead of a magnetic stir bar. 
• Freeze-dryer 
• Sterile 50-mL centrifuge tubes with vented caps (0.2 μm pore size)—for 
example, Corning 50-mL mini bioreactor (Sigma-Aldrich, cat. no. 
CLS431720) 
• Sterile syringes (50-mL volume) 
• Syringe filter units or disposable vacuum filtration units with 
polyethersulfone (PES) membrane (0.2-μm pore size) - for example, 
Nalgene Rapid-Flow sterile disposable filters (Thermo Scientific, cat. no. 
595-3320) 
• Dialysis membrane with a 12-kDa MWCO 
• CL-1000 UV crosslinker (UVP; or similar) with 365-nm wavelength tubes 
CRITICAL Ensure a UV intensity of 2.2–2.8 mW/cm2 in the 
crosslinker centre. The intensity will vary throughout the crosslinker, with 
intensities in the corners only half as high as that in the centre. 
• Teflon casting mold (Supplementary Figure 3.1) CRITICAL Clean the 
Teflon mold with warm water and sterilize it with 70 % (vol/vol) ethanol 
before use; autoclaving may damage the mold. 
• Untreated microscope glass slides CRITICAL Ensure that the same 
brand or type of glass slides is used consistently in order to exclude 
variation of hydrogel properties due to different light permeation through 
different glass slides.  
• Hydrogel cutting guides, laser-cut poly(methyl methacrylate); for details 
see Supplementary Figure 3.2 CRITICAL Do not autoclave; clean 
them with warm water and sterilize with 70 % (vol/vol) ethanol before use. 
Distance of individual cuts of cutting guides can be modified to allow 
hydrogel preparation of certain length. 
• Scalpel holders 
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• Scalpel blades (size 11 or 22) 
Mechanical testing of GelMA-based hydrogels 
• Instron MicroTester 5848 (Instron), or a similar mechanical tester, with a 5 
N-load cell 
• Temperature-controlled water bath 
• Fluidic chamber (hydrogel immersion bath) 
• Aquarium water pump 
 
Bright-field microscopy and CLSM 
• Eclipse (Nikon) or similar fluorescence microscope 
• SP5 (Leica) or similar confocal microscope 
 
Cell viability and proliferation assays 
• Black 96-well plates for fluorescence measurements 
• POLARstar OPTIMA plate reader (BMG Labtech) or similar fluorescent 
plate reader; wavelength measurements of fluorescent signals: excitation 
544 nm, emission 590 nm (AlamarBlue assay); excitation 485 nm, 
emission 520 nm (CyQUANT assay) 
 
Total RNA extraction from GelMA-based hydrogels 
• DNase/RNase-free, 2-mL conical microcentrifuge tubes 
• Standard laboratory bench-top centrifuge for 2-mL conical 
microcentrifuge tubes 
• NanoDrop-ND-1000 photo-spectrometer 
• Bullet Blender tissue homogenizer (Next Advance), Mini-Beadbeater 
(BioSpec Products), TissueLyser LT (Qiagen) or a similar mechanical 
tissue homogenizer 
• Bioanalyser (Agilent Technologies) 
 
Other laboratory equipment 
• Cell culture incubator 
• Sterile 24- and 48-well plates for 3D cell culture 
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• Opaque 96-well plates for photo-spectroscopy 
• Hemocytometer or cell counter 
• Positive-displacement pipette and sterile capillary piston tips (1-mL 
nominal volume) 
• Water bath 
• Heat block 
• Shaker/rocker plate 
• Sterile 1.5-, 2-, 15- and 50-mL conical (micro)centrifuge tubes 
• Glass beaker, 200–500 mL 
• Spatula 
• Forceps 
 
 Reagent setup 3.2.3
CRITICAL Culture cells on tissue culture plastic to ~80 % confluency in 
suitable culture medium (see below) before encapsulation in GelMA-based 
hydrogels. 
 
Medium for human ovarian cancer OV-MZ-6 cell culture: Prepare high-glucose 
(4.5 g/L) DMEM supplemented with 10 mM HEPES, 50 U/mL penicillin, 50 μg/mL 
streptomycin, 20 μg/mL gentamycin, 10 % (vol/vol) FBS, 0.550 mM l-arginine and 
0.272 mM l-asparagine. This medium can be stored at 4 °C for 4–6 weeks. 
 
Human articular chondrocytes: Isolate these cells from the full-thickness cartilage 
of patients undergoing total knee replacement surgery for osteoarthritis, as described 
elsewhere10. Cells encapsulated in GelMA-based hydrogels are cultured in high-
glucose (4.5 g/L) DMEM supplemented with 10 mM HEPES, 50 U/mL penicillin, 50 
μg/mL streptomycin, 0.1 mM MEM non-essential amino acids, 2 mM GlutaMAX, 
0.4 mM l-proline (freshly added at each medium change), 0.1 mM l-ascorbic acid, 
ITS-G (1:100), 1.25 mg/mL BSA, 10 ng/mL TGF-β3 and 0.1 μM dexamethasone. 
This medium can be stored at 4 °C for 4–6 weeks. 
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Human ECFCs: Isolate these cells from the mononuclear cell fraction of human 
cord blood samples, as described elsewhere [306]. Cells are expanded in EBM-2 
supplemented with SingleQuots, 50 U/mL penicillin, 50 μg/mL streptomycin, 2 mM 
GlutaMAX and 20 % (vol/vol) FBS. This medium can be stored at 4 °C for 4–6 
weeks. 
 
Human MSCs: Isolate these cells from the mononuclear cell fraction of human bone 
marrow samples, as described elsewhere [313]. Cells are expanded in MSC growth 
medium supplemented with 50 U/mL penicillin, 50 μg/mL streptomycin, 2 mM 
GlutaMAX, 10 % (vol/vol) FBS and 10 ng/mL bFGF. This medium can be stored at 
4 °C for 4–6 weeks. 
 
Sodium citrate buffer for ninhydrin assay: Prepare a sodium citrate monobasic 
0.5_M solution in demineralized or UltraPure water (107 mg/mL), and adjust the pH 
to 5.5 using 1.0 M HCl. Prepare the solution as required, and store it according to the 
manufacturer’s instructions. 
 
Solutions for CLSM: Prepare a 10 mg/mL stock solution of FDA in PBS by 
dissolving 1 g of FDA in 1 mL of PBS, and store it protected from light at −20 °C 
(can be stored for at least 1 year). Prepare a 4 % (wt/vol) solution of PFA dissolved 
in PBS, and store it at −20 °C (can be stored for at least 1 year). Prepare a glycine 0.1 
M solution in PBS and store it at 4 °C (can be stored for 1–2 months). Prepare a 1 % 
(wt/vol) solution of BSA in PBS by dissolving 1 g of BSA in 100 mL of PBS, and 
store it at 4 °C (can be stored for 1–2 months). Prepare a 5 mg/mL stock solution of 
DAPI in PBS by dissolving 10 mg of DAPI in 2 mL of PBS, and store it protected 
from light at −20 °C (can be stored for at least 1 year). It is recommended that the 
following solutions be filter-sterilized using 0.2-μm syringe filter units before use: 4 
% (wt/vol) PFA, glycine 0.1 M solution and 1 % (wt/vol) BSA in PBS. 
 
Solutions required for CyQUANT assay: Prepare phosphate-buffered EDTA 
(PBE) buffer containing 20 mM Na2HPO4, 30 mM NaH2PO4 × H2O and 5 mM 
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Na2EDTA in 500 mL of demineralized or UltraPure water; adjust the pH to 7.1, and 
autoclave the solution at 121 °C for 15 min. Make a stock solution of 100 mg of 
proteinase K in 10 mL of PBE buffer, and prepare a fresh final concentration of 0.5 
mg/mL proteinase K in PBE buffer. Prepare 5 mL of RNase A solution per 96-well 
plate (180 mM NaCl, 1 mM EDTA, 4.5 mL of UltraPure DNase- and RNase-free 
distilled water, 0.5 mL of 20× CyQUANT lysis buffer and 1.4 U/mL RNase A 
stock). Prepare 10 mL of CyQUANT GR dye solution per 96-well plate (9.5 mL of 
UltraPure water, 0.5 mL of 20× CyQUANT lysis buffer and 50 μL of CyQUANT 
GR dye stock). Prepare the solutions as required, and store them according to the 
manufacturers’ instructions. 
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3.3 PROCEDURE 
 GelMA functionalisation, dialysis, and lyophilisation TIMING 1–2 3.3.1
weeks 
!_CAUTION Perform GelMA functionalisation in a chemical safety fume hood, and 
wear appropriate personal protective equipment, including a lab coat, nitrile gloves 
and safety goggles. 
CRITICAL Ensure cleanliness of all glassware and laboratory equipment to 
avoid chemical contamination during GelMA functionalisation and purification 
steps. 
CRITICAL GelMA is light sensitive; maintain lyophilised GelMA and solutions 
containing GelMA in the dark, for example, by wrapping the dialysis setup and 
conical centrifuge tubes in aluminium foil. 
CRITICAL Maintain the GelMA solution at 37–50 °C to avoid thermal gelation 
between the functionalisation and purification steps - for example, in a water bath or 
an oven. 
1| Soak gelatin to a final concentration of 10 % (wt/vol) in demineralized or 
UltraPure water (or PBS) at RT in a round-bottom flask with a magnetic stir bar. Stir 
the resulting mixture moderately for 10–60 min to facilitate gelatin dissolution. For a 
large reaction volume, an overhead stirrer should be used instead of a magnetic stir 
bar. In our laboratory, we have tested reaction volumes of up to 300 mL, 
corresponding to 30 g of gelatin.  
2| While stirring moderately, heat the mixture to (and keep at) 50 °C in a water bath 
until the gelatin is fully dissolved and the solution becomes clear. 
3| While stirring vigorously, slowly add 0.6 g of methacrylic anhydride (very viscous 
liquid) per 1 g of dissolved gelatin for a high degree of methacryloyl 
functionalisation. Continue stirring vigorously for 60 min. If mixing is sufficient, the 
solution will turn homogeneously opaque owing to the dispersion of methacrylic 
anhydride. Alternatively, this reaction can be run for up to 3 h; however, the reaction 
time and temperature, as well as the mass ratio of methacrylic anhydride to gelatin, 
are used determine the degree of GelMA functionalisation. 
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CRITICAL STEP Ensure adequate stirring during GelMA functionalisation 
while minimizing air uptake. Insufficient stirring will lead to visible phase 
separation. 
CRITICAL STEP Use a glass pipette when handling methacrylic anhydride, as organic 
solvents may dissolve plastic pipette tips. 
CRITICAL STEP DoF can be varied by changing the ratio of methacrylic anhydride to 
gelatin. Use 0.6 g of methacrylic anhydride per 1 g of gelatin for a high DoF (75 ± 9 % DoF 
[177], as assessed using a ninhydrin assay or fluoraldehyde assay, Step 13), or 0.06 g of 
methacrylic anhydride per 1 g of gelatin for a low DoF (31 ± 7 % DoF, as assessed using a 
ninhydrin assay, Step 13). Ultimately, the DoF will influence the crosslinking density and 
hence the porosity and mechanical properties of hydrogel constructs, and it needs to be 
chosen on the basis of the cell type used (see Experimental design and Table 3.1). 
? TROUBLESHOOTING 
4| After the reaction period, transfer the solution into 50-mL tubes, and remove 
unreacted methacrylic anhydride by centrifugation at 3,500g for 3 min at RT. Decant 
the GelMA-containing supernatant (clear solution and separated from the ‘pellet’) 
into a large (200–500 mL) glass beaker, and discard the unreacted methacrylic 
anhydride deposited at the bottom of the 50-mL tubes (opaque and viscous ‘pellet’).  
? TROUBLESHOOTING 
5| Dilute the supernatant solution with two volumes of preheated (40 °C), 
demineralized or UltraPure water. 
6| Transfer the solution to a dialysis membrane with a 12-kDa MWCO and dialyze at 
40 °C against a large volume of demineralized or UltraPure water for 5–7 d in a 
chemical safety fume hood. Change water at least once daily. Alternatively, dialysis 
can be performed at 4 °C in the cold room to minimize degradation. However, this 
may require extended dialysis time owing to reduced diffusion at lower temperatures. 
CRITICAL STEP Methacrylic anhydride and acid byproduct are cytotoxic, and 
they may influence the viability of encapsulated cells. It is therefore crucial to fully 
remove these contaminants by dialysis before proceeding to Step 7. Dialysis is 
completed when the GelMA solution appears clear, and when the odour of residual 
methacrylic anhydride or methacrylic acid byproduct is no longer noticeable. 
? TROUBLESHOOTING  
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7| Adjust the pH of the GelMA solution to 7.4 using 1 M NaHCO3. 
? TROUBLESHOOTING  
8| In a class II biological safety cabinet, filter-sterilize the GelMA solution using 0.2-
μm syringe filter units or disposable vacuum filtration units with a PES membrane. 
CRITICAL STEP Treat GelMA and GelMA solutions as sterile after this step. 
? TROUBLESHOOTING 
9| Divide the GelMA solution into aliquots in 50-mL tubes and snap-freeze them in 
liquid nitrogen. 
 PAUSEPOINT Samples can be stored at −80 °C for at least 1 month. 
10| Transfer all aliquots to the freeze-dryer without allowing the solutions to thaw, 
and lyophilise them until the GelMA is fully dehydrated (typically 4–7 d). To 
maintain a sterile barrier during lyophilisation, the 50-mL tubes need to be sealed 
with vented screw-top caps or press-fitted with 0.2-μm syringe filter units before 
lyophilisation. Exchange vented caps or filters with standard screw-top caps after 
lyophilisation is completed to avoid hygroscopic absorption of water during storage 
specified in Step 11. 
11| Store lyophilised GelMA protected from light and moisture at −20 °C until use. 
 PAUSEPOINT Lyophilised GelMA can be stored safely in the above-mentioned 
conditions for at least 1 year. 
 
 Characterization of GelMA functionalisation TIMING 1-2 h 3.3.2
CRITICAL We recommend that Steps 12 and 13 be performed each time a new 
batch of GelMA is made. 
12| Soak duplicate samples of GelMA and gelatin at 3.5 mg/mL in UltraPure water. 
Although only ~0.2 mg is needed, weigh in at least ~10 mg of these duplicate 
samples for increased accuracy. 
13| Determine the DoF of GelMA by implementing the ninhydrin assay (option A) or 
the fluoraldehyde assay (option B). Both options are equally valid. 
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(A) Ninhydrin assay to determine the DoF  
(i)  Prepare a mixture of one part of sodium citrate monobasic 0.5 M and two 
parts of glycerol - for example, 1 mL of sodium citrate monobasic 
(0.5_M) and 2 mL of glycerol.  
(ii)  Heat the GelMA samples from Step 12 to 50 °C, and mix them until the 
solution becomes homogeneous and transparent.  
(iii)  For gelatin solutions, prepare 50 % (0.5 mL of gelatin solution and 0.5 
mL of UltraPure water), 20 % (0.2 mL of gelatin solution and 0.8 mL of 
UltraPure water) and 10 % (0.1 mL of gelatin solution and 0.9 mL of 
UltraPure water) dilutions to obtain the standard curve.  
(iv) Dissolve ninhydrin in the sodium citrate monobasic/glycerol mixture 
prepared in Step 13A(i) to a final ninhydrin concentration of 2.5 mg/mL.  
(v) Prepare 2-mL tubes containing 0.950 mL of the ninhydrin solution 
prepared in Step 13A (iv).  
(vi) Heat a water bath to 50 °C.  
(vii) Transfer 50-μl aliquots of the GelMA and gelatin solutions prepared in 
Step 13A (ii,iii) into the tubes containing ninhydrin solution prepared in 
Step 13A(v), and include two blanks (50 μl of UltraPure water).  
(viii) Incubate the closed tubes floating in the heated water bath for 12 min.  
(ix)  Remove the tubes and let them cool at RT for 1 h.  
(x)  For absorbance measurements, transfer 250 μl of each solution in 
triplicate into a 96-well plate, and then measure the optical absorbance at 
570 nm with a plate reader.  
(xi)  Calculate the average absorbance of the triplicate measurements and 
draw a linear regression line from the values obtained from the gelatin 
dilution series, by plotting absorbance against relative gelatin 
concentration (from 0 % for blank to 100 % for undiluted gelatin). The 
absorbance at 570 nm corresponds to the concentration of free amine 
groups; any reduction in free amine concentration is assumed to be 
because of methacryloyl functionalisation. The absorbance of each 
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GelMA sample corresponds to a gelatin concentration of X % on the 
standard curve; the DoF is then calculated as DoF = (100 − X) %. 
 
(B) Fluoraldehyde assay to determine the DoF  
(i)  Dissolve 0.5 mg/mL of GelMA in PBS and prepare gelatin solutions in 
PBS to draw a standard curve (0.02, 0.1, 0.5 and 1.0 mg/mL). Warm the 
GelMA and gelatin samples to 50 °C and mix them until they turn 
homogeneous and transparent. Allow all the solutions to cool to RT.  
(ii)  Warm the fluoraldehyde reagent solution to RT before use.  
(iii)  Mix 300 μl of each of the GelMA and gelatin solutions with 600 μl of the 
fluoraldehyde reagent solution in separate test tubes; also prepare a 
sample containing 300 μl of PBS and 600 μl of the fluoraldehyde reagent 
solution as a control. Thoroughly mix all samples for 1 min to ensure 
completion of the reaction.  
(iv)  Pipette 250 μl of each solution in triplicate into a 96-well plate, and 
determine the fluorescence intensity at 450 nm using an excitation 
wavelength of 360 nm by using a plate reader. CRITICAL STEP 
For optimal results, measure the fluorescence intensity of the samples 
within 3 min at the same time interval after mixing. Use opaque 96-well 
plates designed for fluorescence assays only.  
(v)  Take the average fluorescence intensity and subtract the fluorescence 
intensity of the PBS control from the sample and standard solutions to 
determine the net fluorescence. Prepare a linear calibration curve based 
on the standard solutions. Determine the fluorescence intensity of the 
GelMA sample corresponding to a gelatin concentration of X mg/mL on 
the calibration curve and the residual amine concentration. The DoF is 
then calculated as DoF = (0.5 − X)/0.5 × 100 %. 
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 Preparation of the GelMA precursor solution TIMING 1-2h 3.3.3
CRITICAL Perform this preparation 1 d before cell encapsulation. 
CRITICAL For cell culture applications, treat GelMA and GelMA solutions as 
sterile: work in a class II biological safety cabinet and use sealed vessels to transport 
GelMA-containing solutions. Clean all working surfaces with 70 % (vol/vol) ethanol 
before commencing any procedure. 
CRITICAL Use a positive-displacement pipette for a viscous GelMA 
preparation that has a concentration higher than 5 % (wt/vol). 
14| Prepare at least 10 mL of fresh photoinitiator stock solution by weighing in 
≥25_mg of IC2959 in a 50-mL centrifuge tube, and add PBS to a final concentration 
of 2.5 mg/mL. Dissolve IC2959 by placing the centrifuge tube in a water bath heated 
to 70 °C for 5–10 min, or until it is fully dissolved. Let the solution cool to RT, 
transfer it to a class II biological safety cabinet and sterilize it using 0.2-μm syringe 
filter units. The stock concentration of IC2959 can be increased depending on the 
final concentration needed in Step 17. 
15| Determine the mass of GelMA required (mGelMA) for your application based on the 
desired final concentration (cGelMA) and volume (VGelMA) using the equation mGelMA = 
cGelMA × VGelMA, and allow for ≥30 % excess to account for losses during hydrogel 
preparation and to facilitate ease of pipetting. Note that VGelMA is dependent on the 
nominal volume of your casting mold. For example, the nominal volume of each of 
the four recesses of the mold used in this protocol is 400 μl (50 mm × 4 mm × 2 mm; 
see Supplementary Figs. 3.1 and 3.2 for mold and cutting-guide design), which 
produces a total of 12 hydrogel constructs after cutting (Step 25). To prepare 24 
hydrogel constructs, two recesses of the mold need to be filled completely with 
hydrogel precursor solution (Step 23), which requires the preparation of VGelMA ≥ 
1,040 μl (two recesses × 400 μl × 130 %).                                             
CRITICAL STEP The minimum total volume of the GelMA hydrogel precursor 
solution (VGelMA) per hydrogel preparation should be ≥1 mL to facilitate ease of 
pipetting and mixing. 
16| Weigh in the required amount of lyophilised GelMA, and add PBS to four-fifths 
of the total final volume to obtain 1.25× the final desired concentration; for example, 
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prepare a 12.5 % (wt/vol) solution of GelMA if you desire a final GelMA 
concentration of 10 % (wt/vol). 
CRITICAL STEP If other functionalized (methacryloyl-substituted) ECM 
components, such as HAMA, are to be co-polymerized in the hydrogel matrix, they 
may be dissolved in this mixture at 1.25× the desired final concentration (if present 
in solid or lyophilised form). Alternatively, a concentrated stock solution of the 
component may be prepared in PBS and added to the mixture to obtain 1.25× the 
desired final concentration. Take care to adjust the volume of PBS to be added to the 
lyophilised GelMA accordingly, so that all functionalized components are present at 
1.25× the final concentration after this step. 
17| Add the IC2959 stock solution prepared in Step 14 to a final concentration of 
0.05 % (wt/vol), in one-fifth of the total reaction mixture volume (see also Step 16). 
Optionally, the final concentration of IC2959 can be varied to 0.5 % (wt/vol) as 
desired, which will have an influence on the crosslinking kinetics and mechanical 
properties but not on cell viability. For recommended IC2959 concentrations, refer to 
Table 3.1. 
18| Allow the GelMA/IC2959 mixture to soak into the solvent protected from light at 
4 °C overnight. 
CRITICAL STEP GelMA foam needs to be fully immersed into the solvent to enable 
the complete hydration of GelMA. 
 
 Cell encapsulation and hydrogel construct preparation TIMING 3-5 h  3.3.4
19| Sterilize the Teflon casting mold, acrylic hydrogel cutting guides and glass slides 
by spraying them with 70 % (vol/vol) ethanol in a class II biological safety cabinet. 
CRITICAL STEP Ensure that the equipment has fully dried before use. 
20| Transfer the tube containing the soaked GelMA foam with IC2959 to a water 
bath or a cell culture incubator at 37 °C, and allow GelMA to fully dissolve over ~3 
h or until the mixture turns clear. Place the tube on a shaker/rocker or manually 
agitate the solution occasionally to accelerate the dissolution of GelMA. 
? TROUBLESHOOTING 
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21| When GelMA is fully dissolved and the Teflon casting mold, cutting guides and 
glass slides have dried entirely, detach the cells of choice - e.g., OV-MZ-6, 
chondrocytes, ECFCs or MSCs - according to your laboratory’s standard protocol, 
wash the cell pellet with PBS to remove traces of trypsin or Versene, resuspend the 
pellet in a suitable volume of medium (5 or 10 mL) and determine the cell 
concentration (csuspension) using a hemocytometer or cell counter. 
22| Determine the required cell number (ncells) based on the desired final cell 
concentration (ccells) and the total volume of GelMA precursor solution prepared in 
Steps 14–18 (VGelMA) using the equation ncells = ccells × VGelMA. Take the volume (Vcells) 
containing ncells from the cell suspension prepared in Step 21 corresponding to 
Vcells_=_ncells/csuspension, and transfer to a fresh 50-mL tube. Pellet the cells by 
centrifugation at 100–300g for 5 min at RT and discard the supernatant. 
CRITICAL STEP The cell concentration (ccells) is dependent on the cell type and 
specific application, and it needs to be optimized for cell types not listed in this 
protocol. For recommended cell concentrations, refer to Table 3.1. 
CRITICAL STEP If appropriate for the experiment, also prepare controls 
containing no cells. 
23| Wet the pipette tip and carefully aspirate the warm hydrogel precursor solution 
prepared in Step 18 with a pipette, by immersing its tip to a depth of 2–5 mm from 
the solution surface. Resuspend the cell pellet in the hydrogel precursor solution at 
the desired cell concentration by carefully pipetting up and down repeatedly, leaving 
some cell suspension in the tube at all times to avoid introduction of air bubbles. 
Remove existent air bubbles from the cell suspension by centrifugation at 200g for 
30 s at RT and then reheat the suspension to 37 °C if necessary. Once the cell pellet 
is dislodged and the suspension appears homogeneous and free of air bubbles, 
transfer the cell suspension into the Teflon casting mold using a 10 % volume excess 
over the nominal volume of the casting mold (here: 440 μL per recess). Cover it with 
a glass slide in a single movement. 
CRITICAL STEP Avoid introducing air bubbles, as entrapped oxygen inhibits 
radical polymerization of the hydrogel precursor solution and leads to incomplete 
crosslinking. 
? TROUBLESHOOTING 
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24| Photo-crosslink the cell-hydrogel precursor solution in a UV crosslinker at 365 
nm for 10–15 min, depending on the cell type and required hydrogel mechanical 
properties (Table 1). UV exposure time can be significantly reduced to 30–60 s if a 
higher concentration of IC2959 is used, such as 0.5 % (wt/vol), depending on the 
required hydrogel mechanical properties. 
? TROUBLESHOOTING 
25| Remove the crosslinked cell-laden hydrogel constructs from the Teflon mold by 
carefully lifting the glass slide, and cut the hydrogel strip(s) thus obtained into 
smaller units using a cutting guide and a sterile scalpel. 
26| Transfer individual cell-laden hydrogel constructs into a suitable cell culture 
medium (dependent on the cell type; see Reagent Setup) in a multiwell plate (Figure 
3.2), and maintain them in a cell culture incubator at 37 °C. If you wish to perform 
mechanical testing of GelMA, proceed to Step 27; some commonly used cell analysis 
techniques are described from Step 37 onward. 
CRITICAL STEP If IC2959 concentrations above 0.05 % (wt/vol) were used for 
photocrosslinking, replace the cell culture medium three times at 30-min intervals to remove 
traces of the photoinitiator. 
? TROUBLESHOOTING 
 
 Mechanical testing of GelMA-based hydrogels TIMING 1-3 h 3.3.5
27| Take cell-laden hydrogels prepared as described in Steps 19–26 and/or cell-free 
hydrogels (without the inclusion of cells) and incubate them in a suitable buffer, such 
as PBS or cell culture medium, at 37 °C overnight to allow for swelling equilibration 
or culture cell-laden hydrogels for a desired period of time. 
CRITICAL STEP Implementation of Step 28, and those steps that follow it in 
the present procedure, compromises the sterility of the tested hydrogel constructs, 
and thus this procedure must be performed as an end-point analysis. 
28| Determine the hydrogel cross-sectional area by direct measurement of hydrogel 
spatial dimensions (option A) or indirectly by measurement of the hydrogel wet 
weight and height (option B). Both options are equally valid and interchangeable for 
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the measurement of the compressive moduli of GelMA-based hydrogel cultures by 
using unconfined compression tests. 
 
(A) Direct determination of hydrogel cross-sectional area  
 (i)  Use a (digital) caliper to measure the hydrogel’s length and width 
(rectangular hydrogel constructs) or diameter (cylindrical hydrogel 
constructs), and then calculate the cross-sectional area. 
 
(B)  Indirect determination of hydrogel cross-sectional area  
(i)  Remove excess buffer by carefully blotting the equilibrated hydrogel against a 
laboratory wipe, and determine the hydrogel’s wet weight using an analytical 
balance. Calculate the cross-sectional area using the equation A = m/(ρ × h), in 
which A is the hydrogel cross-sectional area (cm2), m is the hydrogel wet weight 
(g), ρ is the hydrogel density in g/cm3 and h is the hydrogel height (cm); 
hydrogel height will be assessed in Step 35. 
CRITICAL STEP This method is commonly used, in particular for 
soft and odd shaped hydrogels that deform strongly when applying a 
caliper, but the hydrogel density needs to be measured separately. For 5 
% (wt/vol) and 10 % (wt/vol) GelMA-based hydrogels, the density is 
~1.03 and 1.05 g/cm3, respectively. 
 
29| Prepare mechanical testing equipment and the hydrogel immersion bath. Equip a 
vertically configured mechanical testing system (e.g., an Instron MicroTester 5848) 
with a nonporous indenter and a suitable load cell (e.g., 5 N-load cell), and follow the 
manufacturer’s load cell calibration and general user instructions. The cross-sectional 
area of the intender must be larger than that of the hydrogel. 
30| For immersed unconfined compression tests, prepare a suitable hydrogel 
immersion bath with a flat-bottom surface that allows heating to 37 °C by filling with 
buffer as appropriate. 
31| Determine the contact point of the indenter with the bottom surface of the 
immersion bath, and set this position as zero gauge length (position 0 mm). 
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32| After the zero gauge length has been reset to the bottom level of the immersion 
bath in Step 31, raise the indenter well above the expected hydrogel height. 
33| Place the hydrogel in the immersion bath underneath the indenter. 
? TROUBLESHOOTING 
34| Using a ramp displacement command, lower the indenter at a rate of 0.01 mm/s, 
until a compressive strain of ≥15 % of the hydrogel height is reached, and record the 
force-displacement data. 
CRITICAL STEP Initiate the linear displacement well above the hydrogel (e.g., 
0.3 mm above the contact point) to allow for accurate determination of the hydrogel 
height and compressive strain. 
CRITICAL STEP Ensure that the hydrogel surfaces are flat and parallel to the 
bottom of the immersion bath. 
CRITICAL STEP For some applications that include engineering of load-
bearing tissues, which undergo large amounts of physical deformation such as 
articular cartilage, the ultimate strength of the hydrogel constructs may be of interest. 
To determine the fracture stress and strain, compress the sample until it breaks, and 
obtain the stress (Pa) and strain (%) values from the stress-strain curve at the point of 
failure. 
35| Determine the hydrogel height from the force-displacement curve, which is the 
point at which the force starts deviating significantly from zero. 
36| Determine the compressive modulus Ec (Pa) as the slope of the linear region of 
the stress-strain curve between 10 and 15 % hydrogel compressive strain using a 
linear regression analysis or the formula Ec = (σ2 − σ1)/(ε2 − ε1), where σ2 is the stress 
at ε2, σ1 is the stress recorded at force (N) divided by cross-sectional hydrogel area 
(m2) at ε1, ε2 is a strain of 0.15 and ε1 is a strain of 0.10. 
? TROUBLESHOOTING 
 
 Bright-field microscopy and CLSM TIMING 3-5 h  3.3.6
37| If you wish to visualize the cell morphology and viability of cell-laden GelMA-
based hydrogels, perform one of the following microscopic procedures [161, 317]. 
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Collect one cell-laden hydrogel after days 1, 7 and 14 of 3D culture (or any other 
desired time point) for each replicate experiment. Perform microscopy of cell-laden 
GelMA-based hydrogels according to option A, if a low-contrast image is sufficient 
(Fig. 2), or option B, if a live-dead assessment is desired (Fig. 4), or option C, if a 
high-contrast image is required (Fig. 2), or perform all determinations in sequence 
during the same experiment using the same cell-laden GelMA-based hydrogel 
sample (if all microscopy assays are being performed, they must be performed in the 
order stated here). 
 
(A) Bright-field microscopy 
CRITICAL STEP Do not open the lid of your ongoing sterile hydrogel culture 24-well 
plate; tape the lid to the plate when taking it out of the cell culture incubator.  
(i) To visualize the cell morphology of encapsulated cells grown within 
hydrogels in a 24-well plate, take bright-field images of the hydrogel 
samples using a standard microscope with a 10/20× air objective. 
 
(B) CLSM of live hydrogel samples using live-dead staining 
CRITICAL STEP Perform fluorescence staining of live and PFA-fixed samples 
protected from light.  
(i)  Wash hydrogel samples in an individual well of a 24-well plate in 1 mL 
of PBS for 5 min in a cell culture incubator at 37 °C.  
(ii) Incubate the samples from Step 37A(i) in 0.5 mL of PBS containing FDA 
2 μg/mL to stain living cells for 15 min at 37 °C.  
(iii)  Wash the samples with PBS for 5 min at 37 °C, as described in Step 
37B(i).  
(iv)  Incubate the samples in 0.5 mL of PBS containing 20 μg/mL PI to stain 
dead cells for 15 min at 37 °C. Alternatively, instead of being subjected 
to two sequential incubations, hydrogel samples can be incubated in PBS 
containing both FDA and PI for 15 min at 37 °C using the same 
concentration as reported above.  
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(v)  Image the samples with a standard fluorescence microscope with a 
10/20× air objective or CLSM with a 10/20× oil objective. Please note 
that at this point hydrogel samples may be discarded. Alternatively, fix, 
permeabilise and immunofluorescently stain as described in Step 37C(i–
vii) before performing CLSM on PFA-fixed hydrogel samples. 
Performing option C is appropriate if you require a high-contrast image 
of 3D-cultured cells. 
 
(C) CLSM of PFA-fixed hydrogel samples  
(i)  Perform fixation of samples with 4 % (wt/vol) PFA dissolved in PBS into 
a 24-well plate on a shaker/rocker for 30 min at RT. 
 PAUSEPOINT Samples can be stored in 4 % (wt/vol) PFA in PBS at 4 °C 
for up to 1 month.  
(ii)  When you are ready to proceed with the fluorescence staining, 
permeabilise the samples in 0.2 % (vol/vol) Triton X-100 in PBS for 30 
min at RT.  
(iii)  Wash the samples with 1 mL of 0.1 M glycine in PBS, and then twice 
with 1 mL of PBS for 5 min each at RT in an individual well of a 24-well 
plate.  
(iv)  Incubate the samples in rhodamine 415–conjugated phalloidin 0.3 U/mL 
diluted in 1 % (wt/vol) BSA in PBS for 1 h at RT to stain F-actin.  
(v)  Wash the samples twice with 1 mL of PBS for 5 min each at RT in an 
individual well of a 24-well plate.  
(vi)  Incubate the hydrogels in 2.5 μg/mL DAPI in PBS for 40–50 min at RT 
to stain cell nuclei.  
(vii)  Wash the samples twice with PBS for 5 min each at RT, as described in 
Step 37C(v).  
(viii)  Image the samples with a 10/20× oil objective at three (or more) different 
positions, and acquire z-stacks with a constant thickness of 2 μm, 
reconstructing a cross-section profile of 100–150 equidistant x-y scans, 
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which will cover a distance of 200–300 μm and spheroids of 50–300 μm 
diameter, using a confocal microscope, and generate maximal projections 
of each image23. If required, larger z-stacks (4-μm slice thickness) can 
also be acquired for bigger spheroids with a diameter >500 μm to cover 
the complete thickness of the hydrogel. 
 
 Cell viability and proliferation assays TIMING 3-4 d 3.3.7
38| If you wish to perform cell viability and proliferation assays, collect cell-laden 
hydrogels after days 1, 7 and 14 of 3D culture in triplicate in biological replicate 
experiments [289]. Optionally, depending on the cell type, hydrogel cultures can be 
set up for additional time points after days 4 and 11 of 3D culture or for long-term 
cultures up to 4 weeks [289]. If required, quintuplicates can be measured per time 
point and replicate experiment. Set up cell-free hydrogels to obtain the baseline 
fluorescent signal for each culture medium depending on the cell type and time point. 
39| Determine cell viability in the cell-laden GelMA-based hydrogel sample, option 
A, or cell proliferation in the same sample, option B, or perform option A followed 
by option B during the same experiment (the assays must be performed in this 
order). 
 
(A) AlamarBlue cell viability assay  
(i)  Culture each individual cell-laden GelMA-based hydrogel in an 
individual well of a 24-well plate for the desired period of time - for 
example, 2–4 weeks as mentioned in Step 38 - in a cell culture incubator 
at 37 °C.  
(ii)  Prepare a fresh, sterile 24-well plate with at least 0.5 mL of the specific 
culture medium for the cell type listed in the Reagent Setup containing 4 
% (vol/vol) AlamarBlue reagent, and place each hydrogel replicate into 
individual wells 6 h before each time point and incubate it in a cell 
culture incubator at 37 °C. Alternatively, 48-well plates can be used.  
(iii)  After 6 h, transfer individual hydrogels into an individual well of a new 
24-well plate in 1 mL of PBS per well on a shaker/rocker for 30 min to 
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destain the AlamarBlue reagent–coloured hydrogels (blue or pink), and 
measure fluorescence signals of the AlamarBlue reagent–containing 
medium in triplicate in a black 96-well plate using a plate reader.  
(iv)  Transfer each individual destained hydrogel to a 2-mL conical tube using 
a spatula, and freeze them at −80 °C for at least 48 h if you plan to also 
perform Step 39B.  PAUSEPOINT Samples can be stored at −80 °C 
for at least 1 month. 
 
(B) CyQUANT cell proliferation assay  
(i)  Implement Step 39A(i) of the present procedure as described above. 
Alternatively, if AlamarBlue cell viability assay has already been 
performed, thaw the hydrogel samples or set them aside at Step 39A(iv).  
(ii) Incubate cell-laden GelMA-based hydrogel samples with 300 μl of 
proteinase K solution (0.5 mg/mL in PBE buffer) in 2-mL conical tubes 
overnight for at least 16 h at 65 °C using a heat block.  
CRITICAL STEP The optimal digestion temperature for proteinase 
K is 65 °C. Make sure that the temperature is kept constant over the 
incubation time for optimal hydrogel degradation.  
(iii)  Centrifuge the samples at 8,000g for 30 s at RT, and pipette 50 μl of each 
hydrogel replicate in triplicate into a black 96-well plate.  
(iv)  Prepare a DNA standard curve using the λDNA standard provided with the 
CyQUANT assay kit over eight concentrations ranging from 0 to 2,000 ng/mL 
in 1× cell lysis buffer, and then pipette 50 μl of each DNA standard 
concentration in triplicate into the same black 96-well plate from Step 
39B(iii).  
CRITICAL STEP If more than one black 96-well plate is needed, it 
is recommended to prepare a DNA standard curve for each individual 
plate. 
(v)  Add 50 μl of RNase A solution to each well (containing samples and 
DNA standards) to degrade any RNA reassuring DNA specificity, and 
incubate the plate for 1 h at RT on a shaker/rocker.  
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(vi)  Add 100 μl of CyQUANT GR dye solution to each well, and incubate the 
plate for 5 min at RT on a shaker/rocker before measuring the 
fluorescence signals using a plate reader.     
 CRITICAL STEP To ensure the integrity of the fluorescence 
signals, ensure that the CyQUANT GR dye solution is added in a light-
protected room and that it is incubated protected from light.  
(vii)  Overlay the standard curve with a linear regression line, and determine 
the DNA content of individual samples.  
 CRITICAL STEP Subtract the fluorescence signal from the cell-free 
hydrogel sample for each cell type and time point measured.  
 CRITICAL STEP If the fluorescence signal of the sample with the 
highest cell number exceeds the fluorescence signal of the DNA standard 
with the highest concentration, repeat the assay by diluting all cell-
containing samples with 1× cell lysis buffer 1:5–1:10. 
 
 Total RNA extraction from GelMA-based hydrogels TIMING 2-4 h  3.3.8
CRITICAL RNA is sensitive to degradation by ubiquitous RNases, and 
precautions need to be taken when working with RNA. If possible, perform RNA 
isolation in a designated area, and treat bench and equipment surfaces with 
commercially available RNase-inactivating agents - for example, an RNase 
decontamination solution. Clean benches with 100 % (vol/vol) ethanol. Change 
gloves regularly and do not touch the surfaces and equipment to avoid reintroducing 
RNases. Always use certified RNase-free disposable plasticware, including filtered 
pipette tips and conical microcentrifuge tubes, and designated RNase-free reagents. 
Avoid cross-contamination between samples. 
CRITICAL It may be necessary to pool multiple cell-laden hydrogels, if cells 
were cultured at densities below 1.0 × 105 cells per mL in the GelMA precursor 
solution. 
40| Culture cell-laden GelMA-based hydrogels for a desired period of time - for 
example 2–4 weeks - as mentioned in Steps 37 and 38, in a cell culture incubator at 
37 °C. 
 Chapter 3: Functionalisation, preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular 
tissue culture platforms 116 
41| Proceed with RNA extraction by implementing the directions in option A, if you 
are extracting RNA from samples with relatively high cell numbers (1.0 × 106 cells 
per individual or pooled hydrogel sample), or option B, which is optimal for low cell 
numbers (1.0 × 105 cells per individual or pooled hydrogel sample) [280, 289]. 
 
(A) Total RNA extraction using TRIzol reagent  
(i)  Transfer each individual hydrogel to a 2-mL conical tube with 1 mL of 
TRIzol reagent using a spatula. If possible, disrupt hydrogels by pipetting 
up and down several times. Incubate the samples at RT for 5 min while 
gently shaking occasionally.  
(ii)  Snap-freeze the samples in liquid nitrogen (freezing facilitates the 
homogenization of hydrogels in the following step), and store them at 
−80 °C until further use.  PAUSEPOINT Samples can be stored at 
−80 °C for at least 1 month.  
(iii)  Thaw the samples at RT and homogenize hydrogels either manually, by 
carefully passing hydrogels through a 19-gauge needle with a 5-mL 
syringe 15–20 times or until hydrogels are completely homogenized, or 
mechanically, by adding five borosilicate beads or three stainless steel 
beads to each sample and homogenizing the resulting mixtures in a Bullet 
Blender tissue homogenizer, Mini-Beadbeater, TissueLyser LT or a 
similar mechanical tissue homogenizer. Proceed by spinning the samples 
twice for 1 min or for 2–5 min at 50 Hz or until hydrogels are completely 
homogenized. Although manual homogenization is suitable for rather 
soft hydrogels (<50 kPa), mechanical disruption using a tissue 
homogenizer needs to be used for stiff hydrogels (>50 kPa).  
 CRITICAL STEP When implementing manual homogenization, 
hydrogel pieces may clog the needle occasionally. Take care to avoid 
spillage and contamination when clearing clogged needles. 
 CRITICAL STEP Ensure best possible sample homogenization to 
maximize cell disruption and RNA yield.  
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(iv) Proceed to phase separation according to the TRIzol reagent 
manufacturer’s instructions for the isolation and purification of total 
RNA using a chloroform and 2-propanol precipitation. 
         CRITICAL_STEP Ensure RNA integrity by agarose gel analysis or 
using a Bioanalyser and probe for the absence of contaminants using a 
NanoDrop spectrophotometer (make sure that the A260 nm/280 nm ratio 
is over 1.8 and the A260 nm/230 nm ratio is in the 2.0–2.2 range) before 
proceeding to downstream applications, such as reverse transcription to 
cDNA. If necessary, perform additional RNA clean-up using commercial 
column-based RNA purification kits. 
 
(B) Total RNA extraction using the RNeasy Micro kit  
(i)  Transfer hydrogels into 0.35 mL of RLT buffer containing 1 % (vol/vol) 
β-mercaptoethanol in 2-mL tubes using a spatula. If possible, disrupt 
hydrogels by pipetting up and down several times. 
(ii)  Snap-freeze the samples in liquid nitrogen (freezing facilitates the 
homogenization of hydrogels in the following step), and store them at −80 °C 
until further use.  PAUSEPOINT Samples can be stored at −80 °C for at 
least 1 month.  
(iii)  Thaw the samples at RT and homogenize the hydrogels either manually, 
as described in Step 41A(iii), or mechanically, by loading the lysate onto 
a QIAshredder spin column placed in a 2-mL conical tube and 
centrifugation at 12,500g for 2 min at RT using a standard bench-top 
centrifuge. 
CRITICAL STEP Ensure best possible sample homogenization to 
maximize cell disruption and RNA yield.  
(iv)  Proceed according to the RNeasy Micro kit manufacturer’s instructions 
for the isolation and purification of total RNA. 
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 Troubleshooting 3.3.9
Troubleshooting advice can be found in Table 3-2. 
  Table 3.2: Troubleshooting table
 
 
 Timing 3.3.10
Steps 1–11, GelMA functionalisation, dialysis and lyophilisation: 1–2 weeks 
Steps 12 and 13, characterization of GelMA functionalisation: 1–2 h 
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Steps 14–18, preparation of GelMA precursor solution: 1–2 h 
Steps 19–26, cell encapsulation and hydrogel construct preparation: 3–5 h 
Steps 27–36, mechanical testing of GelMA-based hydrogels: 1–3 h 
Step 37, bright-field microscopy and CLSM: 3–5 h 
Steps 38 and 39, cell viability and proliferation assays: 3–4 d 
Steps 40 and 41, total RNA extraction from GelMA-based hydrogels: 2–4 h 
 
 Anticipated results 3.3.11
This protocol can be used for a variety of applications in cancer research, as 
well as tissue engineering and regenerative medicine. This modular technology 
platform provides a universal and easily adaptable 3D cell culture system that 
combines natural binding sites with controllable properties. All components of 
GelMA-based hydrogels are affordable, broadly available and easy to handle, 
whereas the chemical modification enables researchers to control reproducibility, 
physicochemical and mechanical properties, and cellular behaviour. In addition, 
GelMA-based hydrogel constructs can be molded into wide-ranging shapes and are 
easy to produce, which has proven to be a great advantage over systems such as 
Matrigel and collagen type I gels, and which allows for a greater variety of 
experimental procedures and analysis. 
After the GelMA functionalisation procedure described herein, by using the 
recommended 0.6 g of methacrylic anhydride per 1 g of dissolved gelatin, an 
estimated DoF of 80 % can be achieved. An estimated DoF of 50 % is the minimum 
to generate 5 % (wt/vol) GelMA-based hydrogels. The mechanical properties of 
GelMA-based hydrogels are largely dependent on the DoF, the polymer and 
photoinitiator concentrations, and the thermal gelation state of the GelMA precursor 
solution, as well as the UV exposure (intensity and time) during photocrosslinking of 
the polymer network [177]. As hydrogel stiffness and crosslinking density are 
directly related to and strongly influence cellular behaviour, mechanical 
characterization represents a cost- and time-effective measure of reproducibility 
between different GelMA batches and hydrogel preparations. Furthermore, it can 
also be performed to assess changes in the physical properties of the hydrogels after 
ECM deposition or enzymatic degradation during 3D cell culture and tissue 
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engineering experiments. The practically achievable range of stiffness is ~1–200 kPa 
[177]. 
Although various 3D matrices are increasingly used for cell-based studies, 
there are difficulties in adapting routinely used cytological methodologies to 3D 
cellular microenvironments. No consideration is given to the different cell 
architecture, cell surface area exposed or interference of the 3D matrix. Our teams 
have optimized the application of two quantitative assays to 3D cell cultures in which 
cells are embedded within different hydrogel materials [280, 289]. Cell viability and 
proliferation of 3D-cultured cells can be determined by performing the AlamarBlue 
and CyQUANT assays, respectively. Although the AlamarBlue reagent enables 
researchers to measure a cell’s metabolic activity, results of the CyQUANT assay 
provide indication of cell proliferation, based on the DNA content of the cell-
containing sample. Both procedures can be performed individually and 
independently from each other using the same cell-laden GelMA-based hydrogel 
sample. 
RNA extraction procedures, using either TRIzol reagent or a RNeasy micro kit, 
can be used to isolate high-quality total RNA from cells encapsulated in GelMA-
based hydrogels for a variety of downstream applications, including reverse 
transcription real-time PCR, (micro)array analysis, whole-transcriptome analysis 
using next-generation sequencing, digital PCR, northern blot analysis and cDNA 
library constructions. 
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4.1 INTRODUCTION 
Tissue engineering is a rapidly growing field of research that aims to develop 
methods and technologies to generate functional biological substitutes that 
recapitulate or improve the morphological, biochemical, as well as mechanical 
properties of tissues found in vivo [318]. As such, it typically involves, but is not 
limited to, a combination of cells, scaffolds, as well as biological and mechanical 
factors (Figure 4.1) [319]. Articular cartilage tissue engineering has been studied 
extensively [231] as an alternative approach for currently administered surgical 
treatments of focal cartilage defects which often fail to restore physiological tissue 
function on a long term basis [113, 320]. Hence, a large variety of cell sources, 
scaffolding materials, and in vitro culture techniques [321] have been investigated 
with varying degrees of success in creating neo-tissue constructs with native-like 
properties. Chondrocytes, as well as other cell types utilized for these purposes, react 
to physiological mechanical stimuli by increased synthesis of extracellular matrix 
(ECM) macromolecules [322] which can significantly improve to the mechanical, as 
well as biochemical characteristics of the newly formed tissue constructs [323, 324]. 
For successful cartilage tissue engineering, the compressive, tensile, and frictional 
properties are of crucial importance as these characteristics significantly govern the 
long-term fate of neo-tissue constructs to be implanted into focal cartilage defects. 
This has motivated the design of a variety of bioreactor systems [325] aiming to 
improve these characteristics by providing a dynamic culture environment that 
favours the production of sufficient amounts of ECM and, hence, allows the 
generation of suitable biological implants in a clinical perspective. The working 
principles of some of these bioreactors involve the application of hydrostatic pressure 
[326, 327], compressive [328, 329] or shear loading [202, 209], or a combination of 
multiple loading regimes [204, 205]. The efficiency of these culture systems has 
been emphasized in multiple studies outlining significant improvements of the 
biochemical and mechanical properties of mechanically stimulated constructs. 
Additionally, besides investigations related to tissue engineering and regenerative 
medicine, such bioreactors have the potential to effectively recreate the 
biomechanical environment chondrocytes and other musculoskeletal cells reside in 
and hence represent a vital tool to study complex phenomena such as 
mechanotransduction. The significance of these investigations becomes clear when 
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considering the pivotal role mechanical stimulation has on the homeostasis of 
articular cartilage in vivo. Facilitated by joint-movement, mechanical stimuli 
significantly influence the development of articular cartilage [227], chondrocyte 
homeostasis [109], matrix-protein biosynthesis and deposition [110], maintenance of 
cartilage volume [111], and MMP-mediated matrix remodelling [111]. However, 
mechanical stimulation also represents a crucial pathogenic factor when loading is 
excessive and may play a role in the development of degenerative conditions such as 
osteoarthritis [113, 116, 117]. Accordingly, mechanical stimulation bioreactors 
mimicking the mechanical environment of a diarthrodial joint are essential for the 
investigation of mechanotransduction pathways involved in both, maintenance of 
tissue homeostasis and tissue pathology.  
 
Figure 4.1: Schematic illustrating typical workflows for functional articular cartilage 
engineering and research. (A) A cartilage or bone marrow biopsy is obtained and (B) target cells are 
isolated using standard cell culture methods. (C) Cells are expanded on tissue culture plastic to obtain 
sufficient cell numbers for (D) encapsulation in hydrogel constructs or seeding onto scaffolds, 
followed by chondrogenic (re-) differentiation of expanded cells in 3D cultures. After a static pre-
culture period, tissue-engineered constructs are (E) cultured in a specialized bioreactor under 
controlled conditions. The replication of physiological mechanical and atmospheric stimuli in the 
bioreactor enhances (F) the maturation of tissue constructs, which (G) can be applied as in vitro 
models (at various stages of the process) or, in a clinical setting, be implanted into focal cartilage 
defects. 
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Tissue engineering and cell biology research increasingly utilise biomaterial-
based hydrogels as three-dimensional scaffolds as they often inherit cell-attachment 
motifs, are enzymatically degradable, possess cell-instructive bioactivity [107], and 
thus recapitulate the native cellular microenvironment better than traditional 2D cell 
culture approaches [107, 164, 167]. As such, gelatin methacryloyl (GelMA) 
hydrogels have attracted great attention for tissue engineering and cell culture 
applications in recent years [281]. GelMA is produced by chemical modification of 
gelatin and can be covalently crosslinked under gentle conditions, allowing the 
encapsulation of chondrocytes with high viability [161]. By addition of small 
amounts of chemically functionalized hyaluronic acid (hyaluronic acid methacrylate, 
or HAMA), differentiation of expanded chondrocytes can be significantly enhanced, 
leading to neo-tissue formation with hyaline-like biochemical composition [161]. 
Although these results are promising, it remains unclear how encapsulated 
chondrocytes react to physiological mechanical stimuli in this hydrogel system - an 
important factor which needs to be considered for potential clinical translation.  
The design of a mechanical stimulation bioreactor system should be inspired 
by observations of the native biomechanical environment of articular cartilage, but 
also reduce its complexity to allow more conclusive investigations into the effects of 
various loading parameters using a variety of model systems such as explant cultures 
or hydrogel systems. The main types of biomechanical loading articular cartilage 
experiences during day-to-day usage are compression and shear [231], and the 
application of these loading types also has functional applications in cartilage tissue 
engineering [330]. Additionally, articular cartilage has a low oxygen tension ranging 
from ~ 6 - 10 % at the articular surface to ~ 1 % near the tidemark [331, 332], and 
evidence suggests that hypoxic culture conditions promote a chondrogenic phenotype 
in vitro [333-335]. Besides the imitation of these mechanical and environmental 
characteristics, an optimal system should also consider more practical aspects of 
tissue culture and allow for easy assembly, as well as cleaning and sterilization to 
ensure sterility of long-term cultures. In addition, it should accommodate a relevant 
number of samples to allow for statistical data interpretation, require minimal hands-
on time with a user-friendly and robust interface, facilitate precise biaxial mechanical 
stimulation (shear and compression), be easily adaptable to specific experimental 
requirements, and be cost-effective. This project was therefore aimed at 
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implementing these factors in an innovative bioreactor design that allows for 
accurate shear and compressive stimulation of various samples types in an oxygen-
controlled atmosphere. Employing this novel bioreactor, we investigated the effects 
of preculture and various loading regimes on chondrocyte gene expression in 
GelMA-HAMA hydrogels, and demonstrate that biaxial mechanical stimulation can 
significantly improve the properties of tissue-engineered cartilage constructs. 
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4.2 MATERIALS AND METHODS 
 Bioreactor design and manufacture  4.2.1
The shear and compression bioreactor system was designed using SolidWorks 
2012 3D CAD software (Dassault Systemes, SA, France). Manufacture and assembly 
was performed at the Queensland University of Technology Design and 
Manufacturing Centre (QUT DMC). The micro-linear acutators (T-NA Micro Linear 
Actuators, Zaber Technologies, Vancouver, Canada), a 50 N load cell (LSB200, 
Futek, Irvine, USA), as well as the hypoxia system (BioSpherix, Lacona, NY, USA) 
were purchased commercially. All commercial parts have been extensively tested 
and characterised by the manufacturers.   
 
 Actuator control and data acquisition 4.2.2
A custom virtual instrument and graphical user interface was developed using 
LabView (National Instruments, Austin, USA) to permit actuator control and 
acquisition of load and displacement data. The acutators and the load cell are 
connected to a laptop via USB without the need of additional control units.  
 
 Macromer synthesis 4.2.3
GelMA [164] and hyaluronic HAMA [161, 240] were synthesized as described 
previously. Briefly, gelatin (porcine skin, Type A, gel strength 300; Sigma Aldrich, 
St. Louis, MO, USA) was dissolved in phosphate-buffered saline (PBS, pH 7.4; 
Invitrogen, Carlsbad, CA, USA) at 10 % w/v and reacted with 0.6 g of methacrylic 
anhydride (MAAh) per gram of gelatin for 1 h at 50 °C under constant stirring. 
Hyaluronic acid (HA, molecular weight 0.86 MDa, Novozymes, Denmark) was 
dissolved in PBS at 1 % w/v and reacted with a 5-fold molar excess of MAAh over 
HA hydroxyl groups for 24 h on ice at pH 8. Insoluble MAAh and low molecular 
weight by-products were removed by dialysis against ultrapure water (MilliQ, Merck 
Millipore) and the pH of the dialysed products was adjusted to 7.4, after which 
macromere solutions were lyophilised and stored at -20 °C until further usage.  
 
 Chapter 4: A novel biaxial mechanical stimulation bioreactor for cartilage research and tissue engineering 129 
 Articular chondrocyte isolation and expansion culture 4.2.4
Human articular cartilage specimens were obtained with ethical approval from 
the Prince Charles Hospital (Brisbane, QLD, Australia) and Queensland University 
of Technology (Ethics RM: 1400001024) from consenting patients undergoing total 
knee arthroplasty surgeries for osteoarthritis. Articular chondrocytes were isolated 
from macroscopically normal cartilage of the lateral femoral condyles, as described 
elsewhere [241]. For gene expression studies, chondrocytes were isolated from a 
total of 4 donors (60, 72 and 74 year old females, 56 year old male), while cells from 
3 donors were used for long-term experiments (66 and 67 year old males, 65 year old 
female). Following isolation, cells were expanded on tissue culture plastic in low-D-
glucose chondrocyte basal medium (Dulbecco’s modified Eagle’s medium (DMEM) 
with 2 mM GlutaMAX™, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES), 0.1 mM nonessential amino acids, 50 U/mL penicillin, 50 µg/mL 
streptomycin, 0.5 µg/mL amphotericin B (Fungizone®) (all Invitrogen, CA, USA), 
0.4 mM L-proline and 0.1 mM L-ascorbic acid (both Sigma-Aldrich)) supplemented 
with 10 % foetal bovine serum (FBS) (Hyclone, Logan, UT, USA). All cell 
cultures/hydrogel constructs were incubated at 37 °C in a humidified 5 % CO2/95 % 
air CO2 incubator with the medium replaced every 3-4 days. 
 
 Chondrocyte encapsulation and culture 4.2.5
GelMA and HAMA were dissolved in PBS containing 0.05 % w/v Irgacure 
2959 (1-[4-(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propanone; BASF, 
Ludwigshafen, RLP, Germany) at 37 °C. Passage 1 human articular chondrocytes 
were suspended in the hydrogel precursor solutions at 7 – 10 million cells/mL and 
photocrosslinked by exposure to 365 nm light at an intensity of ~2.6 mW/cm2 in a 
CL-1000 crosslinker (UVP, Upland, CA, USA) for 15 min in a custom 
polytetrafluoroethylene (PTFE) casting mold which produces constructs with 
dimensions of 4 mm x 4 mm x 2 mm (L x W x H). For short term experiments 
(Figure 4.4), cells were encapsulated in 14.5 % w/v GelMA and 0.5 % w/v HAMA, 
while 10 % w/v GelMA and 0.5 % w/v HAMA was employed for long-term 
experiments to allow better comparison of neo-tissue formation under dynamic 
loading conditions with our previously published results obtained under static 
conditions [161, 162]. Cell-hydrogel constructs were cultured in serum-free high-D-
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glucose basal chondrocyte medium (see 2.4. for composition) with ITS-G 
(100 × dilution), 1.25 mg/mL bovine serum albumin (BSA), 0.1 μM dexamethasone 
(all Sigma-Aldrich) and 10 ng/mL transforming growth factor beta 3 (TGF-β3) 
(GroPep, Adelaide, SA, Australia) for up to 28 days, with and without biaxial 
mechanical stimulation. 
 
 Uni- and biaxial mechanical stimulation of cell-hydrogel constructs 4.2.6
For short-term gene expression experiments, constructs were precultured under 
free swelling conditions for 7 or 14 days, followed by dynamic uni- or biaxial 
mechanical loading for 1 h at a frequency of 1 Hz with various loading regimes 
outlined in Figure 4.4 (n = 4-6 technical replicates, one donor per study). Samples 
were terminated for total RNA isolation 0 h, 2 h, or 4 h after loading had ceased, as 
indicated. For long term experiments, constructs were either cultured under free 
swelling conditions for 28 days (free swelling controls), or precultured for 14 days, 
followed by daily biaxial dynamic loading for 1h at 1 Hz with a compressive strain 
of 30 % of construct height and shear amplitude of 1 mm for another 14 days (3 
donors, 2 constructs per donor for DNA and GAG analysis; 3 donors, 1 construct per 
donor for viability and immunofluorescence analysis). 
 
 Cell viability 4.2.7
Live and dead chondrocytes were visualized with fluorescein diacetate (FDA) 
and propidium iodide (PI, both Sigma), respectively. Constructs were washed in PBS 
at room temperature (RT), followed by incubation with 10 μg/mL FDA and 5 μg/mL 
PI in PBS for 3 minutes at RT, and then washed again in PBS.  Z-stack fluorescence 
images were captured using a Carl Zeiss Axio microscope, and cell viability was 
quantified in at least 6 images from 3 biological replicates, respectively, using an 
ImageJ script (National Institutes of Health, USA). Cell viability is expressed as 
percentage of living to total cells. 
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 Biochemical analysis 4.2.8
To analyse the DNA and glycosaminoglycan (GAG) content of cell-laden 
GelMA-HAMA constructs, samples were weighed and enzymatically digested in a 
two-step procedure by overnight incubation in phosphate-buffered EDTA (pH 7.1) 
containing 1 mg/mL hyaluronidase (Sigma) at 37 °C, followed by addition of 0.5 
mg/mL proteinase K (Invitrogen) and overnight incubation at 56 °C. DNA 
concentration in the digests was measured using the Quant-iT™ PicoGreen® dsDNA 
quantification assay (Invitrogen). GAG concentrations were measured using the 
dimethyl-methylene blue (DMMB) assay at pH 1.5 and obtained values were 
corrected using values for cell-free gels to determine the amount of GAGs produced 
by cells. GAGs secreted to the culture media were measured at the last media change 
and expressed as GAGs secreted to the media within 24 h of culture, with and 
without 1 hour of mechanical loading. 
 
 Mechanical testing 4.2.9
The Young’s modulus of constructs submerged in PBS at 37 °C was measured 
in unconfined compression tests using an Instron 5848 microtester equipped with a 
5_N load cell (Instron, Melbourne, VIC, Australia). Constructs were compressed at 
0.01 mm/s using a non-porous aluminium and the Young’s modulus was determined 
as the slope of the stress-strain curve from 10 % - 15 % strain [164].  
 
 Gene expression analysis 4.2.10
Cell-laden hydrogel constructs were homogenized in TRIzol reagent 
(Invitrogen), and total RNA was isolated according to the manufacturer’s 
instructions. Complementary DNA (cDNA) was synthesized using the SuperScript™ 
III First Strand Synthesis System (Invitrogen) with DNase and RNase digestions 
performed before and after cDNA synthesis, respectively. Quantitative reverse 
transcription real-time polymerase chain (qRT-PCR) was performed using 
SybrGreen® Mastermix (Invitrogen) and either a 7900HT fast real-time PCR system 
or QuantStudio™ 7 Flex Real-Time PCR system (both Applied Biosystems).  
 Chapter 4: A novel biaxial mechanical stimulation bioreactor for cartilage research and tissue engineering 132 
The cycle threshold (Ct) value of each gene was normalized to the geometric 
mean of the housekeeping genes B2M and TBP using the comparative Ct method     
(2-ΔCt). The primer sequences (5’  3’) used for PCR were as follows: B2M: F: 
ATGAGTATGCCTGCCGTGTGA, R: GGCATCTTCAAACCTCCATGATG; TBP: 
F: GAGCCAAGAGTGAAGAACAGTC, R: CATCACAGCTCCCCACCATATT; 
COL2A1: F: GGCAATAGCAGGTTCACGTACA, R: CGATAACAGTCTTGCC-
CCACTT; COL1A1: F: CAGCCGCTTCACCTACAGC, R: TTTTGTATT-
CAATCACTGTCTTGCC; ACAN: F: GCCTGCGCTCCAATGACT, R: 
TAATGGA-ACACGATGCCTTTCA; PRG4: F: GAGTACCCAATCAAGG-
ATTATCA, R: TCCATCTACTGGCTTACCATTGC. 
 
 Immunofluorescence analysis 4.2.11
Constructs were embedded in Optimal Cutting Temperature compound (OCT) 
(Sakura, Finetek, Tokyo, Japan), sectioned at a thickness of 10 μm, and air-dried. 
Sections were fixed with ice-cold acetone for 10 min, air-dried, rehydrated in 50 mM 
BaCl2/100 mM Tris HCL buffer (pH 7.3) for 1 h, and incubated in 100 mM Tris 
HCL buffer (pH 7.3) for 5 min. Sections stained for collagen I and II were incubated 
with 0.1 % hyaluronidase (Sigma-Aldrich) at 37 °C for 30 min for antigen retrieval. 
Primary antibodies for aggrecan (969D4D11, Invitrogen; 1:400 dilution in PBS with 
2 % donkey serum), collagen type I (I-8H5, MP Biomed, Solon, OH, USA; 1:300 
dilution in PBS with 2 % goat serum), collagen type II (II-II6B3, Developmental 
Studies Hybridoma Bank (DSHB), Iowa City, IA, USA; 1:150 dilution in PBS with 2 
% goat serum), and CD44 (H4C4, DSHB, 1:200 dilution) were applied overnight at 
4 °C in a humidified chamber. Integrated fluorescence density measurements were 
performed on at least 6 immunofluorescence images from corresponding areas in the 
centre and periphery of hydrogel constructs. Intensity values for ECM proteins were 
normalized to intensities obtained for DAPI staining to correct for differences in cell 
numbers. 
 
 Statistical analysis 4.2.12
Statistical analysis was performed using GraphPad Prism software (version 7; 
GraphPad, CA, USA) with a significance level of 0.05. One-way analysis of variance 
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(ANOVA) Tukey’s post-hoc tests were performed to investigate the effects of culture 
duration and culture condition on chondrocyte viability and gene expression, as well 
as total DNA content, wet weight, and Young’s moduli of cell-laden constructs. The 
gene expression data presented in Figure 4.6 were log2-transformed before statistical 
analysis to correct for skew in the dataset. Unpaired student’s t-tests were performed 
to investigate statistical differences in GAG and extracellular matrix synthesis 
between free swelling and loaded constructs at day 28 of culture. Statistical 
differences are indicated in figures using symbols. 
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4.3 RESULTS 
 Shear and compression bioreactor system 4.3.1
The bioreactor was designed to apply mechanical sliding shear and 
compressive stimulation to a variety of sample types such as articular cartilage 
explants or cell/hydrogel constructs for tissue engineering, but can be readily adapted 
to various other applications or sample types. The device can be subdivided into two 
main structural components, (i) the stand and base plate, and (ii) the polycarbonate 
culture chamber (Figure 4.2A). The aluminium stand and base plate were anodized 
(blue colour) to prevent corrosion and carry two orthogonally aligned micro linear 
actuators with a resolution (microstep size) of ˂ 50 nm and a repeatability of ˂ 1 μm 
to facilitate accurate biaxial mechanical stimulation, translating to an unidirectional 
accuracy of 15 μm. The actuators allow for a travel range of 25 mm, up to 8 mm/s 
speed and 50 N continuous thrust, and provide real-time position feedback by 
integrated controllers. Their relative position to the culture chamber is adjustable for 
increased adaptability to specific experimental parameters. Static or dynamic 
compression is facilitated by PTFE plungers attached to a vertically driven loading 
plate. A modular design allows for quick and easy exchange of the loading plate and 
plungers, permitting the use of various standard cell culture plates, such as 24 or 48-
well plates. Customized or standard tissue culture plates can be placed in a sliding 
platform which is driven horizontally on stainless steel rods with Teflon sliding 
bearings to enable the exertion of precise shear stimulation while minimizing effects 
of friction and inertia (Figure 4.2B). To ensure backlash-free movement, the well 
plate is secured by a spring-loaded fastening mechanism (Figure 4.2D). All 
mechanical feed-throughs are equipped with Teflon bearings in order to minimize 
friction during actuator movement. Misalignment of the actuators relative to the 
loading plate or sliding platform is counteracted by specially developed components 
installed in-line of the axes of movement. These components are comprised of two 
stainless steel parts with a tangential globular and a flat surface, respectively, 
surrounded by a firm piece of tubing. This design allows correction of parallel and 
angular misalignments while ensuring backlash-free linear movement.  
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Figure 4.2: Images illustrating the biaxial loading bioreactor system. (A) Front view depicting the 
bioreactor stand (anodized in blue) and the removable culture chamber. (B) Close-up view of PTFE 
pistons lowered into a standard 24-well plate on the actuator-driven sliding platform. (C) Compressive 
loading is facilitated by actuator-driven PTFE pistons, while the movement of the sliding platform 
results in shear deformation of hydrogel construct. (D) Top-view of the culture chamber with PTFE 
linear bearings and the spring-loaded fastening mechanism used to secure standard cell culture plates. 
(E) Culture chamber with front door and removable lid. The sealed chamber also functions as a 
hypoxia chamber and the space underneath the sliding platform fits up to two standard well plates for 
unstimulated controls. 
 
The bioreactor chamber and interior were manufactured from fully 
autoclavable materials (polycarbonate, Teflon, stainless steel) and allow for easy 
cleaning to ensure sterile long-term tissue culture. Specifically designed connectors 
facilitate quick detachment of the chamber from the linear actuators without the 
necessity of tools to enable transfer to a biological safety cabinet for sampling or 
media change. To insert or access the well plate and samples, the O-ring sealed 
chamber lid is removable via stainless steel latches that secure the lid to the chamber. 
The device is fitted with a 50_N miniature load cell for providing real-time force 
feedback and mechanical testing. Additionally, the load cell assists in the 
determination of the plunger contact point to the underlying samples, as well as the 
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average construct height. The chamber can be equipped with an oxygen sensor and a 
sterile gas inlet, which enables supply of an oxygen-free gas mixture with 5 % CO2, 
regulated by a commercial ProOx P110 compact oxygen controller. Hence, 
experiments can be performed under hypoxic or normoxic atmosphere. In the latter 
case, the gas inlets are protected with sterile filters to ensure adequate and aseptic gas 
exchange. Experiments involving mechanical loading under hypoxic atmosphere 
require unloaded control samples. Therefore, the bioreactor chamber was designed to 
accommodate additional well plates underneath the sliding platform which can be 
accessed through an O-ring sealed door in the front. The assembled device is light 
(approximately 2.5 kg) and compact (L x W x H: 40 cm x 23 cm x 33 cm), and can 
be placed in a standard cell culture incubator for long-term culture in a pH and 
temperature controlled environment. 
 
 Actuator control and data acquisition 4.3.2
We developed a user-friendly LabView virtual instrument permitting control of 
actuator and mechanical stimulation parameters, as well as graphical display and 
optional acquisition of load cell and actuator position-readings in real-time (Figure 
4.3). The software allows for individual absolute actuator target position or relative 
displacement commands with integrated motion velocity control (from 0.00022 
mm/s to 8 mm/s). Actuators can be homed individually or together to enable removal 
of the culture chamber. In the latter case, homing of the vertical actuator precedes the 
horizontal actuator to retract plungers from the well plate and prevent stalling. The 
software additionally allows control of dynamic uniaxial or biaxial stimulation 
parameters such as loading frequency, individual amplitudes of shear and 
compressive loading, waveform (triangular, sinusoidal, square, or ramp), and loading 
duration. To minimize hands-on time for long-term experiments, it further allows 
control of total loading cycle repetitions and specification of dwelling time between 
loading cycles, enabling the bioreactor to automatically apply, for example, 1 hour of 
dynamic stimulation every day for a specified amount of days. Static compression 
significantly inhibits chondrocyte biosynthesis [110, 336, 337]. We have therefore 
incorporated parameters to control the actuator position between loading cycles, 
hence permitting plungers to be lifted off the samples during dwelling before 
returning to their initial position and the start of a new loading cycle.  
 Chapter 4: A novel biaxial mechanical stimulation bioreactor for cartilage research and tissue engineering 137 
 
 
Figure 4.3: Screenshot of the LabView graphical user interface permitting actuator control and 
acquisition of displacement and load data. The custom developed software allows control of 
actuator position using relative and absolute displacement commands, as well as dynamic uni- or 
biaxial mechanical stimulation parameters, and provides a graphical interface for force- and actuator 
position feedback.   
 
 Effects of pre-culture and loading and chondrocyte gene expression 4.3.3
In order to determine suitable culture conditions for functional cartilage tissue 
engineering applications, we investigated the effects of pre-culture duration and 
various uni- and biaxial loading regimes on chondrocyte gene expression. Consistent 
with our previously published results using alginate hydrogels [60], compressive 
loading had no significant (ACAN) or only adverse effects on the expression of 
chondrogenic marker genes COL2A1 and PRG4 when cell-laden constructs were pre-
cultured for only 7 days before loading (Figure 4.4A). When static preculture was 
extended to 14 days, however, there was a trend towards increased transcription of 
chondrogenic markers ACAN, COL2A1, and PRG4, which was statistically 
significant at various strain levels when compared to free swelling controls (Figure 
4.4B). To investigate temporal changes of gene expression following compression at 
10 % strain, constructs were sampled for total RNA isolation either directly after (0 
h), or 2 h and 4 h after loading had ceased. Chondrogenic marker genes COL2A1 and 
PRG4 were upregulated directly after loading and levels remained elevated for at 
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least 4 hours (Figure 4.4C). For ACAN, significant changes were observed after 2 h 
and 4 h, while the expression of COL1A1 remained at control level at all investigated 
time points (Figure 4.4C). We then proceeded to investigate the effects of uniaxial 
shear loading on chondrocyte gene expression. There was a general trend towards 
up-regulation of chondrogenic markers with increasing shear amplitudes which was 
significant at 1.5 mm compared to free swelling controls, while the expression of 
COL1A1 was down-regulated at this amplitude (Figure 4.4D). Dynamic biaxial 
loading with a constant dynamic compressive strain of 30 % and shear amplitudes 
ranging from 0.5 – 1.5 mm led to increased transcript levels of all investigated 
chondrogenic markers ACAN, COL2A1, and PRG4, dependent on the shear 
amplitude (Figure 4.4E). However, first signs of wear-and-tear (small cracks and 
increased surface roughness) were observed on a number of cell-hydrogel constructs 
which were loaded at 30 % compression and 1.5 mm shear amplitude, indicating that 
this loading regime may be too harsh for tissue engineering applications. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 (next page): Chondrocyte gene expression in response to short-term uni- and biaxial 
loading. Relative expression of chondrogenic (ACAN, COL2A1), de-differentiation (COL1A1), and 
superficial chondrocyte (PRG4) marker genes following dynamic (A-D) uni- or (E) biaxial stimulation 
for 1 hour at 1 Hz after (A) 7 or (B-E) 14 days of free swelling preculture. (A+B) Cell-laden GelMA-
HAMA constructs were compressed at 10 %, 30 %, or 50 % strain. (C) To investigate the optimal 
sampling time point for gene expression analysis, constructs were compressed at 10 % and samples 
taken for total RNA isolation 0 h, 2 h, or 4 h after compression. (D) A static offset compression of 10 
% of construct height was applied, and constructs were stimulated at 0.5 mm, 1.0 mm, or 1.5 mm 
shear amplitude. (E) Constructs were stimulated with 30 % compressive strain and either 0.5 mm, 1.0 
mm, or 1.5 mm shear amplitude. Gene expression levels of loaded constructs (L) were normalized to 
free-swelling controls (FS) cultured for the same duration (mean of FS controls indicated by broken 
line). Stars indicate a statistical difference between loaded and FS constructs (* p < 0.05, ** p < 0.01, 
*** p < 0.001), while hashtags indicate statistical differences between loading regimes (# p < 0.05). 
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 Effects of intermittent biaxial loading on tissue-engineered constructs in 4.3.4
long-term cultures 
Cell viability and proliferation 
Based on the results obtained in earlier gene expression studies, we 
performed long-term experiments in which chondrocyte-laden constructs were 
statically precultured for 14 days, followed by 14 days with intermittent biaxial 
mechanical stimulation for 1 h daily at 30 % compressive strain and 1 mm shear 
amplitude.  Similar to our previously published results using static culture techniques 
[161], viability of human chondrocytes was high (~90 %) and no significant effect of 
loading was observed (Figure 4.5A-D). At early time-points, chondrocytes appeared 
as single cells which were evenly distributed throughout the constructs, while cells in 
both free swelling and loaded constructs increasingly appeared isolated or in small 
clusters of 2 – 3 cells at later time-points (Figure 4.5A-C). Total DNA content 
increased approximately 1.5-fold over the culture duration. No effects of loading on 
DNA levels were observed.  
 
Figure 4.5: Viability of human articular chondrocytes in GelMA-HAMA constructs. Viability of 
chondrocytes embedded within hydrogel constructs at (A) day 2 and (B) day 28 of free swelling 
culture, or (C) after 14 days of free swelling preculture and 14 days of intermittent biaxial mechanical 
stimulation at 30 % compressive strain and 1 mm shear amplitude at a frequency of 1 Hz for 1h daily. 
Living cells appear green, while dead cells appear red. (D) Quantified viability (3 donors, 1 construct 
each) and (E) total DNA content (3 donors, 2 constructs each). Stars indicate a statistical difference 
between constructs at day 28 and day 2 (* p < 0.05, ** p < 0.01). 
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Physical and biochemical properties 
The wet weight of constructs increased similarly in both free swelling and 
loaded cultured (Figure 4.6A). Consistent with our previous studies [162], the 
Young’s moduli of free swelling constructs increased from ~ 40 kPa to ~ 80 kPa over 
28 days in both free swelling and loaded cultures (Figure 4.6B). Accumulation of 
GAGs in the constructs was not affected by loading (Figure 4.6C, D). Interestingly, 
secretion of GAGs into the media was significantly higher in free swelling construct 
compared to loaded constructs.  
 
 
 
 
Figure 4.6: Physical and biochemical properties. Hydrogel construct (A) wet weights and (B) 
Young’s moduli at day 2 and day 28 of free swelling culture, or after 14 days of free swelling 
preculture followed by 14 days of intermittent biaxial mechanical stimulation at 30 % compressive 
strain and 1 mm shear amplitude at a frequency of 1 Hz for 1h daily. Total GAG content retained in 
the constructs (C) normalized to construct wet weight or (D) DNA content. GAGs secreted into the 
media in 24 h with or without 1 hours of mechanical loading (E) normalized to construct wet weight 
and (F) DNA content. In (A) and (B), stars indicate a statistical difference between constructs at day 
28 and day 2, while stars in (C-F) indicate differences between free swelling and loaded constructs (* 
p < 0.05, *** p < 0.001) (3 donors, 2 constructs each). 
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Extracellular matrix synthesis and accumulation 
GelMA-HAMA constructs supported the synthesis and accumulation of 
hyaline-like ECM which was further enhanced by application of intermittent biaxial 
loading. Strong immunoreactivity for collagen II was observed in free swelling and 
loaded constructs (Figure 4.7A, E) which appeared to gradually decrease towards the 
construct centre (Figure 4.8A, E). The accumulation of collagen II in mechanically 
stimulated constructs was significantly higher than in free swelling constructs 
(Figure 4.7E, I) and stronger interterritorial staining was observed. Immunoreactivity 
for collagen I was minor within both free swelling and loaded constructs. However, 
stronger intra- and pericellular staining was observed in loaded constructs (Figure 
4.7B, F). As previously reported [161, 162], strong collagen I immunoreactivity was 
observed at the outer surface of cell-hydrogel constructs (Figure 4.8B, C), likely 
deposited by cells adherent to the gel surface displaying spreading and de-
differentiated morphologies (Figure 4.8D), similar to chondrocytes propagated on 
tissue culture plastic [338]. Interestingly, no immunoreactivity was observed on gel 
surfaces which were loaded (Figure 4.8F, G). We hence investigated whether biaxial 
loading may cause necrotic cell death of surface-adherent cells using live-dead 
staining in a separate short-term experiment (Figure 4.8D, H). In free swelling 
controls, a dense monolayer of mainly viable cells was observed on the outer 
construct surfaces (Figure 4.8D), while loaded construct surfaces displayed high 
percentages of dead cells (Figure 4.8H).  
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Figure 4.7: Extracellular matrix production in statically cultured and intermittently loaded 
constructs after 28 days. Immunofluorescence staining for (A, E) collagen II, (B, F) collagen I, (C, 
G) aggrecan, and (D, H) proteoglycan 4 of (A-D) statically cultured and (E-H) loaded constructs. 
Immunoreactive regions for collagen II and aggrecan appear green, while immunoreactive regions for 
collagen I and proteoglycan 4 appear red. Nuclei were counterstained with DAPI (blue). Integrated 
fluorescence densities of (I) collagen II, (J) collagen I, (K) aggrecan, and (L) proteoglycan 4 were 
normalized to DAPI intensities to account for differences in cell numbers. Stars indicate a statistical 
difference between free swelling and loaded constructs (* p < 0.05, *** p < 0.001). 
 
Aggrecan immunostaining appeared strong, particularly in pericellular areas 
and more diffuse in interterritorial areas (Figure 4.7C, G). Although there was no 
significant effect of loading on quantified integrated fluorescence intensities 
compared to controls (Figure 4.7K), interterritorial staining appeared slightly 
stronger in loaded constructs. Immunoreactivity for proteoglycan 4, which is 
predominantly expressed by superficial zone chondrocytes [339], was low and 
appeared diffuse throughout the interterritorial matrix (Figure 4.7D,H). Contrary to 
our PCR data, immunoreactivity was further reduced with loading (Figure 4.7L). 
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Figure 4.8: Effects of biaxial loading on collagen deposition and viability of chondrocytes 
adherent to the surface of GelMA-HAMA constructs. Immunofluorescence staining for (A, E) 
collagen II and (B, C, F, G) collagen I in (A-C) statically cultured and (E-G) intermittently loaded 
constructs after 28 days. Immunoreactive regions for collagen II appear green, while immunoreactive 
regions for collagen I appear red. Nuclei were counterstained with DAPI (blue). Viability of 
chondrocytes adherent to the outer surface of GelMA-HAMA construct at day 14 under (D) free 
swelling conditions or (H) after 1 hour of dynamic biaxial mechanical loading (1 Hz, 30 % 
compressive strain, 1.5 mm shear amplitude). Living cells appear green, while dead cells appear red 
(viability staining presented in panels (D) and (H) were performed in a separate, short-term 
experiment).      
 
  
 Chapter 4: A novel biaxial mechanical stimulation bioreactor for cartilage research and tissue engineering 145 
4.4 DISCUSSION 
 Shear and compression bioreactor system 4.4.1
Articular cartilage and chondrocytes experience mechanical stimuli throughout 
life. Remarkably, already during human embryonic development, mechanical signals 
induced by developing muscles contribute to the development of articular cartilage 
[340]. In later life, mechanical loading represents a key factor for tissue maintenance, 
and if excessive, can lead to the development of pathological conditions such as 
osteoarthritis. As a result, the ability of chondrocytes to respond to mechanical 
stimuli by changes in gene and protein expression is increasingly utilised to improve 
functional tissue engineering outcomes. The aim of this work was to develop and 
validate an automated biaxial mechanical stimulation bioreactor system for cartilage 
research and functional tissue engineering. 
Previously described bioreactors used for studies on chondrocyte biology and 
cartilage tissue engineering include system applying compressive loading [38, 200], 
hydrostatic pressure [201], shear loading [202], and hybrid bioreactors incorporating 
multiple loading regimes [203-207]. However, most hybrid bioreactors exhibit a 
number of limitations such as a minor sample capacity [203, 204, 207], use of non 
autoclavable materials [204], open culture chambers [203, 205, 206], or inability to 
measure loads applied to samples [203, 204, 341]. Other design approaches did not 
incorporate separate culture wells. Instead, all samples are placed in the same media 
[204, 341], posing significant limitations if the investigation of secreted factors such 
as cytokines and proteins from individual patient-derived samples is desired. 
Additionally, the reviewed bioreactors do not mimic the hypoxic environment typical 
for articular cartilage [203-206, 341]. We addressed these limitations in our novel 
design which combines precision of loading and monitoring capabilities facilitated 
by well-characterised commercial hardware, user-friendly handling, aseptic culture 
techniques, atmospheric oxygen control, statistically relevant sample capacity, cost-
efficiency, and experimental flexibility. Nevertheless, our system poses some 
features which may be considered as limitations: to ensure homogenous loading 
facilitated by PTFE pistons, the height of all samples must be similar. An alternative 
design compensating this limitation would have to incorporate a number of linear 
actuators individually loading single samples. However, this design would require 
significantly more hands-on-time as sample height and loading protocols would need 
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to be individually determined and tailored. Additionally, such a system would lead to 
increased costs and higher susceptibility to hard- and software failure. Our aim was 
to design a robust bioreactor system which can be operated and maintained by 
researchers in the fields of cell biology and tissue engineering without significant 
knowledge in mechatronics and engineering. Hence, particular emphasis was placed 
on designing a compact system which is easy to use and allows for assembly by hand 
without compromising on its capability to apply precise and reproducible mechanical 
stimulation to various sample types.  
In preparation for an experiment, the culture chamber is cleaned and sterilised 
by either autoclaving, or by sterilisation with 70 % (v/v) Ethanol. However, it should 
be noted that repeated autoclaving limits the life-span of the culture chamber due to 
deterioration of polycarbonate parts (particularly at the interfaces of metal and plastic 
parts). Hence, we typically only autoclave the loading plate and PTFE pistons as 
these are the only parts with direct contact to the samples. Following sterilization, 
samples are placed into commercial cell culture well plates. One challenge in the 
operation of the bioreactor was the fixation of samples to the bottom of the well 
plate. We, therefore, trialled several approaches to secure positions of the sample 
underneath the pistons with varying degrees of success: First, we designed and 
manufactured 0.5 mm high stainless steel rings to fit into individual wells and 
incorporated recesses to fixate samples in place. However, as compressive 
mechanical loading causes lateral sample expansion according to their Poisson’s 
ratio [342], we observed that hydrogel-based samples exhibited signs of cracking 
even after short loading durations due to the expansion against the steel rings. Hence, 
we decided to manufacture similar retaining rings of medical grade PDMS (silicone, 
0.3 mm height) which are softer and more gentle on hydrogel samples (indicated in 
grey in Figure 4.2C). Using this technique, sample wear was only observed at harsh 
loading regimes involving high compressive strains and shear amplitudes. Another 
interesting approach was recently published and involves the creation of similar rings 
from hydrogel materials rather than PDMS [343]. However, this method appears 
more tedious than the use of PDMS rings and requires large quantities of sterile 
hydrogel material which in turn could lead to increased material costs and 
preparation times.  
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The bioreactor system is capable of controlling oxygen levels within the 
culture chamber using a commercial hypoxia system; however, the effects of hypoxia 
were not investigated in this study as we aimed to examine the reproducibility of 
tissue engineering using GelMA-HAMA as scaffold for human chondrocytes [161, 
162], as well as the effects of uni- and biaxial mechanical stimulation in this system. 
Nevertheless, future experiments will involve the examination of chondrocyte 
response to loading under various atmospheric oxygen concentrations.  
 
 Effects of preculture and loading on chondrocyte gene expression 4.4.2
In this study, we employed GelMA-HAMA hydrogels which were previously 
shown to induce chondrogenesis and support the accumulation of hyaline-like ECM 
in free swelling cultures [161, 162]. However, until now, it was unclear whether 
outcomes could be further improved using mechanical stimulation techniques. It was 
confirmed that a prolonged static preculture of 14 days was necessary to increase the 
expression of chondrogenic marker genes ACAN and COL2A1 in response to 
mechanical loading (Figure 4.4A, B). This observation is consistent with our 
previously published results using alginate gels as culture system for human 
chondrocytes and is likely related to the absence of a protective pericellular matrix at 
early time points [60]. The mechanisms of chondrocyte mechanotransduction are still 
being investigated, but evidence suggests that binding of transmembrane receptors 
such as integrins to ECM proteins improves their mechanosensitivity [344]. Hence, 
binding to proteins of the newly synthesized chondrocyte PCM may trigger 
intracellular signalling by changes in cytoskeletal tension in response to dynamic 
loading, in turn leading to increased ECM gene expression [344]. In contrast, down-
regulation of chondrogenic marker genes in the absence of a protective PCM [57] at 
early time points may be a cellular stress-response [345] to excessive mechanical 
stresses experienced by chondrocytes. However, more detailed gene expression 
studies are needed to investigate this hypothesis. When constructs were precultured 
for 14 days, chondrogenic marker gene expression increased with applied 
compressive strains and the highest expression levels were observed at 50 % strain 
(Figure 4.4B). While this strain level may initially seem excessive compared to 
approximately 7-10 % compressive strain which knee-cartilage is estimated to 
experience during walking [346, 347], it has to be considered that hydrogels typically 
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exhibit stiffness levels which are 1-2 orders of magnitudes lower than native articular 
cartilage [348]. Hence, the mechanical stress on chondrocytes in these culture 
systems is likely to be substantially lower than in the native tissue.  
Uniaxial shear loading similarly led to up-regulation of chondrogenic marker 
gene transcription in an amplitude-dependent manner, while expression of the de-
differentiation marker COL1A1 was significantly lower at 1.5 mm amplitude 
compared to controls (Figure 4.4D). When dynamic biaxial loading was performed, 
PRG4 expression was significantly higher compared to controls at 1 mm and 1.5 mm 
shear. Additionally, there was a trend towards higher expression of ACAN and 
COL2A1 with increasing shear levels (Figure 4.4E). In contrast, expression of 
COL1A1 was significantly lower in loaded constructs at all investigated amplitudes 
(Figure 4.4E). Earlier studies performed in our laboratory reported the presence of 
subpopulations of chondrocytes which adhere to the outer surfaces of GelMA-based 
hydrogels [161, 162]. Since it was found that these cells exhibit cell morphologies 
associated with chondrocyte de-differentiation and secrete high amounts of collagen 
I (Figure 4.8), we hypothesized that the observed down-regulation of COL1A1 may 
be due to the death of cells in this surface layer caused by shear loading. Hence, we 
performed viability stainings on these surface-adherent cells which indicated 
substantially higher percentages of dead cells when constructs were mechanically 
stimulated (Figure 4.8D, H). Further confirming this assumption, the strong 
immunoreactivity for collagen I found on the surface of free-swelling cultures 
(Figure 4.8B, C) was not observed on surfaces which were exposed to sliding shear 
motion (Figure 4.8F, G). Generally, ECM marker gene expression in response to 
various loading regimes did not exceed up-regulation beyond 3-fold compared to 
controls (Figure 4.4). While this initially may seem biologically insignificant, it has 
to be considered that the baseline expression of chondrogenic marker genes of 
human chondrocytes in free swelling GelMA-HAMA constructs is already high. 
Accordingly, even minor up-regulation of chondrogenic marker genes may have a 
significant impact on the synthesis of ECM molecules, which is further suggested by 
immunofluorescence analysis of long-term cultures. 
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 Effects of intermittent biaxial loading on tissue-engineered constructs in 4.4.3
long-term cultures 
Although gene expression analysis indicated that biaxial loading at 30 % 
compressive strain and 1.5 mm shear amplitude had the greatest effect of 
chondrogenic marker gene transcription (Figure 4.4E), signs of wear-and-tear were 
observed on a number of samples. Since this was not the case at 30 % compression 
and 1 mm shear amplitude, and gene expression profiles were similar to harsher 
loading regimes (Figure 4.4E), we decided to use this regime for our long-term 
experiments. Intermittent biaxial loading had no significant effects on chondrocyte 
viability (Figure 4.2A-D) and the total DNA content of tissue engineering constructs 
(Figure 4.2E) in this study. It was previously reported that excessive loading can lead 
to chondrocyte death due to excessive magnitudes of mechanical stresses and strains 
[349], as well as high stress and strain rates in response to impact-loading [350]. 
Considering ECM gene expression was up-regulated in response to the chosen 
loading regime (Figure 4.4E) and no increase in cell death was observed (Figure 
4.5A-D), it can be concluded that loading had no significant cytotoxic effects.  
Mechanical loading can induce increased proliferation [351-353]; however, 
this was not observed in our study. Contrary to our expectations, loading did not 
enhance the stiffness of tissue-engineered constructs compared to free swelling 
controls (Figure 4.6B); nevertheless, an approximate 2-fold increase was observed 
for both culture conditions over 28 days of culture. This may be related to levels of 
construct-retained GAGs which also appeared to be unaffected by loading (Figure 
4.6C, D). In articular cartilage, GAGs substantially contribute to the compressive 
properties of the tissue by attracting water. The resultant increase in swelling is 
restrained by the crosslinked collagen network, in turn leading to increased 
hydrostatic pressure and compressive stiffness of the tissue [21]. Accordingly, the 
production and retention of GAGs in GelMA-HAMA constructs likely led to 
increased swelling as indicated by the increase of wet weights (Figure 4.6A), in turn 
leading to observed increase in stiffness. The synthesis and accumulation of collagen 
II, the most abundant structural component of articular cartilage, was highly 
dependent on the culture condition. Immunoreactivity in free swelling cultures was 
similar to our previous studies [161, 162]. Remarkably, collagen II immunoreactivity 
was significantly higher and appeared more homogenous in the interterritorial 
regions following intermittent mechanical loading (Figure 4.7, Figure 4.8). It is 
 Chapter 4: A novel biaxial mechanical stimulation bioreactor for cartilage research and tissue engineering 150 
unlikely that this effect stems from improved nutrient-diffusion since constructs were 
only loaded for 1 h daily; instead, we hypothesize that chondrocyte 
mechanotransduction translated to higher expression of chondrogenic genes and, in 
turn, matrix production. This assumption is also supported by the up-regulation of 
chondrogenic genes following uniaxial shear loading (Figure 4.4D), since this 
loading regime does not cause significant volumetric changes of hydrogel construct 
that could improve diffusion. The intensities of collagen I stainings were low within 
both free swelling and loaded construct, but mechanical stimulation led to 
significantly higher levels compared to static controls (P = 0.023). However, the 
increased immunoreactivity was mainly localized to intra-/pericellular areas, while 
immunoreactivity in the interterritorial spaces appeared very low for both, loaded 
and free swelling constructs (Figure 4.7, Figure 4.8). Loading had no significant 
effect on the intensities of aggrecan stainings (Figure 4.7C, G, K) and partially 
inhibited proteoglycan 4 accumulation (Figure 4.7D, H, L), although gene expression 
analysis revealed that various loading regimes tested resulted in up-regulation of 
corresponding genes (Figure 4.4). Similar to our previous studies [161, 162], direct 
comparison of collagen II and collagen I immunoreactivity (Figure 4.7, Figure 4.8) 
suggests that GelMA-HAMA constructs supported chondrogenesis of expanded 
human chondrocytes and deposition of hyaline-like matrix, independent of the donor.  
 
4.5 CONCLUSION 
We have designed an innovative and user-friendly bioreactor capable of applying 
defined compressive and shear stimulation to various sample types. The system can 
be used to study chondrocyte mechanobiology and improve outcomes of functional 
tissue engineering. We have further validated the effectiveness of the system using 
chondrocyte-laden GelMA-HAMA constructs which exhibited significant 
improvements to collagen II accumulation following intermittent biaxial loading. 
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5.1 INTRODUCTION 
Hydrogels are excellent candidates for applications as drug delivery vehicles 
[354], bioinks [215], stimuli-responsive actuators [355], extracellular matrix mimics 
[356], and scaffolds for tissue engineering [107]. However, the use of conventional 
hydrogels for tissue engineering of load-bearing tissues is severely limited by their 
high brittleness, lack of effective energy dissipation, and inadequate toughness [194]. 
This has inspired various strategies aiming to enhance the mechanical properties of 
hydrogels by, for example, increasing polymer concentrations and crosslinking 
densities [190], reinforcement with 3D-printed fibres [163], or the development of 
sliding-ring hydrogels [191], nanocomposite hydrogels [192], and double-network 
(DN) hydrogels [193]. Fibre-reinforcement of hydrogels was previously shown to 
greatly enhance stiffness under low compressive strains whilst retaining bioactivity, 
as well as cyto- and biocompatibility; however, these constructs are brittle and 
cannot sustain large compressive strains without failure [163]. Synthetic DN 
hydrogels, on the other hand, exhibit high mechanical strength and capability to 
resist large deformations and stresses (fracture compressive stress of 17.2 MPa and 
strain of 92 %) [193], but their suitability for cell encapsulation, direction of tissue-
specific cell differentiation, extracellular matrix accumulation, as well as enzymatic 
degradation remains largely unexplored [194].  
Although the potential of DN gels for tissue engineering applications has been 
emphasized in previous studies, surprisingly, only short-term cytocompatibility has 
been demonstrated [195-198] and functional assessment of their suitability for cell-
based tissue engineering applications has rarely been performed [195]. This may 
stem from the synthetic nature of most previously described DN gels which allow for 
fabrication of composites with extreme stiffness and ultimate mechanical strength 
[193, 194, 357], but often lack bioactivity and do not allow for cell-encapsulation 
due to harsh crosslinking conditions, thus making them better candidates for 
substitutes of load-bearing tissues rather than true tissue engineering scaffolds. Only 
a few instances of cell-laden DN gels have been reported [195-198], most of which 
were based on a combination of biopolymers, or a blend of a bio- and synthetic 
polymers. Although an improvement of mechanical properties compared to single-
network gels was achieved, the ultimate strength of synthetic DN gels is often 
significantly higher (compressive failure stress of 5.3 – 6.9 MPa [197, 358] vs. 17.2 
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MPa [193]). Some of these early studies demonstrated trends of decreasing cell 
viabilities over time [197, 198], raising questions about their suitability for functional 
tissue engineering. Additionally, it remains unclear how encapsulated articular 
chondrocytes react to physiological loading conditions in such DN gel systems.  
Hydrogels as cell-laden tissue engineering scaffolds require adequate (i) 
cytocompatibility, (ii) biocompatibility, (iii) enzymatic degradability without toxic or 
irritant degradation products, (iv) cell-instructive bioactivity, and from a more 
practical aspect, (iv) cost-efficiency and (vi) ease of production. Accordingly, the use 
of biomaterials mimicking the biological and physicochemical aspects of native 
extracellular matrices which naturally possess these characteristics has been 
increasing steadily [359]. Recently, hydrogels based on the semi-synthetic 
biopolymer gelatin methacryloyl (GelMA) have attracted great attention in tissue 
engineering research due to excellent control over mechanical and biological 
properties [216], and their broad range of applications as 3D cell culture models and 
scaffolds for tissue engineering [164, 305]. It was further shown that, with the 
addition of naturally occurring glycosaminoglycans (GAGs) such as hyaluronic acid, 
chondrogenic re-differentiation of expanded articular chondrocytes could be 
significantly improved, in turn leading to neo-tissue formation with native-like 
composition [161]. Another popular biopolymer for chondrocyte culture and 
cartilage tissue engineering is alginate [360], a brown algae-derived polysaccharide 
which can be ionically crosslinked in the presence of divalent cations [361]. Unlike 
GelMA, alginate is considered bioinert [362] and does not usually allow for the 
accumulation of an interconnected collagenous ECM [239] unless very high cell 
densities are used [363]. 
Here, we report a simple and fast one-pot method to fabricate hybrid 
physically-chemically crosslinked micro-structured GelMA-alginate DN hydrogels 
which can withstand large magnitudes of compression without failure and display 
recoverable energy dissipation, while retaining the chondrogenic properties of 
alginate and the ability of GelMA to accumulate large amounts of newly-synthesized 
ECM. We further investigate the potential of these composites as cell-laden scaffolds 
for articular cartilage tissue engineering using clinically-relevant human articular 
chondrocytes and biomimetic mechanical stimulation techniques. Lastly, we 
 Chapter 5: Tough double-network hydrogels for functional cartilage tissue engineeringBibliography 156 
demonstrate the capability for advanced manufacturing techniques by 3D bioprinting 
of DN gels in a proof-of-concept study. 
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5.2 MATERIALS AND METHODS 
 Synthesis of gelatin methacryloyl (GelMA) 5.2.1
Gelatin (porcine skin, Type A, gel strength 300; Sigma Aldrich, St. Louis, MO, 
USA) was functionalized with methacryloyl groups following a previously published 
protocol [164]. Briefly, gelatin was dissolved in phosphate-buffered saline (PBS, pH 
7.4; Invitrogen, Carlsbad, CA, USA) at 10 % w/v and reacted with 0.06 g of 
methacrylic anhydride (MAAh) per gram of gelatin for 1 h at 50 °C. After the 
reaction period, insoluble MAAh was removed by centrifugation, followed by 
dialysis against ultrapure water. The pH of the dialyzed solution was adjusted to 7.4, 
after which the product was lyophilised and stored at -20 °C until usage. 
 
 Human cartilage explants, chondrocyte isolation and culture 5.2.2
Articular cartilage was obtained with ethical approval from the Prince Charles 
Hospital (Brisbane, QLD, Australia) and Queensland University of Technology 
(ethics number: 1400001024) from consenting patients undergoing total knee 
arthroplasty surgeries for osteoarthritis. Chondrocytes were isolated from 
macroscopically normal regions of the femoral cartilage of three donors (66 and 67 
year old male, 65 year old female), as described elsewhere [241]. Cells were 
propagated on tissue culture plastic (3000 cells/cm2) in low-D-glucose chondrocyte 
basal medium (Dulbecco’s modified Eagle’s medium (DMEM) with 2 mM 
GlutaMAX™, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
0.1 mM nonessential amino acids, 50 U/mL penicillin, 50 µg/mL streptomycin, 0.5 
µg/mL amphotericin B (Fungizone®) (all Invitrogen, CA, USA), 0.4 mM L-proline 
and 0.1 mM L-ascorbic acid (both Sigma-Aldrich)) supplemented with 10 % foetal 
bovine serum (FBS) (Hyclone, Logan, UT, USA). Articular cartilage explants were 
prepared from the lateral femoral condyles of two donors (72 year old female, 58 
year old male) using a 3 mm biopsy punch and stored in PBS at room temperature 
(RT) for up to 24 h before mechanical testing. All cells and cell/hydrogel constructs 
were maintained at 37 °C in a humidified 5 % CO2/95 % air CO2 incubator with the 
medium refreshed every 3-4 days. 
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 Hydrogel construct fabrication and culture  5.2.3
Hydrogel precursor solutions were prepared by dissolving GelMA (DoF: 32 ± 
1.7 %, unless indicated otherwise [164] and alginate (Pronova UP LVG, unless 
indicated otherwise; FMC Biopolymers, PA, USA) in PBS at 37 °C. The 
photoinitiator Irgacure 2959 (BASF, Ludwigshafen, RLP, Germany) was added at a 
final concentration of 0.05 % w/v to all precursor solutions containing GelMA. 
Hydrogels were prepared in a custom-manufactured Teflon casting mold which 
produces gels with dimensions of 4 mm × 4 mm × 2 mm. To prepare double-network 
hydrogels containing 10 % w/v GelMA and 2 % w/v alginate (hereafter referred to as 
GelMA-Alg), the warm precursor solution was transferred to the mold, covered with 
a glass slide, and allowed to cool to RT for 10 min for (reversible) physical gelation 
of GelMA. The GelMA network was then covalently crosslinked by 10 min exposure 
to 365 nm light at an intensity of ~2.6 mW/cm2 in a CL-1000 crosslinker (UVP, 
Upland, CA, USA), followed by ionic crosslinking of alginate by immersion in 100 
mM CaCl2 in PBS for 15 min. Single-network hydrogels formed of 10 % w/v GelMA 
(referred to as GelMA) or 2 % w/v alginate (referred to as Alg) were prepared by 
cooling to RT, followed by either photocrosslinking or ionic crosslinking as above. 
To fabricate cell-laden constructs, passage 1 human articular chondrocytes from 
three individual donors (see 2.2.) were suspended in the precursor solutions at a 
density of 10 million cells/mL before crosslinking. Cell-free constructs were stored 
in DMEM at 37 °C until mechanical testing. Cell-containing constructs were cultured 
in serum-free high-D-glucose basal chondrocyte medium (see 2.2. for composition) 
with ITS-G (100 × dilution), 1.25 mg/mL bovine serum albumin (BSA), 0.1 μM 
dexamethasone (all Sigma-Aldrich) and 10 ng/mL transforming growth factor beta 3 
(TGF-β3) (GroPep, Adelaide, SA, Australia) for up to 28 days, with and without 
biaxial mechanical stimulation.  
 
 Hydrogel microstructure 5.2.4
Transmission electron microscopy (TEM, JEM-2100 Plus, Jeol, MA, USA) 
was performed to assess the structure of dried hydrogel precursor solutions. Briefly, 
5 μl precursor solution of GelMA, Alg, and GelMA-Alg hydrogels were transferred 
onto a TEM copper grids covered with a perforated carbon film, allowed to dry at 
room temperature, and imaged at 80 kV and 60,000 × magnification. To investigate 
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the microstructure of crosslinked hydrogels, gels were incubated in Eosin Y solution 
(0.5 % w/v in 90 % w/v ethanol; Sigma) for 30 min, followed by incubation in 90 % 
w/v ethanol for 30 min and rehydration in PBS with Ca2+ and Mg2+ for 1 h. Gels 
were then cut in half, and the cross-section was imaged using a Nikon SMZ25 
fluorescence stereomicroscope. 
 
 Mechanical stimulation of cell-laden hydrogel constructs 5.2.5
Dynamic biaxial mechanical stimulation was carried out in a custom-
manufactured shear and compression bioreactor system (Figure 5.1B-D) replicating 
the mechanical environment of an articulating joint. The system was designed to 
apply precise mechanical loading facilitated by two orthogonally aligned micro 
linear actuators with a resolution (microstep size) of ˂ 50 nm and a repeatability of ˂ 
1 μm (T-NA Micro Linear Actuators, Zaber Technologies, Vancouver, Canada).  
Cell-hydrogel constructs were either cultured under free swelling conditions 
for up to 28 days, or pre-cultured for 14 days under free swelling conditions [60], 
followed by 14 days of intermittent biaxial dynamic mechanical stimulation with a 
compressive strain of ~30 % and 1 mm shear amplitude (frequency of 1 Hz, 1 h 
daily).    
 
 Physical properties 5.2.6
The mechanical properties of hydrogel constructs and cartilage explants were 
measured submerged in DMEM at 37 °C in unconfined, uniaxial compression tests 
using an Instron 5848 microtester equipped with a 5N or 500N load cell (Instron, 
Melbourne, VIC, Australia). Stereomicroscopic photographs were used to determine 
the surface area of hydrogels and explants using ImageJ software (National Institutes 
of Health, USA). A displacement rate of 0.01 mm/s was applied using a non-porous 
aluminium indenter until construct failure as defined by yielding of Alg constructs 
(decreasing slope of stress-strain curve), or cracking of GelMA-Alg and GelMA 
constructs, as well as cartilage explants (sudden drop of the stress-strain curve). The 
Young’s modulus 𝐸 was determined as the slope of the stress–strain curve from 10 
% to 15 % strain. Failure stress and failure strain were defined by the maxima of the 
stress-strain curve before yielding or cracking occurred. The toughness was 
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determined as the area under the stress-strain curve until failure. Hydrogel constructs 
were dynamically compressed to 30 % strain for 1000 cycles using a sinusoidal 
waveform at a frequency of 1 Hz to investigate energy dissipation and relaxation 
behaviour. Effective swelling was determined by the ratio of equilibrium wet weight 
of constructs swollen in DMEM at 37 °C to wet weight immediately after 
crosslinking. Stepwise stress-relaxation tests were performed to determine the 
equilibrium moduli of hydrogel constructs. In more detail, samples were subjected to 
three consecutive 10 % compression steps to a total of 30 % strain, each followed by 
relaxation periods of 20 min, 40 min, and 60 min, respectively. Equilibrium stress 
values were calculated at each strain level by fitting the recorded stress-strain curves 
using a standard linear solid model (Kelvin body) described by Equation 1, in which 
ER is the stress at equilibrium, τσ is the time of stress relaxation under constant strain, 
and τε is the time of relaxation of strain under constant stress: 
 
𝜎(𝑡) = 𝐸𝑅 �1 − �1 − 𝜏𝜎𝜏𝜀� 𝑒− 𝑡𝜏𝜀�1(𝑡)    (1) 
 
The equilibrium modulus EEq was determined as the slope of equilibrium 
stress-strain curve. To assess dynamic mechanical properties, constructs were first 
compressed to 10 % strain with a displacement rate of 0.01 mm/s, followed by 60 
cycles of sinusoidal compression at 1 Hz with 2 % strain amplitude. The last 
compression cycle was used to determine the storage modulus 𝐸′ (Equation 2), loss 
modulus 𝐸′′ (Equation 3), and the loss factor 𝑡𝑡𝑡𝑡 (Equation 4) according to the 
viscoelastic theory [364], where σ0 and ε0 are the amplitudes of stress and strain, 
respectively, and δ is the phase shift between maxima of recorded stress and strain. 
 
𝐸′ =  σ0
ε0
cos δ       (2) 
𝐸′′ =  σ0
ε0
sin δ      (3) 
 𝑡𝑡𝑡𝑡 =  𝐸′′
𝐸′
        (4) 
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 Viability assay 5.2.7
Live and dead cells were visualized with fluorescein diacetate (FDA) and 
propidium iodide (PI, both Sigma), respectively. Briefly, hydrogel constructs were 
washed in PBS at RT, incubated in a solution of 10 μg/mL FDA and 5 μg/mL PI for 
3 minutes at RT, then washed in PBS again. Z-stack images were captured using a 
Carl Zeiss Axio fluorescence microscope images. Live and dead cells were counted 
using an ImageJ script (National Institutes of Health, USA) and cell viability was 
expressed as percentage of living to total cells. 
 
 Biochemical analyses 5.2.8
For biochemical analyses of DNA and glycosaminoglycan (GAG) content, 
samples were weighed using a microbalance and subsequently digested overnight at 
56 °C in phosphate-buffered EDTA (pH 7.1) containing 0.5 mg/mL proteinase K 
(Invitrogen). Total DNA content in the digests was determined using the Quant-iT™ 
PicoGreen® dsDNA quantification assay (Invitrogen) according to the 
manufacturer’s instructions. GAG content was determined using the dimethyl-
methylene blue (DMMB) assay at pH 1.5 [365]. Absorbances were measured at 525 
and 595 nm, and the GAG concentration was calculated using the absorbance ratios, 
compared to a quadratic standard curve prepared from chondroitin sulfate C (Sigma). 
To determine the quantity of GAGs produced by cells, GAG amounts measured for 
cell-free gels were subtracted. Secreted GAGs were measured at the last media 
change and expressed as GAGs secreted to the media within 24 hours of culture, with 
and without 1 hour of mechanical loading.    
 
 Gene Expression Analysis  5.2.9
Hydrogel constructs were transferred to 1 mL of TRIzol reagent (Invitrogen) 
and homogenized. Total RNA was isolated according to the manufacturer’s 
instructions. SuperScript™ III First Strand Synthesis System (Invitrogen) was used 
to synthesize complementary DNA (cDNA). DNase and RNase digestions were 
performed before and after cDNA synthesis, respectively. Quantitative real-time 
polymerase chain reaction (qRT-PCR) was carried out using SybrGreen® Mastermix 
(Invitrogen) and a QuantStudio™ 7 Flex Real-Time PCR system (Applied 
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Biosystems). The cycle threshold (Ct) value of each gene was normalized to the 
geometric mean of the housekeeping genes RPL13A and TBP using the comparative 
Ct method (2-ΔCt). The primer sequences (5’  3’) used for PCR were as follows: 
RPL13A: F: CATAGGAAGCTGGGAGCAAG, R: GCCCTCCAATCAGT-
CTTCTG; TBP: F: GAGCCAAGAGTGAAGAACAGTC, R: CATCACA-
GCTCCCCACCATATT; COL2A1: F:GGCAATAGCAGGTTCACGTACA, R: 
CGATAACAGTCTTGCCCCACTT; COL1A1: F: CAGCCGCTTCACCTACAGC, 
R: TTTTGTATTCAATCACTGTCTTGCC; COL10A1: F:ACCCAACACCAAG-
ACACAGTTCT, R:TCTTACTGCTATACCTTTACTCTTTATGG-TGTA; ACAN: 
F:GCCTGCGCTCCAATGACT, R: TAATGGAACACGATGCCTTTCA; PRG4: F: 
GAGTACCCAATCAAGGCATTATCA, R: TCCATCTACTGGCTTACCA-TTGC; 
MMP2: F: CCGTCGCCCATCATCAA, R: AGGTATTGCACTGCCAACTCT; 
MMP13: F: ACTTCACGATGGCATTGCTG, R:CATAATTTGGCCCAGGAGGA.  
 
 Immunofluorescence Analysis  5.2.10
Constructs were snap-frozen in Optimal Cutting Temperature compound 
(OCT) (Sakura, Finetek, Tokyo, Japan) with liquid nitrogen, sectioned at a thickness 
of 10 μm, and air-dried. Sections were fixed with ice-cold acetone for 10 min, air-
dried, and rehydrated in 50 mM BaCl2/100 mM Tris HCL buffer (pH 7.3) for 1 h, 
followed by incubation with 100 mM Tris HCL buffer (pH 7.3) for 5 min. Antigen 
retrieval with 0.1 % hyaluronidase (Sigma-Aldrich) at 37 °C for 30 minutes was 
performed on sections to be stained for collagen type I and collagen type II. Primary 
antibodies for aggrecan (969D4D11, Invitrogen; 1:400 dilution in PBS with 2 % 
donkey serum), collagen type I (I-8H5, MP Biomed, Solon, OH, USA; 1:300 dilution 
in PBS with 2 % goat serum), collagen type II (II-II6B3, Developmental Studies 
Hybridoma Bank (DSHB), Iowa City, IA, USA; 1:150 dilution in PBS with 2 % goat 
serum), and CD44 (H4C4, DSHB, 1:200 dilution) were applied in a humidified 
chamber at 4 °C overnight. Cell membranes were visualized with CellMask™ 
plasma membrane stain (Invitrogen, 1:400 dilution in PBS). Secondary antibodies 
were diluted 1:150 in PBS with 2 % goat/donkey serum and 5 μg/mL 4′,6-diamidino-
2-phenylindole (DAPI) (Invitrogen) and applied for 1 h in the dark (AlexaFluor® 
488-labelled donkey anti-mouse, AlexaFluor® 488-labelled goat anti-mouse, 
AlexaFluor® 594-labelled goat anti-mouse; all Jackson ImmunoResearch, West 
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Grove, PA, USA). A mouse IgG isotype control antibody (Jackson 
ImmunoResearch; 1:1000 dilution) and secondary antibody only were used as 
negative controls. After two washing steps in PBS and drying, sections were 
mounted with ProLong Gold (Invitrogen) and imaged using either a Carl Zeiss Axio 
microscope (for quantitative analysis) or a Nikon SMZ25 fluorescence 
stereomicroscope (for qualitative analysis).  
To quantify fluorescence intensities, 6-8 centre and peripheral regions of each 
histological section were imaged. The integrated fluorescence intensities were 
calculated using ImageJ software (National Institutes of Health, USA) and 
normalized to the integrated fluorescence intensity of DAPI stainings in order to 
correct the obtained values for differences in cell numbers between microscopic 
images. 
 
 Rheological characterization and bioprinting  5.2.11
 Rheological analysis of DN and SN hydrogel precursor solutions was 
performed using an Anton Paar MCR 302 rheometer (Anton Paar GmbH, Graz, 
Austria) in a cone-plate configuration (25 mm diameter, 1° cone angle). To 
investigate the shear thinning behaviour of hydrogel precursors, viscosities at 25 °C 
and 37 °C were determined in oscillatory mode at 0.1 % - 100 % shear strain for 
angular frequencies ranging from 100 rad/s to 0.1 rad/s. To investigate temperature-
dependent viscosities of hydrogel precursor solutions, an oscillatory angular 
frequency of 10 rad/s at 1 % shear strain was applied and the temperature of pre-
warmed solutions was reduced from 37 °C to 4 °C at 2 °C/min. Preliminary 
bioprinting experiments were performed using a Gesim BioScaffolder 3.1 (Gesim, 
Dresden, Germany). GelMA-Alg and GelMA precursor solutions were heated to 
37_°C, transferred into printing cartridges, and allowed to cool to 25 °C in the 
temperature-controlled cartridge holders. Polymers were then extruded at 8 mm/s x-y 
translation speed using a nozzle with 400 μm inner diameter and 250 kPa pneumatic 
pressure, resulting in a layer height of approximately 300 μm. 
 
 Chapter 5: Tough double-network hydrogels for functional cartilage tissue engineeringBibliography 164 
 Statistical analysis 5.2.12
Where applicable, data are expressed as mean ± standard deviation, or box 
plots. For box plots, each box represents the 25th to 75th percentiles. Lines inside the 
boxes represent the median, while whiskers outside the boxes represent the 
maximum and minimum values, respectively. Statistical analyses were performed 
using SPSS software (version 21, IBM Corporation, USA). One- or two-way 
analyses of variance (ANOVA) with Tukey’s post-hoc tests were performed to 
determine the effects of gel type, mechanical loading, and culture duration, with a 
significance level of 0.05.  
 
  
 Chapter 5: Tough double-network hydrogels for functional cartilage tissue engineeringBibliography 165 
5.3 RESULTS AND DISCUSSION 
 Mechanical properties of double- and single-network hydrogels 5.3.1
As proposed by Gong et al. [194, 357], the mechanical properties of DN gels 
rely on the specific structural composition involving a 1st, tightly crosslinked rigid 
and brittle polymer network with high swelling capacity, and a 2nd loosely 
crosslinked network composed of a soft and ductile, and often neutral polymer. The 
classic two-step polymerization method for DN gels involves crosslinking of the 1st 
network followed by swelling in a solution containing a 20-30-fold molar excess of 
monomers of the 2nd network for 1-2 days, and crosslinking of the second network. 
More recent advances led to the development of improved fabrication processes such 
as molecular stent [366] and particularly one-pot methods [367] which allow for 
advanced manufacturing techniques such as 3D printing. Our aim was to apply these 
concepts to biomaterials which have proven suitable for articular chondrocyte 
culture, and we hence chose alginate and GelMA for our investigations. GelMA, 
based on type A gelatin derived from porcine skin, has approximate molecular 
weights ranging from 50-100 kDa (according to manufacturer), while molecular 
weights of the alginate used in this study range from 75-200 kDa (according to 
manufacturer), leading to a theoretical ~4-20-fold molar excess of GelMA over 
alginate in DN gels composed of 10 % w/v GelMA and 2 % w/v alginate (GelMA-
Alg). Alginate is comprised of mannuronic acid (M) and guluronic acid (G) units 
which are arranged in blocks rich in M or G, respectively, or blocks of alternating M 
and G [368]. The G blocks form ionic crosslinks in the presence of divalent cations 
such as Ca2+ [368]. Thus, by employing alginates rich in G blocks (here: G/M ratio of 
>1.5), the crosslinking density of the biopolymer can be maximised to form the 1st, 
tightly crosslinked network of GelMA-Alg DN gels. The crosslinking density of 
GelMA, on the other hand, can be tailored by varying the degree of functionalisation 
(DoF) or crosslinking parameters such as the light exposure time in photo-initiated 
polymerization techniques. Here, we employed GelMA with a relatively low DoF of 
32 ± 1.7 % to form the second, ductile network of GelMA-Alg gels. We 
hypothesized that the combination of these materials would lead to composites with 
increased mechanical strength and recoverable energy dissipation based on the 
elasticity of GelMA and the reversible ionic crosslinking of alginate (Figure 5.1A).  
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Figure 5.1: Preparation and energy dissipation of double-network hydrogels and biaxial 
mechanical stimulation bioreactor. (A) Double-network hydrogels are fabricated in a one-pot 
method by cooling the warm precursor solution to room temperature to allow for partial triple-helix 
formation of GelMA, followed by photopolymerization of GelMA and ionic crosslinking of alginate. 
As the GelMA-Alg double-network hydrogel is deformed, Ca2+ is released from ionic crosslinks and 
mechanical energy is dissipated, while the GelMA network maintains the elasticity of the hydrogel. 
As the hydrogels relaxes from deformation, ionic crosslinks partially reform (adapted from Hong, et 
al., 2015, [198]). (B) Custom biaxial mechanical stimulation bioreactor with (C) PTFE pistons to 
apply (D) dynamic compressive and shear loading to cellular hydrogel constructs. 
 
Using these fabrication parameters, GelMA formed soft SN hydrogels with 
Young’s moduli of 18.5±3.9 kPa (Figure 5.2C), which were ductile and resisted 
compression to 89±1.3 % strain (Figure 5.2E) and 1.5±0.4 MPa stress (Figure 5.2D), 
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and displayed an ultimate toughness of 101.1±17.4 kJ/m3 (Figure 5.2F). We 
performed dynamic compression tests with a sinusoidal strain of 30 % to investigate 
energy dissipation and viscoelastic stress relaxation. GelMA displayed characteristics 
of elastic materials as evidenced by the negligible hysteresis between loading and 
unloading cycles, as well as nearly complete shape-recovery with minor stress-
relaxation over the duration of testing (Figure 5.2B). Alg gels had a higher Young’s 
modulus of 33.2±6.1 kPa (Figure 5.2C), but irreversible yielding occurred at lower 
compressive strain of 69.0±6.5 % (Figure 5.2E) and stress of 0.25±0.1 MPa (Figure 
5.2D), leading to an ultimate toughness of 35.1±16.2 kJ/m3 (Figure 5.2F). In dynamic 
compression tests at 30 % strain, Alg displayed efficient energy dissipation as 
indicated by pronounced hysteresis, but retained significant permanent deformation 
after only one compression cycle (Figure 5.2B). This behaviour can be attributed to 
the unzipping of the alginate network (release of divalent cations from ionic bonds) 
under compressive strain, followed by re-formation of ionic bonds when the sample 
is unloaded [369]. As not all ionic bonds are released, some energy is stored 
elastically, leading to partial shape-recovery. The pronounced stress-relaxation 
behaviour of Alg also stems from the ionic nature of alginate bonds, as well as 
effects of recoverable viscoelastic water exudation [370] in response to prolonged 
dynamic or static loading. When compressed to high strains, shape-recovery did not 
occur and the constructs yielded substantially, leading to plastic deformation without 
apparent cracking (Figure 5.3). Hybrid GelMA-Alg displayed characteristics of both 
GelMA and Alg, but the synergistic interaction of both independent, interpenetrating 
hydrogel networks significantly improved the mechanical properties as evidenced by 
increased stiffness, ultimate strength, and toughness. The Young’s modulus of 
GelMA-Alg was 96.7±9.9 kPa (Figure 5.2C), an approximate 3-fold increase 
compared to Alg, and 5-fold increase compared to GelMA SN gels. Remarkably, 
GelMA-Alg hybrids withstood compression to 93.7±1.2 % strain (Figure 5.2E) and 
3.3±0.5 MPa stress (Figure 5.2D). The toughness of GelMA-Alg was approximately 
2-fold higher than the summed toughness of parent SN gels, reaching values of 
261.3±41.0 kJ/m3 (Figure 5.2F). Dynamic tests revealed that GelMA-Alg hydrogels 
overcome the mechanical limitations of both GelMA and Alg SN gels by providing 
efficient energy dissipation, elastic shape-recovery, as well as stress-relaxation 
behaviour similar to articular cartilage (Figure 5.2B) [7]. Mechanistically, these 
properties rely on the progressive unzipping of G blocks of alginate with increasing 
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compressive strain while the GelMA network provides elastic energy, leading to 
pronounced hysteresis and good shape-recovery. We found that GelMA-Alg hybrids 
could even recover from much higher compressive strains without apparent damage 
(Figure 5.3). In contrast to classic DN gels in which high toughness relies on energy 
dissipation through sacrificial covalent bonds breaking irreversibly upon loading 
[194, 357, 371], this system allows for recoverable energy dissipation provided by 
reversible crosslinking of alginate. Interestingly, when ionic crosslinking of alginate 
was performed prior to crosslinking of GelMA, the mechanical properties of hybrid 
gels remained similar to parent SN gels (Supplementary Fig. S5.1). This suggests 
that the high crosslinking density of alginate, which was not allowed to swell before 
the second crosslinking step, may have sterically impeded the photo-initiated 
polymerization of GelMA. The resulting decrease in crosslinking density of GelMA 
also led to higher wet weights compared to hybrid gels prepared by 
photopolymerization followed by ionic crosslinking (Figure 5.2L and Supplementary 
Fig. S5.1), despite having the same chemical composition. It is apparent that 
decreasing the crosslinking density of GelMA increases the ductility of hydrogels, as 
GelMA SN gels with high crosslinking densities tend to fail under less than 40 % 
compressive strain [162] compared to 89±1.3 % (Figure 5.2E). This may be 
explained by the localisation and density of crosslinks between GelMA molecules. 
Unsaturated methacryloyl groups in GelMA are mainly localized to lysine residues 
which are located throughout the length of the proteinaceous macromolecules [164]. 
As evidenced by rheological observations [302], GelMA molecules entangle due to 
molecular interactions in a thermo-responsive manner and, upon crosslinking, the 
molecular constellation of GelMA may thus be partially fixed in its current state of 
entanglement. At low crosslinking densities, GelMA molecules can untangle under 
loading without sacrificing covalent bonds. At high crosslinking densities, however, 
untangling of the biopolymer chains may be sterically impeded, in turn leading to 
failure of covalent bonds and macroscopic cracking under mechanical deformation. 
We also examined the mechanical properties of articular cartilage from two 
human donors (Supplementary Fig. S5.2). Generally, the Young’s moduli, failure 
stress, and ultimate toughness were one order of magnitude higher compared to 
GelMA-Alg, whereas strain to failure was approximately 15 % lower. It may seem 
desirable to match these properties, however, previous efforts demonstrated that high 
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initial stiffness of hydrogels limits cell proliferation and functional maturation of 
tissue engineering constructs by impeding the formation and distribution newly 
formed ECM [372-374], hence posing a significant disadvantage when the 
regeneration of native-like tissue is desired.  
 
Figure 5.2: Mechanical properties of cell-free double- and single-network hydrogels prepared of 
10 % GelMA and 2 % alginate (GelMA-Alg), 2 % alginate (Alg), or 10 % GelMA (GelMA). (A) 
Typical compressive stress/strain curves recorded with a displacement rate of 0.01 mm/s. (B) Stress-
relaxation behaviour in response to 30 % dynamic compression at 1Hz for 1000 cycles illustrating 
effective energy dissipation in alginate-containing hydrogels. (C) Young’s moduli, (D) failure stress, 
(E) failure strain, (F) toughness, (G) effective swelling, (H) equilibrium moduli, (I) storage moduli, 
(J) loss moduli, (K) loss factors, and (L) wet weights of double- and single-network hydrogels (* p < 
0.05, ** p < 0.01, *** p < 0.001). 
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Another important consideration for cartilage tissue engineering is the swelling 
behaviour (Figure 5.2G) of hydrogel scaffolds. Generally, it is desired to develop 
cell-laden hydrogel materials that are injectable into focal cartilage defects and can 
be crosslinked in situ, hence eliminating the need for costly and timely in vitro 
cultivation before implantation. If a material swells substantially upon crosslinking, 
it may impede proper integration and retention in the defect site. GelMA SN gels 
were crosslinked loosely, leading to pronounced swelling (Figure 5.2G) and, in turn, 
stretching of GelMA molecules. Alg on the other hand displayed significantly lower 
swelling, similar to hybrid GelMA-Alg gels, suggesting that the tight crosslinking of 
alginate limits swelling capability of GelMA in DN gels (Figure 5.2G). Thus, 
GelMA molecules may not be in a pre-stretched state, suggesting that, at low 
compressive strains, a large proportion of mechanical energy is dissipated into the 
alginate network. With increasing strain, more energy is dissipated by progressive 
unzipping the alginate network, causing the GelMA network bear increasing 
proportions of mechanical energy. At high compressive strains, nearly all alginate 
bonds are released, and GelMA molecules untangle increasingly and begin to stretch 
elastically, which is associated with a non-linear increase in the stress-strain curve 
(Figure 5.2A). This is also supported by the failure behaviour of GelMA-Alg which 
is characterised by cracking similar to GelMA SN gels (Figure 5.2A, sudden drop in 
stress-strain curve), indicating that at the time of failure most ionic alginate bonds 
were already released. However, in contrast to GelMA SN gels (Figure 5.3), cracked 
GelMA-Alg constructs did not split macroscopically, suggesting that parts of the 
alginate network were bridging the cracks [375]. The increased modulus at low strain 
rates may be attributed to the internal friction of GelMA and alginate molecules, as 
well as a decrease in hydraulic permeability causing increased frictional drag as the 
interstitial fluid redistributes in, or exudes from, the solid hydrogel matrix. The 
higher polymer concentration of GelMA-Alg compared to parent SN gels may only 
play a minor role as suggested by the lack of increase in moduli when physical 
crosslinking was performed before covalent crosslinking (Supplementary Fig. S5.1).  
 Precursor solutions of GelMA and Alg are clear, while GelMA-Alg 
precursors appear cloudy (Supplementary Fig. S5.3), indicating that phase separation 
may occur when GelMA and alginate are mixed under the present conditions. It has 
previously been reported that colloidal solutions of proteins and anionic 
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polysaccharides may undergo entropically driven liquid-liquid phase separation 
resulting from the electrostatic interaction of two oppositely charged 
macromolecules, a phenomenon otherwise known as complex coacervation [376]. 
Complex coacervate systems are characterised by two separated liquid phases in 
which a dilute colloidal phase (equilibrium phase) coexists with a highly 
concentrated colloidal phase (coacervate phase) [376]. The coexistence of both liquid 
phases results from the amphoteric nature of biopolymers such as gelatin, leading to 
areas with opposite and similar electrostatic charges and hence phases of strong and 
weak molecular attraction between soluble proteins and anionic polysaccharides 
[376]. Systems that undergo complex coacervation are often cloudy (depending of 
the degree of interaction) and display a synergistic increase in viscosity resulting 
from strong molecular interaction in the coacervate phase which is dependent on 
macromere concentrations and ratios, pH, salt ionic strength, and temperature [376]. 
However, liquid coacervation is distinct from precipitation, in which solid-like 
complexes are formed. Since complex coacervation was recently reported for 
colloidal mixtures of type B gelatin and sodium alginate [377], we hypothesized that 
GelMA derived from type A gelatin and sodium alginate interact in a similar matter, 
leading to the observable turbidity and high viscosity of GelMA-Alg precursor 
solutions (Figure 5.8). We hence investigated dried precursor solutions of DN and 
SN gels using TEM which indicated the presence of microscale coavervate droplets 
in GelMA-Alg precursors (Supplementary Fig. S5.4A). However, it is likely that 
drying caused shrinkage and other imaging artefacts, and hence this investigation 
was not fully conclusive. Additionally, this technique did not allow investigation of 
the hydrogel structure in a crosslinked state. We thus stained sections of crosslinked 
DN and SN gels with Eosin Y which acts as a fluorescent dye binding to positive 
charges of biopolymers (Supplementary Fig. S5.5). The fluorescence intensity of Alg 
gels was minor due to the anionic nature of alginate at physiological pH (pKa (M): 
3.38, pKa (G):3.20) [360]. Similar to collagens of native ECMs [378], GelMA 
appeared to be eosinophilic indicating cationic charges at pH 7.4 (isoelectric point of 
type A gelatin of 7-9, according to supplier). Staining appeared strong and 
homogenous suggesting a uniform hydrogel network structure of crosslinked GelMA 
SN gels (Supplementary Fig. S5.4D). In contrast, fluorescence of cell-free GelMA-
Alg gels appeared inhomogeneous with areas of strong and weak staining 
(Supplementary Fig. S5.4C). We hence hypothesize that this observation stems from 
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the complex coacervation of GelMA and alginate in GelMA-Alg precursor solutions 
which form a micro-structured DN hydrogel upon sequential crosslinking. Thus, the 
observed highly fluorescent areas may correspond to the coacervate phase, while the 
less fluorescent areas indicate the equilibrium phase. Based on this hypothesis, the 
improved mechanical properties of GelMA-Alg DN gels may partially result from 
the presence of a coacervate phase with strong molecular interaction between 
alginate and GelMA. In a simplified comparison, GelMA molecules in the micro-
structured DN hydrogel may thus behave similar to a twisted elastic rubber band 
which untangles when it is stretched, and reshapes to a similarly entangled structure 
when it is relaxed. 
 
Figure 5.3: Photographs of double- and single network hydrogels compressed to 85 % strain. 
(A) GelMA-Alg hydrogels sustain high compressive strains without failure and fully recover after 
relaxation. (B) Under high compressive strains, alginate hydrogels exhibit yielding behaviour as ionic 
crosslinks reform under mechanical stress. (C) GelMA hydrogels are elastic, but fail under high 
compression. 
 
Viscoelasticity is characterised by the presence of both viscous and elastic 
material properties which give rise to time- or rate-dependent creep and stress-
relaxation behaviours and result from the biphasic nature of cartilage and hydrogels 
[63]. In response to deformation, initially, interstitial fluid pressure rises rapidly and 
mechanical forces are predominantly supported by the fluid phase. With prolonged 
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deformation, pressurization decreases dependent on the hydraulic permeability of the 
matrix, resulting in a progressive transfer of load to the solid phase [63]. While the 
Young’s modulus is a measure of stiffness of both, the solid and fluid phase, the 
equilibrium modulus captures the stiffness of the solid components. We determined 
equilibrium moduli of 45.0±8 kPa for GelMA-Alg, 3.2±1 kPa for Alg, and 17.9±4 
kPa for GelMA gels, corresponding to approximate reductions of 53 %, 90 %, and 
3.5 %, respectively, compared to previously discussed Young’s moduli. The large 
difference of Young’s and equilibrium moduli in Alg gels illustrates the non-covalent 
nature of ionic bonds which give raise to strong yielding behaviour under prolonged 
compression. In contrast, the decrease for GelMA was minor, suggesting a cohesive 
and elastic network structure, while GelMA-Alg gels displayed intermediate 
behaviour. The storage and loss modulus are a measure of the elastic and viscous 
proportions, respectively, while the loss factor is the ratio of storage to loss modulus 
and hence is indicative of the viscoelasticity [379]. At dynamic compressive strains 
of 2 %, all gel types displayed mainly elastic responses as suggested by the low loss 
factors of approximately 0.04. In comparison, the equilibrium modulus and loss 
factors of human articular cartilage determined in similar tests are approximately one 
order of magnitude and 3-fold higher, respectively [379], suggesting more viscous 
behaviour and a higher stiffness of the solid matrix components of articular cartilage.   
 
 Double- and single network hydrogels as scaffolds for functional cartilage 5.3.2
tissue engineering 
Chondrocyte viability, proliferation and morphology 
Human articular chondrocytes were encapsulated in DN and SN gels and 
cultured for up to 28 days with and without 14 days of intermittent mechanical 
stimulation to assess the suitability of DN and SN hydrogel as cell-laden scaffolds 
for cartilage tissue engineering. Initial cell viability after construct preparation was 
high in all construct types (~76 – 88 %), but approximately 10 % lower in GelMA-
Alg compared to parent SN gels (Figure 5.4G), potentially due to elevated shear 
stresses on cells during mixing, stemming from the increased viscosity of the 
GelMA-Alg precursor solution (Figure 5.8D). Nevertheless, chondrocytes 
proliferated significantly in GelMA and GelMA-Alg over the time of culture, 
increasing the total cell number by 2- to 3-fold, and elevating the percentage of 
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viable cells in GelMA-Alg to levels of SN gels (Figure 5.4H). Remarkably, although 
GelMA-Alg had the lowest amounts of viable cells at early time-points, the average 
DNA content was the highest in these constructs after 28 days; however, the 
differences to GelMA were not statistically significant. There was also a trend 
towards higher DNA content in mechanically stimulated GelMA-Alg and GelMA 
constructs compared to unstimulated controls, but not in Alg (Figure 5.4H). While 
alginate is bioinert and lacks cell-adhesive moieties [380], GelMA retains cell 
attachment sites of natural collagens [164]. Hence, mechanical loading may cause 
changes in cytoskeletal tension through binding of cell-surface receptors to GelMA, 
in turn leading to increased proliferation via mechanotransduction [351-353].  
Chondrocytes are highly differentiated cells and the rounded cell morphology 
in native cartilage is intrinsically linked to the cell phenotype [165, 381]. When 
grown on tissue culture plastics coated with ECM molecules, subpopulations of 
rounded and spread cells become evident [381]. While round cells express collagen 
II, spreading cells de-differentiate and produce mainly collagen I [381] which is 
associated with the mechanically inferior fibrocartilage. We hence investigated cell 
morphologies using immunofluorescence staining of the cell-surface glycoprotein 
CD44 (Figure 5.4I-K). Similar to our previously published results [161], 
chondrocytes in GelMA SN gels acquired a highly spread, fibroblast-like 
morphology indicative of de-differentiated cells (Figure 5.4K). Cells in Alg, on the 
other hand, appeared mainly rounded as single cells or small clusters (Figure 5.4J). 
When both materials were combined to form GelMA-Alg DN gels, subpopulations 
of mainly rounded and, to a lesser extent, spreading cells were observed (Fig 4-4I 
and Supplementary Fig. S5.5B). Interestingly, cells appeared in clusters filling voids 
within GelMA-Alg. As single cells were observed on day 2 (Figure 5.4A, insert) and 
no polarised (migratory) cell morphologies [382] were observed in the interterritorial 
matrix at day 28 (Figure 5.4I), it is likely that clusters originated from monoclonal 
proliferation. Spreading cells in GelMA appeared to be distributed throughout the 
matrix. This observation together with the increase in DNA content (Figure 5.3H) 
suggests that cell proliferation, as well as migration occurred in the enzymatically 
degradable [383] GelMA-matrix. As previously reported [161, 162], a subpopulation 
of cells in GelMA-containing hydrogels adhere to the surface of the gel construct and 
acquire a highly spread, de-differentiated cell phenotype (Supplementary Fig. S5.5B) 
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similar to the chondrocytes cultured on tissue culture plastics [384]. As a result, 
strong immunoreactivity for collagen I was observed at the surface of constructs 
(Supplementary Fig. S5.5A). The correlation of cell morphology and phenotype 
becomes even more apparent when accumulation of collagen I and II in GelMA-Alg, 
Alg, and GelMA is compared (Supplementary Fig. S4.5A): In Alg, cells were 
rounded and produced mainly collagen II which accumulated in the pericellular 
regions, whereas cells in GelMA were partially de-differentiated and secreted high 
proportions of collagen I. However, GelMA supported the accumulation of 
substantial amounts of newly formed matrix, while alginate did not. The combination 
of both materials led to mainly rounded cell morphologies and strong 
immunoreactivity for collagen II, while reactivity for collagen I was minor and 
mainly limited to the construct surfaces.  
 
Figure 5.4: Viability, proliferation and morphology of chondrocytes encapsulated in double- and 
single network hydrogels. Viability of (A-C) statically and (D-F) dynamically cultured (A, D) 
human articular chondrocytes encapsulated in GelMA-Alg, (B, E) Alg, and (C, F) GelMA at day 28 
(inserts show representative images at day 2, scale bars: 100 μm). (G) Quantified viability and (H) 
total DNA content of statically cultured (FS) and dynamically loaded (L) double- and single-network 
hydrogels (n = 3, 6 images each; ## p < 0.01 compared to other gel types at day 2, * p < 0.05 and ** p 
< 0.01 compared to day 2 FS within gel type). (I-K) Morphology of chondrocytes cultured for 28 
days based on immunofluorescent staining of CD44 cell surface marker (scale bars: 50 μm). 
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Physical and biochemical properties 
We next investigated the physical and biochemical properties of in vitro tissue-
engineering construct using DN and SN gels as cell-laden scaffolds. 
Macroscopically, all construct types displayed good shape-retention over 28 days of 
culture (Figure 5.5A). GelMA SN gels, however, exhibited slightly rounded edges 
due to the contraction by fibroblast-like chondrocytes [385]. While the wet weight of 
both GelMA and particularly GelMA-Alg increased over culture time (Figure 5.4B), 
this may originate from different reasons. GelMA-Alg constructs had the highest 
Young’s moduli at day 2 of culture which decreased over culture duration, whereas 
the moduli of GelMA constructs increased over time. This suggests that the effective 
crosslinking density of GelMA-Alg decreased, potentially due to localized enzymatic 
degradation causing to formation of voids within the gel structure (Figure 5.4I), in 
turn leading to higher swelling without an increase in hydrostatic pressure. However, 
to further test this hypothesis, enzymatic activity in GelMA-Alg gels should be 
investigated in future studies, for example by using in situ zymography techniques 
[386]. The increase in GelMA wet weight and Young’s modulus likely also relies on 
higher swelling; however, as the GelMA hydrogel matrix appears to be 
interconnected and homogenous (Supplementary Fig. S5.4D), this may be 
accompanied with an increase in hydrostatic pressure and hence Young’s moduli. 
Loading did not have a significant effect on wet weights or Young’s moduli. It 
should also be noted that all constructs, independent of the composition, were softer 
with the encapsulation of cells likely due to the dilution of the precursor solutions by 
the introduced volume of cells.  
 
 
 
 
 
 
 
Figure 5.5 (next page): Physical and biochemical properties of double- and single network 
hydrogels. (A) Macroscopic appearance of double- and single network hydrogels formed after 28 
days of static chondrogenic differentiation culture. (B) Wet weight and (C) Young’s moduli at 
statically cultured constructs at day 2 (Day 2 FS), day 28 (Day 28 FS), or after intermittent mechanical 
stimulation for 1 hour daily in the last 14 days of culture (30 % compression, 1 mm shear amplitude, 
1Hz) (Day 28 L). (D) Construct-retained glycosaminoglycans (GAGs) normalized to wet weight and 
(E) total DNA content, as well as GAGs secreted to the medium normalised to (F) construct wet 
weight and (G) total DNA content. * p < 0.05, ** p < 0.01, *** p < 0.001 between free swelling and 
loaded constructs within gel type; gel types sharing the same Roman numeral are statistically similar, 
while gel types with different numerals are significantly different (p < 0.01; the effect of gel type was 
compared within each culture condition as indicated by capital, lower-case, and lower-case italic 
numerals). 
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 The compressive mechanical properties of articular cartilage primarily rely on 
fluid pressurization [387] within the tissue and, by attracting water, GAGs such as 
chondroitin sulfate, keratan sulfate, and hyaluronic acid significantly contribute to 
these characteristics [21]. When normalized to wet weight, the amount of GAGs 
retained in statically cultured GelMA-Alg and Alg were similar, while accumulation 
in GelMA SN gels was lower (Figure 5.5D). Intermittent mechanical loading led to 
accumulation of greater amounts of GAGs within GelMA-Alg (Figure 5.5D), and 
when normalized to DNA content, in both GelMA-Alg and Alg (Figure 5.5E). We 
also measured the amount of GAGs secreted to the culture media to investigate the 
ability of hydrogel matrices to retain newly synthesized polysaccharides. Levels of 
GAGs secreted to the culture media were highest for Alg constructs (Figure 5.5F, D); 
however, the ratio of secreted to retained GAGs was similar between all construct 
types within culture conditions, except for loaded GelMA-Alg and Alg constructs 
which retained higher levels of GAGs. This suggests that total GAG production was 
the highest in Alg constructs, while retention capacities were similar between 
GelMA-Alg and Alg, but lower in GelMA SN constructs. Contrary to our hypothesis, 
GAG secretion to the media was not significantly higher following mechanical 
stimulation, indicating that the retention ability predominantly relies on molecular 
interactions with the ECM and may not be influenced by loading.  
 
Gene expression 
The expression levels of chondrogenic (ACAN, COL2A1, PRG4), de-differentiation 
(COL1A1), and hypertrophy (COL10A1) marker genes, as well as matrix metalloproteinases 
(MMP2, MMP13) at day 28 of culture are presented in Figure 5.6. There was no significant 
effect of mechanical loading on the expression levels of investigated genes; however, a 
comparison of mRNA transcript levels between GelMA-Alg and parent SN gels suggests 
greatest chondrogenesis occurred in Alg gels, while gene expression profiles between 
GelMA-Alg and GelMA were mostly similar. Since subpopulations of cells attached to the 
surfaces of GelMA-Alg and GelMA and de-differentiated similar to monolayer-expanded 
chondrocytes (Supplementary Fig. S5.5B), it seems likely that increased levels of COL1A1 
may predominantly stem from these populations rather than cells embedded within the 
matrices. This hypothesis is further supported by immunofluorescence stainings of collagen I 
and II, as discussed in sections below in more detail. Transcript levels of the hypertrophy 
marker COL10A1 were low in all constructs types, but higher in statically cultured GelMA-
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Alg compared to Alg. Expression in mechanically loaded constructs was similar between all 
groups. There were no differences in the mRNA levels of MMP2 and MMP13, irrespective 
of gel type and culture condition.  
 
 
Figure 5.6: Chondrocyte gene expression in double- and single network hydrogels. Relative 
expression levels of (A) ACAN, (B) COL1A1, (C) COL2A1, (D) COL10A1, (E) MMP2, (F) MMP13, 
and (G) PRG4 in statically cultured (free swelling) and intermittently loaded (loaded) double- and 
single network hydrogels. Expression of each gene was normalized to the geometric mean of 
chondrocyte housekeeping genes TBP and RPL13, and presented on a log2 scale. Mechanically 
stimulated constructs were terminated 2 h after the last loading cycle had finished. Gel types sharing 
the same Roman numeral are statistically similar, while gel types with different numerals are 
significantly different (p < 0.01; the effect of gel type was compared within each culture condition as 
indicated by capital or lower-case numerals, respectively). 
 
  
 Chapter 5: Tough double-network hydrogels for functional cartilage tissue engineeringBibliography 180 
Matrix production and accumulation 
While articular cartilage is primarily composed of water (60-80 % of wet 
weight), the solid fraction mainly consists of collagen II and large amounts of 
proteoglycans such as aggrecan [12]. Collagen I, on the other hand, is a marker of 
fibrocartilage and associated with the de-differentiation of articular chondrocytes 
[384]. GelMA-Alg and GelMA constructs supported the deposition of large amounts 
of newly formed ECM with strong staining intensities diminishing gradually from 
pericellular to in inter-territorial regions, while deposition in Alg was minor and 
limited to intra- and pericellular spaces. Nonetheless, we observed a more hyaline-
like ECM composition in GelMA-Alg compared to GelMA, as evidenced by 
increased collagen II/collagen I ratios (Supplementary Fig. S5.5C). Similarly, high 
levels of aggrecan were observed in both GelMA-Alg and GelMA. Intermittent 
mechanical stimulation significantly enhanced collagen II deposition in all gel types, 
but particularly in GelMA-Alg DN constructs. Staining intensities for collagen I, on 
the other hand, decreased with loading in GelMA-Alg, while intensities increased in 
GelMA. In contrast, Aggrecan intensities increased with mechanical stimulation in 
GelMA-Alg, but decreased in GelMA. These observations suggest that mechanical 
loading did not directly influence the phenotype or differentiation status of embedded 
chondrocytes, but rather reinforced the phenotype instructed by cell-ECM 
interactions in the different construct types.  
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Figure 5.7: Immunofluorescence analysis of extracellular matrix production. Extracellular matrix 
production after 4 weeks of static culture (free swelling) or 2 weeks of static pre-culture followed by 2 
weeks of intermittent mechanical stimulation (loaded) for 1 hour daily (30 % compression, 1 mm 
shear amplitude, 1Hz). Immunofluorescence staining for (A) collagen II (green), (B) collagen I (red), 
and (C) aggrecan (green). Nuclei were stained with DAPI (blue). Integrated fluorescence intensities of 
(D) collagen II, (E) collagen I, and (F) aggrecan were normalised to DAPI intensities to correct for 
variations in cell numbers. * p < 0.05, ** p < 0.01, *** p < 0.001 between free swelling and loaded 
constructs within gel type; gel types sharing the same Roman numeral are statistically similar, while 
gel types with different numerals are significantly different (p < 0.01; the effect of gel type was 
compared within culture condition as indicated by capital and lower-case numerals, respectively).  
 
Rheological characterization and bioprinting 
Advanced manufacturing techniques such as bioprinting allow for the 
fabrication of complex and anatomically-shaped tissue engineering constructs with 
clinical relevance. To be printable with high shape fidelity, hydrogel precursor 
solutions (also referred to as “bioinks” when printed) must exhibit high viscosity and 
shear thinning behaviour [215]. Shear thinning is defined as the non-Newtonian 
behaviour in which the viscosity decreases as a function of increasing shear rate and 
primarily relies on the molecular reorganization of hydrogel macromers to a more 
untangled and stretched conformation when shear stress is applied [215]. We 
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observed strong shear thinning behaviour for GelMA-Alg and GelMA hydrogel 
precursors at 25 °C, but not for Alg precursors (Figure 5.8A-C). Appreciable shear 
thinning was not observed at 37 °C, indicating that the partial formation of entangled 
coil/helix structures of GelMA macromeres associated with its sol-gel transition 
[302] (Figure 5.1A) was necessary to obtain this behaviour. Supporting the 
hypothesis of complex coacervation of GelMA and alginate, the viscosity of GelMA-
Alg precursors at 37 °C was approximately two orders of magnitude higher than 
measured values for GelMA alone (Figure 5.8D). Furthermore, the increase in 
viscosity following sol-gel transition upon cooling was substantially higher for 
GelMA compared to GelMA-Alg (Figure 5.8D), suggesting that the molecular 
interaction of oppositely charged GelMA and alginate in the complex coacervate 
system may have partially impeded the formation of entangled GelMA structures. 
GelMA-Alg and GelMA-Alg/GelMA-hybrids were successfully printed into porous 
structures with high shape fidelity in preliminary experiments (Figure 5.8E), 
suggesting their suitability for use as bioinks in advanced functional tissue 
engineering applications. 
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Figure 5.8: Rheological characterization of double- and single-network hydrogel precursor 
solutions and bioprinting of GelMA-Alg. Viscosity of (A) GelMA-Alg, (B) Alg, and (C) GelMA at 
25 °C (orange) and 37 °C (grey) as a function of shear rate. (D) Viscosity of GelMA-Alg (grey), Alg 
(orange), and GelMA (blue) as a function of temperature. (E)  Preliminary bioprinting of GelMA-Alg 
and GelMA-Alg/GelMA-hybrid gels. 
 
5.4 CONCLUSION 
Here, we developed mechanically tough micro-structured DN hydrogels based 
on inexpensive, bio- and cytocompatible, and enzymatically degradable biopolymers, 
which can be fabricated in a simple and time-effective one-pot procedure and allow 
for cell encapsulation with high cell viabilities. DN hydrogels displayed superior 
mechanical properties, recoverable energy dissipation, shape recovery, and withstood 
large magnitudes of compression without failure. Additionally, bioactive DN gels 
induced chondrogenic re-differentiation of monolayer-expanded human articular 
chondrocytes and supported the synthesis and accumulation of high quantities of 
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hyaline cartilage-like ECM and GAGs which was further enhanced by application of 
intermittent biomimetic mechanical loading. Hydrogel precursor solutions displayed 
shear-thinning behaviour and could be 3D printed into complex shapes, allowing for 
advanced manufacturing techniques.  
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6.1 SUMMARY OF FINDINGS 
Our understanding of numerous biological processes stems from experiments 
in which cells were grown on stiff two-dimensional surfaces such as glass or 
polystyrene. Cells cultured in these environments, however, often display 
unphysiological behaviours such as flattened cell morphologies, abnormal 
polarization, de-differentiation, and even altered response to pharmaceutical reagents 
[167]. Cells in native tissues, on the other hand, are embedded within an ECM 
comprised of proteinous networks with filamentous [388] or sheet-like organisation 
[389]. The mechanical, biological, or structural cues provided by the interaction of 
cells and their ECM drastically influence the cellular phenotype and regulate 
processes including motility, proliferation, differentiation, and mechanotransduction 
[344, 390]. This is particularly important for articular cartilage since the interaction 
of chondrocytes with their surroundings is almost exclusively limited to cell-ECM 
interactions which act as a transducer of mechanical signals necessary for tissue 
maintenance. Hence, novel culture systems capable of replicating key aspects of the 
ECM and biomechanical environment of articular cartilage are needed to bridge the 
gap between traditional cell culture platforms and the native environments cells 
experience in vivo. The development of hydrogels and bioreactors for these purposes 
is an active field of cartilage research, and also the topic of this thesis. The central 
aims of this work were to develop and apply hydrogel culture systems and 
mechanical stimulation bioreactors to identify factors which may improve the 
outcome of functional cartilage tissue engineering applications.  
In Chapter 2, a bilayered hydrogel system permitting control over the surface 
frictional properties without affecting other bulk physicochemical hydrogel 
characteristics was developed and characterised. Negative charge facilitated by SSA 
was covalently incorporated into the PEG-based surface hydrogel layer which led to 
a decrease in surface friction with increasing concentrations of SSA. When sliding 
shear motion replicating the movement of two articulating cartilage surfaces against 
each other was applied to hydrogel constructs, the magnitude of shear deformation 
was highly dependent on the surface frictional properties. Mechanistically, all 
constructs showed a similar behaviour in response to sliding shear motion: first, the 
loading platen adhered to the surface of the hydrogels and its displacement caused 
shear deformation in the hydrogel constructs until the gels began slipping with a 
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steady-state peak shear strain. The magnitude of this peak shear strain correlated with 
the surface friction of the hydrogel. When chondrocytes were embedded in the bulk 
hydrogel layer formed of ALMA and intermittent shear loading was applied, their 
metabolic response was highly dependent on the surface frictional properties and 
hence the shear strain magnitude the constructs underwent during loading. 
Intermittent shear stimulation of low friction constructs significantly improved 
chondrogenesis compared to unstimulated controls, while stimulation of constructs 
with high surface friction caused inhibition of chondrogenesis and enhanced 
transcription of key proteases involved in cartilage pathology. These findings 
demonstrate that the frictional properties of tissue-engineered cartilage may 
significantly govern cellular response to mechanical loading, emphasizing the 
importance of low surface friction as a key factor for functional tissue engineering of 
articular cartilage.  
The biomaterial used for chondrocyte culture in Chapter 2 was ALMA, a 
photocrosslinkable derivative of the bioinert polysaccharide alginate. Although 
ALMA hydrogels are cytocompatible and support a chondrogenic phenotype, the low 
mechanical properties and limited ECM molecule accumulation pose significant 
limitations for functional tissue engineering applications. To overcome these 
limitations, biomaterials with cell-guiding bioactivity and capacity to accumulate 
hyaline-like ECM are needed. Chapter 3 comprises a protocol for the synthesis and 
application of GelMA hydrogels as 3D cell culture platforms with various 
applications ranging from in vitro tissue models, microfluidic lab-on-a-chip systems, 
as well as tissue engineering of functional vascular networks and articular cartilage. 
The unfunctionalised base material, gelatin, is produced by the partial hydrolysis of 
collagens and thus retains attributes of native ECMs including amino acid motifs 
facilitating cell attachment and proteolytic degradation. Functionalisation of primary 
amines and, to a lesser extent, primary hydroxyls with methacryloyl groups allows 
for the formation of thermally stable hydrogels by photo-initiated radical 
polymerization with precise control over physicochemical properties such as 
hydrogel stiffness and porosity. The addition of small amounts of HAMA to GelMA-
based hydrogels improved chondrogenic differentiation of monolayer-expanded 
chondrocytes and supported the accumulation of GAGs and cartilaginous ECM with 
hyaline-like composition, in turn leading to a an increase in mechanical properties 
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over culture time [161]. The bioactive properties inherent to gelatin render GelMA as 
a promising biomaterial for cartilage tissue engineering applications, and hence this 
material was chosen for the investigations performed in Chapter 4 and Chapter 5. 
The bioreactor used in Chapter 2 is capable of applying uniaxial shear 
stimulation to cell/hydrogel constructs. Cartilage in a native joint, however, is 
exposed to more complex mechanical stimuli arising from a normal gait cycle, most 
importantly compression and shear. Hence, in Chapter 4 of this thesis, a novel 
biaxial mechanical stimulation bioreactor system was developed, manufactured, and 
characterised. The custom-made system is capable of applying precise displacement-
controlled compressive and shear stimulation to better mimic the biomechanics of 
articulating joints while a miniature load cell provides force feedback and allows for 
monitoring of tissue maturation. A user-friendly LabView software was developed 
for the control of the actuators and load cell, as well as the acquisition of 
force/displacement data. Both uni- and biaxial loading of chondrocyte-laden GelMA-
HAMA constructs facilitated by the bioreactor system led to upregulation of 
chondrogenic marker genes following 1 hour of loading. Accumulation of cartilage-
specific ECM was significantly increased when intermittent biaxial loading was 
applied to cell/hydrogel constructs in a long-term experiment, suggesting the 
bioreactor’s usefulness for functional tissue engineering and research related to 
cartilage mechanobiology.  
The GelMA-HAMA hydrogels used in Chapter 4 support the accumulation of 
significant amounts of hyaline-like ECM, but their brittleness [162] limits the 
mechanical functionality of the engineered neotissues. Aiming to overcome the 
mechanical limitations of this system, Chapter 5 focused on the development of 
tough double-network hydrogels for functional cartilage tissue engineering. These 
hydrogels comprised of interpenetrating networks of covalently crosslinked GelMA 
and ionically crosslinked alginate exhibited significantly improved mechanical 
durability and recoverable energy dissipation, were cyto- and biocompatible, and 
supported the accumulation of hyaline-like ECM and GAGs which was further 
increased when intermittent biaxial loading was applied. Mechanistically, the 
improved mechanical toughness likely relies on the synergistic interaction of the 
elastic GelMA network and the efficient energy dissipation facilitated by the 
reversible release of divalent cations from alginate network. Furthermore, gel 
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precursor solutions exhibited strong shear-thinning behaviour, allowing for advanced 
biofabrication of complex-shaped constructs by 3D bioprinting. Taken together, 
these findings demonstrate that the concept of DN hydrogels, which was originally 
developed for synthetic hydrogel materials, can be applied to biomaterials suitable 
for chondrocyte culture and functional tissue engineering, resulting in cartilage 
neotissue formation with increased mechanical toughness.  
 
6.2 FUNCTIONAL CARTILAGE TISSUE ENGINEERING 
In cartilage tissue engineering, hydrogels are often used as both model systems 
and biomaterials for clinical application. Yet, despite major advances in the field, the 
generation of cartilage neotissues with mechanical functionality remains challenging. 
In order to address these limitations, research efforts have been focusing on the 
development of mechanically resilient hydrogels and hydrogel hybrids as scaffolds 
for cartilage regeneration. In this section, some of the key factors influencing 
chondrocyte differentiation, ECM production, and the mechanical functionality of 
hydrogels and neo-engineered cartilage tissues are discussed.  
 
 Hydrogel composition and structure 6.2.1
The molecular composition and physicochemical properties of hydrogel 
materials play a key role in guiding chondrocyte differentiation and matrix synthesis 
[107]. In this thesis, four different hydrogel compositions were trialled for their 
potential to induce chondrogenesis of monolayer-expanded chondrocytes with 
varying degrees of success. ALMA and alginate as used in Chapters 2 and 5 
respectively, successfully promoted chondrogenic redifferentiation of monolayer-
expanded chondrocytes and generally induced the highest COL2A1/COL1A1 gene 
expression ratios (Figure 5.6), but, similar to our previously published work using 
alginate [60], accumulation of cartilaginous ECM appeared minor and mainly limited 
to pericellular regions (Figure 5.7). When cultured in 10 % GelMA hydrogels 
(Chapter 5), chondrocytes displayed de-differentiated cell morphologies and 
produced substantial amounts of ECM rich in aggrecan and both collagen type I and 
II, indicative of fibrocartilage production. However, chondrogenic differentiation 
was improved with the addition of 2 % alginate to form GelMA-Alg DN gels, 
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leading to accumulation of ECM with more hyaline-like composition compared to 
GelMA alone. Chondrogenesis was also promoted in hydrogels composed of 9.5 % 
GelMA and 0.5 % HAMA (Chapter 4), leading to synthesis and accumulation of 
large amounts of ECM with hyaline-like composition and only minimal reactivity for 
collagen I within the tissue constructs, further confirming the results obtained by 
Levett et al. [161]. While not investigated in detail in this thesis, it is likely that the 
observed differences in chondrocyte differentiation predominantly stem from 
variations in cell-biopolymer interactions. Chondrocytes express a variety of 
integrins including α1β1 specifically binding to collagen types VI and II, as well as 
α5β1 and αVβ3 binding to RGD (Arg-Gly-Asp) sequences which are present in 
many ECM proteins [391]. Integrin binding of ECM proteins results in the activation 
of intracellular signalling networks including several tyrosine and serine kinases 
which can affect gene expression and regulate chondrocyte differentiation in vitro 
[391]. However, besides evidence suggesting an involvement in chondrocyte 
mechanotransduction, the function of integrins in native cartilage is still poorly 
understood [391, 392]. Chondrocytes in pure GelMA exhibit highly stretched cell 
morphologies and actin stress fibres consistent with binding of integrins in focal 
adhesion complexes to the RGD sequences of GelMA [239]. Similar to chondrocytes 
cultured on tissue culture plastic coated with RGD-containing ECM proteins [381], 
binding of certain integrins may be thus associated with chondrocyte 
dedifferentiation in GelMA hydrogels. This is further supported by the rounded 
chondrocyte morphologies and enhanced chondrogenic differentiation observed in 
hydrogel materials which do not directly allow integrin binding such as alginate and 
ALMA, or pure HAMA [239]. However, it has to be kept in mind that chondrocytes 
in alginate cultures quickly accumulate a pericellular matrix rich in collagen VI 
which may facilitate integrin binding and mechanotransduction [60]. Chondrocytes 
also exhibited similarly rounded morphologies in hydrogels composed of 9.5 % 
GelMA and 0.5 % HAMA, suggesting that the presence of HAMA, even in such 
small concentrations, inhibits direct integrin binding to GelMA and promotes a 
chondrogenic phenotype. Interestingly, chondrocytes in both alginate [60] and 
GelMA-HAMA only responded favourably to mechanical loading when constructs 
were precultured statically for 14 days, suggesting that the presence of a newly 
synthesized PCM is a requirement for anabolic mechanotransduction, potentially 
facilitated by integrin binding. However, the involvement of integrins in this model 
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should be investigated in future studies using, for example, integrin blocking 
antibodies. 
 
 Mechanical properties 6.2.2
Cartilage must withstand forces of multiple times our body weight for millions 
of loading cycles throughout life. Yet, conventional hydrogels used for cartilage 
tissue engineering, although very promising from a biological perspective, are 
generally soft and brittle materials unable to resist such forces without failure. 
Furthermore, like cartilage, damage to hydrogels is not easily repaired. Given that the 
ultimate aim of tissue engineering approaches is to restore the mechanical function of 
the damaged or diseased tissue, surprisingly little research focuses on the mechanical 
characteristics of neotissues as a measure of successful tissue (re-)generation. This is 
particularly true for the ultimate strength of hydrogels and hydrogel-based tissue 
constructs which are frequently not considered adequately. Instead, the production 
and accumulation of cartilage ECM proteins and GAGs is commonly used as a 
benchmark for cartilage tissue engineering. While this is, of course, an important 
aspect which should equally be considered, ultimately it is the mechanical properties 
which govern the function of tissue-engineered cartilage upon implantation into 
cartilage defects. In an effort to increase awareness among researchers working in the 
field of cartilage tissue engineering, Butler et al. first proposed novel guidelines for 
tissue engineering in the year 2000, emphasizing the importance of a functional, and 
hence mechanical, assessment of tissue quality [179]. Since then, several research 
groups have adopted some of these guidelines and developed novel scaffolds and 
culturing techniques aiming to improve the functionality of cartilage neotissues. One 
such example is the woven scaffold/hydrogel composite developed by the Guilak 
group [393], which was shown to approach the mechanical properties of articular 
cartilage.  
The mechanical properties of hydrogels and tissue-engineered constructs have 
been investigated in some detail in this thesis. It was found that the stiffness of 
constructs based on 9.5 % GelMA and 0.5 % HAMA increased over culture duration; 
however, contrary to the hypothesis, mechanical loading did not enhance construct 
stiffness compared to unstimulated controls. This may be explained by the lack of 
increase in GAG levels, which are predominantly attributed to the compressive 
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stiffness of cartilage tissue, following mechanical stimulation. The ultimate strength 
of GelMA-HAMA constructs statically cultured for 63 days has been characterised 
previously [162]. The results of this study suggested construct failure at compressive 
strains of approximately 35 %, reaching failure stress values of approximately 60 kPa 
[162]. In comparison, human cartilage explants tested in a similar manner resisted 
compression to approximately 75 % strain and 15-25 MPa stress, and cell-free 
single-component GelMA hydrogels with a lower crosslinking density resisted 
compression to almost 90 % strain and 1.5 MPa (Chapter 5). Hence, although 
chondrocyte culture in GelMA-HAMA hydrogels induces a chondrogenic phenotype 
and allows for the accumulation of large amounts of ECM with hyaline-like 
composition, strategies to enhance the mechanical functionality need to be explored 
further. Recently, reinforcement of hydrogels with high-porosity PCL microfiber 
meshes produced by melt-electrospinning writing was trialled in order to generate 
cartilaginous tissues with better mechanical functionality [163]. In this study, 
reinforcement of 10 % GelMA led to an increase in stiffness of up to 54-fold over 
GelMA hydrogels and PCL meshes alone, reaching values of approximately 400 kPa 
[163]. Despite this synergistic increase in stiffness, reinforced hydrogels did not 
recover from compressive strains over 35 % without failure [163]. In contrast, the 
DN gels developed in Chapter 5 of this thesis resisted and recovered from 
compression to 85 % strain; however, the Young’s moduli of these constructs were 
approximately 4-fold lower (approximately 100 kPa) compared to fibre-reinforced 
hydrogels [163] and further decreased over the duration of chondrogenic 
differentiation culture. This reason for the observed decrease in mechanical 
properties is currently unknown and warrants further investigation.  
Previously, Shin et al. [197] investigated DN gels prepared by the classic two-
step method involving formation of a first hydrogel network of gellan-methacrylate 
and swelling in a solution of GelMA monomers for 2 days, followed by crosslinking 
to form the second network. DN gels formed of 0.5 % gellan-methacrylate and 20 % 
GelMA had a swollen polymer content of approximately 15 % and displayed similar 
mechanical improvements over SN gels as reported using GelMA and alginate 
hydrogels in Chapter 5. In particular, DN hydrogels reached compressive failure 
strains of up to 80 % and stresses of nearly 7 MPa, depending on their molecular 
composition. Since both macromolecules, gellan-methacrylate and GelMA, are 
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crosslinked covalently, mechanical loading is likely to cause partial failure of at least 
one of the hydrogel networks, in turn leading to decrease in stiffness. This concept, 
known as sacrificial bonds, has originally been described for synthetic DN hydrogels 
in which the first brittle hydrogel network breaks into small clusters to dissipate 
mechanical energy, while the second ductile network facilitates the gels ability to 
deform extensively [394]. In such systems, the fragmentation of the first network is 
accumulative and irreversible, leading to a drop in mechanical toughness [394]. In 
contrast, DN gels based on GelMA and alginate efficiently dissipate mechanical 
energy into the reversible unzipping of the alginate network rather than breakage of 
covalent bonds. Furthermore, the use of multiple crosslinking modalities in this 
system allows for a much more rapid formation of DN gels in a one-pot reaction. 
 
6.3 REGULATION AND CLINICAL STATUS OF CELL-BASED CARTILAGE 
REPAIR 
Cartilage damage resulting from trauma frequently results in gradual tissue 
degeneration and the development of OA. Currently, the only surgical intervention 
for end-stage OA remains total knee arthroplasty. To avoid the complexities of such 
secondary degenerative joint pathologies, most surgical therapies target symptomatic 
cartilage lesions early after the injury occurred. Yet, as outlined in section 1.3., these 
techniques are not long-term solutions, prompting the development of tissue 
engineering strategies to restore the function of articular cartilage. For the past 
decades, cartilage tissue engineering techniques have been at the forefront of 
translational medical research, however, with mixed success. The rapid advance of 
tissue regeneration therapies has, to some extent, outpaced the development of 
regulatory structures serving to administer it. In this constantly evolving field, the 
costs and regulatory challenges for novel tissue engineering therapies are difficult to 
overcome and have been the downfall for many ventures which were subject to 
acquisitions or merging, or have ceased to exist entirely [395]. The clinical 
translation of two-stage cellular cartilage therapies is particularly challenging since it 
requires costly ex vivo cell culture under Good Manufacturing Practice (GMP) 
conditions and the delivery to the patients is complex and may require a two-step 
surgical procedure. Nevertheless, as summarized in Table 6.1, a number of cell-based 
cartilage therapies are available commercially or are currently in clinical trials.  
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The USA Food and Drugs Administration (FDA) regulatory pathways for 
cartilage repair technologies differ depending on whether the therapy is classified as 
a drug, medical device, or biologic product. In some cases, cartilage tissue 
engineering products may also be composed of multiple components that require 
independent FDA review, for example constructs of cells and scaffolds or hydrogels. 
Autologous cellular products represent the largest fraction of clinical trials related to 
cartilage defect repair [395]. The majority of autologous cellular products utilize 
cells which are derived from a tissue or blood biopsy and propagated in the 
laboratory before re-implantation with or without a scaffold, while others aim to 
create more mature cartilage constructs through extended ex vivo 3D tissue culture 
[396]. Regulation and approval of such products is overseen by the Center for 
Biologics Evaluation and Research (CBER) and requires phased clinical trials with 
dose-ranging (phase I), small-scale safety and efficacy testing (phase II), followed by 
large-scale randomised safety and efficacy studies (phase III). To gain marketing 
approval, a Biologics Licensing Application (BLA) must be submitted to CBER 
following the completion of phase III clinical trials. The first approved autologous 
cellular cartilage repair product, Carticel® (Genzyme) entered the US market in 1997 
and remains to be the only FDA-approved cell therapy for cartilage regeneration in 
the USA [397], suggesting the difficulty and expense of the FDA approval process.  
In Europe, commercialisation of regenerative medicine therapies involving 
cultured cells or tissues requires European Medicines Agency (EMA) approval under 
the Advanced Therapy Medicinal Products (ATMP) scheme. The regulatory 
pathways for ATMP approval involve rigorous evaluation and clinical trials which 
typically take many years to complete, while the approval process for accellular 
therapies categorized as medical devices only requires CE marking which is far less 
stringent. All cartilage therapies approved before the introduction of ATMPs in 2007 
were required to undergo re-assessment under the newly introduced guidelines. The 
first product approved under the new legal framework in 2009 was ChondroCelect® 
(TiGenix NV), an ACI therapy intended to repair single symptomatic cartilage 
defects of the femoral condyles of the knee. However, in June 2016, the marketing 
authorization holder TiGenix requested a withdrawal of ChondroCelect® by the 30th 
of November 2016 due to commercial reasons. MACI (originally developed by 
Genzyme), a third generation ACI product originally approved in some European 
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countries in 1998 before the introduction of the new legal framework for advanced 
therapies, became the second ATMP approved therapy available in the European 
Union in 2013 following a re-assessment period. However, after the acquisition of 
marketing rights by Aastrom in 2014, manufacturing of MACI in Denmark is 
scheduled to be discontinued temporarily in late 2016 until production in the U.S. 
becomes available.  
The tissue engineering strategies in clinical products differ concerning cell 
source and passage number, construct formation with or without a scaffold, and 
whether the construct is pre-cultured in vitro with or without application of external 
stimuli such as hypoxia or mechanical loading before implantation. Most autologous 
cellular products on the market or in clinical trials involve a chondrocyte expansion 
stage, while of the reviewed products (Table 6.1) only CaReS® uses primary 
chondrocytes. Since chondrocyte de-differentiate increasingly during expansion 
[398], it is generally desired to minimise the population doublings. Information 
concerning the maximal population doublings used for most of the cell-based 
therapies listed in Table 6.1 are limited; however, Cartipatch®, Hyalograft® C, and 
MACI use chondrocytes up to passage 3, while NOVOCART®_3D uses passage 1 
cells [399]. Chondrocytes for these purposes are generally propagated in DMEM or 
Ham’s F-12 media, either serum-free or supplemented with foetal bovine, 
autologous, or allogeneic serum [399]. Once a sufficient cell number is obtained, 
chondrocytes are either directly injected into the defect site (traditional ACI), or 
seeded onto 3D matrices and cultured for 3-35 days before implantation to allow for 
chondrocyte redifferentiation and construct maturation. In some cases such as 
NeoCart®, external biomimetic stimuli in form of hydrostatic pressure, hypoxia, and 
direct perfusion are applied by specialised bioreactors to improve construct 
maturation.  
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  Table 6.1: Cell-based cartilage tissue engineering products 
Product  Description Regulatory status Reference(s) 
BioCart™ II 
(Histogenics) 
Autologous chondrocytes expanded in 
media with autologous serum and 
FGF2 and seeded onto fibrin/HA 
scaffolds 3 – 4 days before 
implantation. 
Phase II clinical trials 
in the USA; 
commercially 
available in Israel 
[400, 401] 
BioSeed®-C 
(Biotissue) 
Expanded autologous chondrocytes 
seeded onto polyglactin/polydiaxanon 
carrier. Fixation in defect with fibrin 
glue. 
Available in some 
European countries 
[160, 402] 
CaReS®-1S    
(Athro Kinetics) 
Primary autologous chondrocytes pre-
cultured in vitro for 10 -13 days in rat 
tail-derived collagen-I hydrogel with 
autologous serum. Fixation in defect 
with fibrin glue. 
Available in some 
European countries, 
Turkey, Iran, and 
China 
[403, 404] 
Carticel® 
(Genzyme) 
Original commercial therapy for 
expanded autologous chondrocyte 
implantation. 
Available in the USA [405] 
Cartipatch®       
(TBF Genie 
Tissulaire) 
Expanded autologous chondrocytes 
encapsulated in an alginate-agarose 
hydrogel. 
Phase III clinical trial 
and product 
development 
terminated. 
[399, 406] 
ChondroCelect® 
(TiGenix) 
Implantation of characterised 
expanded autologous chondrocytes, 
sealed with collagen membrane. 
Available in some 
European countries; 
however, withdrawal 
scheduled for 
30/11/2016 due to 
commercial reasons 
[407] 
Hyalograft® 
(Anika 
Therapeutics) 
Expanded autologous chondrocytes 
seeded onto non-woven HA-based 
mesh (Hyaff 11) scaffold. 14 days in 
vitro preculture before implantation. 
Withdrawn from EU 
market in 2013. 
[396] 
MACI       
(Genzyme) 
Expanded autologous chondrocytes 
seeded onto bilayers collagen I/III 
scaffolds. Fixation in defect with 
fibrin glue. 
Available in some 
European countries; 
however, (temporary) 
withdrawal scheduled 
for late 2016. 
[408] 
NeoCart® 
(Histogenics) 
Expanded autologous chondrocytes 
seeded onto lyophilised bovine 
collagen I scaffold, pre-cultured for 6 
weeks in high-pressure bioreactors 
with perfusion and controlled oxygen 
tension. 
Phase III clinical trial 
in the USA. 
[409-411] 
NOVOCART® 3D 
(TETEC) 
Expanded autologous chondrocytes 
seeded onto bilayered collagen I 
sponge containing chondroitin sulfate 
Phase III clinical trials 
in the USA. Available 
in Europe since 2003 
[412-414] 
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Besides the two-stage therapies listed in Table 6.1, a number of single-stage 
treatments are currently under investigation. Among these, two hydrogel-based 
therapies, GelrinC and ChonDux™, have been applied in clinical cartilage lesion 
repair. The surgical procedure used for these therapies comprises conventional 
microfracture followed by injection of a cell-free hydrogel precursor solution into the 
defect site and photocrosslinking with UV light. GelrinC, developed primarily by 
Professor Dror Seliktar and currently being commercialised by Regentis 
Biomaterials, is a hydrogel based on PEGDA which has been covalently bound to 
denatured fibrinogen [415]. Following microfracture and crosslinking of the 
precursor solution in the defect site, the cell-free hydrogel degrades slowly over 6 – 
12 months while it is being replaced by the repair tissue. The therapy is currently in 
phase I/II clinical trials which demonstrated significant pain relief and functional 
improvements for femoral cartilage defects at 2-year follow-up [416]. ChonDux™ 
has been developed by the research group led by Professor Jennifer Elisseeff and 
comprises a PEGDA-based hydrogel which is injected and photopolymerized in the 
defect site following conventional microfracture surgery. The hydrogel is applied in 
combination with functionalised chondroitin sulfate which acts as high strength 
adhesive facilitating the integration with the surrounding cartilage tissue [417, 418]. 
A pilot clinical study with 15 patients demonstrated good tissue fill of the defect and 
greater pain relief than microfracture alone at 6 month follow-up [418]. However, a 
larger clinical trial in Europe was terminated prematurely for unknown reasons 
[419].  
 
6.4 LIMITATIONS 
The primary aims of this thesis were to progress the fields of cartilage biology 
and tissue engineering using hydrogel-based in vitro models and mechanical 
stimulation bioreactors. While in vitro models allow the investigation of isolated 
factors under controlled and reproducible conditions, they cannot fully replicate the 
complexity and challenges related to cartilage repair in vivo. In more detail, in vitro 
models cannot be effectively used to study, for example, immune response to 
hydrogel materials, integration of tissue-engineered cartilage with the living native 
tissue, or whether a therapy provides long-term pain relief and functional cartilage 
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restoration in a human joint. Hence, although in vitro studies are an essential step 
aiding in the identification and testing of materials and culture techniques for 
potential cartilage repair therapies, they must be complemented with subsequent in 
vivo studies to truly evaluate their suitability for clinical application.  
In this thesis, the effects of various biomaterials and mechanical stimulation 
techniques on chondrogenesis and ECM production of expanded human 
chondrocytes were investigated. Due to the limited availability of chondrocytes from 
healthy human donors, cells were derived from cartilage samples collected from 
patients undergoing total knee arthroplasties for OA. Although chondrocytes were 
strictly isolated from cartilage regions which appeared macroscopically normal or 
only slightly degenerated, it cannot be excluded that the phenotype of these cells 
differed from healthy individuals without incidence of degenerative joint pathology. 
Nevertheless, the results obtained in this thesis demonstrate that chondrocytes 
derived from OA-affected joints can be re-differentiated after in vitro expansion, are 
capable to react to mechanical loading, and synthesize substantial amounts of 
hyaline-like ECM if cultured under suitable conditions with good consistency 
between donors. 
The response of chondrocytes to mechanical loading is dependent on various 
factors including cell-ECM interactions and ECM stiffness, to name a few. The 
results obtained in the bioreactor experiments (Chapter 2, 4, and 5) are hence not 
directly applicable to native human cartilage or other hydrogel system in which these 
factors differ from the culture systems used in this thesis. Additionally, the 
underlying biological phenomena leading to the observed outcomes in Chapters 2, 4, 
and 5, were not investigated in this thesis.  
The photoinitiator used for crosslinking of methacryloyl-substituted 
biomaterials was IC2959. Despite its proven cytocompatibility and extensive use in 
cartilage tissue engineering applications, the molar extinction coefficient of IC2959 
at 356 nm – the wavelength typically used for hydrogel polymerization – is very low 
and trails off almost entirely before 370 nm [420], in turn severely limiting hydrogel 
crosslinking efficiency. The UV exposure required to form hydrogels with a certain 
degree of crosslinking is likely to be substantially higher than exposure at lower 
wavelengths. However, use of lower wavelengths would likely cause increased 
damage to irradiated cells. Recently, visible-light photoinitiator such as lithium 
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phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) have been increasingly applied for 
photopolymerization of  cell-laden hydrogels with very good cytocompatibility and 
short gelation times [421, 422]. Since UV irradiation may lead to the formation of 
reactive oxygen species and subsequent cell damage [423], it is expected that the use 
of LAP and other visible-light photoinitiators in cartilage tissue engineering 
applications will further increase in future.   
 
6.5 FUTURE DIRECTIONS 
Further research is required to advance hydrogels and culture conditions used 
in this thesis towards their application for functional cartilage tissue engineering. 
In Chapter 2, a bilayered hydrogel system with controlled frictional surface 
properties was applied to study the response of human chondrocytes to shear loading. 
Chondrogenesis in low friction constructs which underwent only minor shear strain 
in response to loading was promoted, while it was inhibited in high friction 
constructs. Since shear strains appeared to decrease from the surface to the deeper 
regions, techniques such as fluorescence in situ hybridisation could be used in future 
studies to investigate spatial differences in chondrocyte gene expression throughout 
the depth of the constructs. Such studies would aid in further testing the hypothesis 
that the biological behaviour of chondrocytes in this model is governed by the shear 
strain they experience during loading. Additionally, it would be interesting to 
perform a similar study in which a more physiological loading regime incorporating 
biaxial stimulation facilitated by the bioreactor developed in Chapter 4 is applied to 
hydrogels constructs.  
Chapter 3 comprises a protocol and examples for the application of GelMA-
based hydrogels for 3D cell culture. While this protocol yields a reproducible DoF of 
GelMA, various factors influencing the reaction efficiency remain to be investigated 
in more detail. Future studies should examine the effects of variations in pH, buffer 
composition, reagent concentration, reaction temperature, and reaction time in order 
to further optimize the synthesis of GelMA. Additionally, future studies should 
investigate the usage of LAP as photoinitiator for free radical polymerization of 
GelMA-based hydrogels which is expected to be more efficient and gentle on cells. 
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The bioreactor developed in Chapter 4 is capable of controlling atmospheric 
oxygen tension within the sample chamber using a commercial ProOx110 hypoxia 
system (Biospherix). Hypoxia was shown to enhance chondrogenic differentiation of 
MSCs [424] and chondrocytes [425]. Following these findings, it is reasonable to 
hypothesize that the application of mechanical loading under hypoxic conditions 
further enhances chondrogenic differentiation and maturation of tissue engineered 
cartilage constructs. Hence, the effects of hypoxia on mechanically-stimulated 
chondrocytes should be investigated in future studies. Additionally, future studies 
should aim to further optimise the loading regimes for functional tissue engineering 
applications. While the effects of various shear amplitudes and compressive strains 
on chondrocyte gene expression were investigated, other factors such as loading 
frequency and loading duration remain to be examined in future studies.  
In Chapter 5, a DN hydrogel system based on GelMA and alginate has been 
developed. The results of this study were promising, but some limitations exist which 
should be addressed in future studies. Although DN gels withstood and recovered 
from harsh loading conditions, the compressive stiffness was one order of magnitude 
lower than native human cartilage and decreased with culture duration. To increase 
the stiffness and further tailor the mechanical properties towards the native tissue, 
reinforcement strategies, for example with electrospun PCL microfibres [163], 
should be trialled in future studies. Using this method, hydrogel/PCL composites 
with compressive moduli of approximately 1.5 MPa and viscoelasticity similar to 
cartilage were reported recently [342], rendering this technique promising for 
functional cartilage tissue engineering applications. Another limitation which could 
be addressed in future studies is the incomplete chondrogenic differentiation 
observed in DN hydrogels. Compared to GelMA-HAMA hydrogels cultured under 
similar conditions, reactivity for the fibrocartilage marker collagen I appeared higher. 
Since the addition of small amounts of HAMA to GelMA-based hydrogels was 
previously shown to significantly enhance chondrogenic differentiation, construct 
stiffness, and distribution of newly synthesized ECM [161, 162], it is possible that 
similar effects could also be observed when the compound is copolymerized with 
GelMA in the present DN hydrogel system. Future studies should hence investigate 
if chondrogenic differentiation can be further enhanced with HAMA while retaining 
the mechanical toughness of such hydrogels. To further develop such hydrogels 
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towards clinical cartilage repair, thorough in vivo studies should be performed. These 
studies should aim to identify whether construct preconditioning in mechanical 
stimulation bioreactors improves in vivo outcomes, and how the outcome of such 
therapies compares to microfracture surgery.  
 
6.6 CONCLUSION 
Hydrogels and bioreactors can be engineered to replicate elements of the native 
cartilage microenvironment to study chondrocyte mechanobiology in vitro and 
identify key factors governing the outcomes of functional cartilage tissue engineering 
applications. One such factor is the surface friction of tissue-engineered cartilage 
constructs which was shown to highly influence chondrogenesis and ECM 
accumulation following intermittent mechanical stimulation. Owing to their cell-
instructive bioactivity, GelMA-based hydrogels were identified as versatile 3D 
culture platforms with applications ranging from cancer and angiogenesis models to 
lab-on-a-chip and cartilage tissue engineering studies. Hydrogels formed of GelMA-
HAMA supported the accumulation of large amounts of hyaline-like ECM, which 
was further increased following biaxial mechanical stimulation facilitated by a novel 
shear and compression bioreactor system. Overcoming the mechanical limitations 
posed by the brittleness of conventional hydrogel systems, DN hydrogels based on 
GelMA and alginate were shown to possess superior toughness while supporting 
chondrogenesis, mechanotransduction, and hyaline-like ECM deposition.  
Cartilage tissue engineering is a dynamic and steadily growing field of research 
with scientists world-wide striving to identify ways to improve clinical outcomes of 
cartilage repair. However, despite the wide-reaching advances in the past decade, the 
generation of tissues with native-like biochemical composition and function remains 
challenging. Hydrogels systems prove to be promising biomaterials aiding in 
chondrocyte differentiation and cartilage tissue formation, but the progress of the 
past decades of research remains to be realised in clinical practice. Accordingly, we 
expect the development of new products and culture techniques for clinical cartilage 
repair in the coming years.  
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Supplementary figures  
 
 
Supplementary Figure S2.1: Relative gene expression levels after short-term mechanical 
stimulation. Relative mRNA expression levels of, a) aggrecan, b) collagen type II, c) proteoglycan 4, 
d) collagen type I, and, e) MMP3 of ALMA, PEG-40S, and PEG-80S constructs after 7 days 
preculture and short-term shear stimulation with either 0 mm, 0.15 mm, 0.315 mm, or 1 mm 
amplitude. Gene expression of shear-stimulated constructs (shear) was normalized to static controls 
(static; mean relative expression indicated by broken line). Significant differences between shear 
loading amplitudes are indicated by * (p < 0.05), ** (p < 0.01), or *** (p < 0.001) (n = 3). 
 
 Appendices 232 
 
Supplementary Figure S3.1: Technical drawing and dimensions for the custom-made Teflon 
casting mould. This mould produces hydrogel strips of 50 mm x 4 mm x 2 mm (length x width x 
height), which can be cut into smaller units using a cutting guide. All dimensions are in mm (not to 
scale). 
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Supplementary Figure S3.2: Technical drawing and dimensions for the custom-made Teflon 
cutting guide. This guide can be used to cut hydrogel strips obtained after polymerization in the 
Teflon casting mould into smaller units of 4 mm x 4 mm x 2 mm (length x width x height). All 
dimensions are in mm (not to scale). 
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Supplementary Figure S5.1: Influence of crosslinking parameters on the mechanical properties 
of double-network hydrogels. (A) Young’s moduli, (B) failure stress, (C) failure strain, and (D) wet 
weight of double- and single-network hydrogels formed of 10 % GelMA (DoF: 28±8 %) and 2 % 
alginate (Pronova, UP LVG). GelMA-Alg hydrogels were prepared by either ionic crosslinking 
followed by photopolymerization (Ca2+  UV, red), or photopolymerization followed by ionic 
crosslinking (UV  Ca2+, blue) (n=6).   
 
 
Supplementary Figure S5.2: Mechanical properties of human cartilage. (A) Human articular 
cartilage explants were obtained from macroscopically normal regions of the lateral femoral condyles 
of two donors undergoing total knee arthroplasties for osteoarthritis.  (B) Young’s moduli, (C) failure 
stress, (C) failure strain, and (D) toughness of articular cartilage explants obtained in unconfined 
compression tests (n=7-8). 
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Supplementary Figure S5.3: Complex coacervation of GelMA-Alg hydrogel precursor solutions. 
(A) TEM micrographs of dried GelMA-Alg, Alg, and GelMA precursor solutions indicating presence 
of coacervate droplets in GelMA-Alg solutions. (B) Images illustrating hydrogel precursor solutions. 
GelMA-Alg precursors appear turbid, indicating complex coacervation GelMA and alginate. 
 
Supplementary Figure S5.4: Structure of crosslinked double- and single network hydrogels 
investigated by Eosin Y staining. Microscopic images in (A) and (B) indicate inhomogeneous 
hydrogel structures in GelMA-Alg. Staining of single-network hydrogels are shown in (C) and (D). 
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Supplementary Figure S5.5: Collagen accumulation in double- and single network hydrogels. 
(A) Immunofluorescence staining for collagen II (green) and collagen I (red) of a mechanically 
stimulated GelMA-Alg construct at day 28 illustrating surface immunoreactivity for collagen I. (B) 
Cell morphologies of chondrocytes encapsulated within GelMA-Alg and on the construct surface. Cell 
membranes were stained with CellMask (green) and nuclei were stained with DAPI (blue). (C) Direct 
comparison of collagen II (green) and collagen I (red) accumulation in mechanically stimulated 
double- and single network hydrogels (14 days static pre-culture, 14 days intermittent biaxial loading 
at 30 % compressive strain, 1 mm shear amplitude, 1 Hz, 1 hour daily). In all fluorescence images, 
nuclei were counterstained with DAPI (blue). 
 
 
